benzo[b]fluoranthene - Ontology Report - Rat Genome Database

benzo[b]fluoranthene - Ontology Report - Rat Genome Database

Submit Data | Help | Video Tutorials | News | Publications | Download | REST API | Citing RGD | Contact

Advanced Search (OLGA)

CHEBI ONTOLOGY - ANNOTATIONS

Subscribe to Updates

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:	benzo[b]fluoranthene	go back to main search page
Accession:	CHEBI:34565	browse the term
Definition:	An ortho- and peri-fused polycyclic arene that consists of a benzene ring fused with a acephenanthrylene ring.
Synonyms:	exact_synonym:	benzo[e]acephenanthrylene
	related_synonym:	2,3-Benzfluoranthene; 2,3-Benzofluoranthene; 3,4-Benzfluoranthene; B(b)F; BF; Formula=C20H12; InChI=1S/C20H12/c1-2-7-14-13(6-1)12-19-16-9-4-3-8-15(16)18-11-5-10-17(14)20(18)19/h1-12H; InChIKey=FTOVXSOBNPWTSH-UHFFFAOYSA-N; SMILES=c1ccc-2c(c1)-c1cccc3c4ccccc4cc-2c13
	xref:	CAS:205-99-2; KEGG:C14320
	xref_mesh:	MESH:C006703
	xref:	PMID:18830893; Reaxys:1872553; Wikipedia:Benzo(b)fluoranthene

Loading Annotations...

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

X

List All Objects | CSV Export | Add Objects | Clear

show annotations for term's descendants Sort by:
Rat (1533) Mouse (1653) Human (1562) Chinchilla (0) Bonobo (0) Dog (0) Squirrel (0) Pig (0) Green Monkey (0) Naked Mole-rat (0) All
Genes (1533)

benzo[b]fluoranthene

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

aladin WD repeat nucleoporin

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of AAAS mRNA

NCBI chr 7:135,342,901...135,362,545
Ensembl chr 7:133,464,315...133,483,961

G

aminoadipate-semialdehyde synthase

decreases expression

benzo(b)fluoranthene results in decreased expression of AASS mRNA

NCBI chr 4:52,572,146...52,628,811
Ensembl chr 4:51,606,462...51,663,136

G

apoptosis-associated tyrosine kinase

increases expression

benzo(b)fluoranthene results in increased expression of AATK mRNA

NCBI chr10:105,789,171...105,825,634
Ensembl chr10:105,291,585...105,327,112

G

ATP binding cassette subfamily A member 1

increases expression

benzo(b)fluoranthene results in increased expression of ABCA1 mRNA

NCBI chr 5:72,473,676...72,596,563
Ensembl chr 5:67,681,297...67,801,170

G

ATP binding cassette subfamily A member 7

increases expression

benzo(b)fluoranthene results in increased expression of ABCA7 mRNA

NCBI chr 7:10,342,092...10,362,094
Ensembl chr 7:9,691,449...9,711,425

G

ATP binding cassette subfamily A member 8

increases expression

benzo(b)fluoranthene results in increased expression of ABCA8B mRNA

NCBI chr10:95,416,984...95,490,647
Ensembl chr10:94,917,520...94,990,988

G

ATP binding cassette subfamily B member 1A

increases expression

benzo(b)fluoranthene results in increased expression of ABCB1A mRNA

NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:25,158,362...25,442,709

G

ATP-binding cassette, sub-family B member 1B

increases expression

benzo(b)fluoranthene results in increased expression of ABCB1B mRNA

NCBI chr 4:26,197,706...26,280,156
Ensembl chr 4:25,242,798...25,325,199

G

ATP binding cassette subfamily B member 4

increases expression

benzo(b)fluoranthene results in increased expression of ABCB4 mRNA

NCBI chr 4:26,106,895...26,164,440
Ensembl chr 4:25,151,953...25,209,202

G

ATP binding cassette subfamily C member 5

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of ABCC5 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ABCC5 mRNA

PMID:26377693 PMID:27858113

NCBI chr11:93,975,579...94,071,659
Ensembl chr11:80,473,872...80,567,253

G

ATP binding cassette subfamily G member 2

decreases expression

benzo(b)fluoranthene results in decreased expression of ABCG2 mRNA

NCBI chr 4:89,006,056...89,132,915
Ensembl chr 4:87,745,319...87,802,409

G

ATP binding cassette subfamily G member 4

decreases expression

benzo(b)fluoranthene results in decreased expression of ABCG4 mRNA

NCBI chr 8:53,508,005...53,525,314
Ensembl chr 8:44,611,187...44,626,881

G

abhydrolase domain containing 14b

decreases expression

benzo(b)fluoranthene results in decreased expression of ABHD14B mRNA

NCBI chr 8:107,087,157...107,092,122
Ensembl chr 8:107,088,069...107,092,119

G

ABI family, member 3

increases expression

benzo(b)fluoranthene results in increased expression of ABI3 mRNA

NCBI chr10:81,266,571...81,277,561
Ensembl chr10:80,769,822...80,780,816

G

ABI family member 3 binding protein

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ABI3BP mRNA

NCBI chr11:57,381,282...57,597,989
Ensembl chr11:43,913,043...44,128,929

G

actin-binding LIM protein 1

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of ABLIM1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of ABLIM1 mRNA

PMID:26377693 PMID:27858113

NCBI chr 1:256,083,747...256,372,075
Ensembl chr 1:256,084,297...256,371,969

G

abraxas 2, BRISC complex subunit

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ABRAXAS2 mRNA

NCBI chr 1:197,077,177...197,102,753
Ensembl chr 1:187,647,067...187,672,655

G

acetyl-CoA carboxylase alpha

increases expression

benzo(b)fluoranthene results in increased expression of ACACA mRNA

NCBI chr10:69,511,627...69,773,888
Ensembl chr10:69,014,170...69,276,457

G

ArfGAP with coiled-coil, ankyrin repeat and PH domains 3

increases expression

benzo(b)fluoranthene results in increased expression of ACAP3 mRNA

NCBI chr 5:171,783,382...171,797,709
Ensembl chr 5:166,500,781...166,515,481

G

apoptotic chromatin condensation inducer 1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ACIN1 mRNA

NCBI chr15:32,072,121...32,117,004
Ensembl chr15:28,102,112...28,147,001

G

atypical chemokine receptor 2

increases expression

benzo(b)fluoranthene results in increased expression of ACKR2 mRNA

NCBI chr 8:130,438,703...130,451,106
Ensembl chr 8:121,561,211...121,573,582

G

atypical chemokine receptor 4

decreases expression

benzo(b)fluoranthene results in decreased expression of ACKR4 mRNA

NCBI chr 8:113,595,325...113,599,762
Ensembl chr 8:104,716,067...104,723,617

G

acyl-CoA thioesterase 1

multiple interactions
decreases expression

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ACOT1 mRNA
benzo(b)fluoranthene results in decreased expression of ACOT1 mRNA

PMID:26377693 PMID:27858113

NCBI chr 6:109,367,274...109,375,268
Ensembl chr 6:103,636,041...103,644,163

G

acyl-CoA oxidase-like

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ACOXL mRNA

NCBI chr 3:135,514,340...135,820,291
Ensembl chr 3:115,061,060...115,364,686

G

adenosine deaminase

increases expression

benzo(b)fluoranthene results in increased expression of ADA mRNA

NCBI chr 3:172,818,174...172,842,283
Ensembl chr 3:152,398,747...152,447,088

G

ADAM metallopeptidase domain 15

increases expression

benzo(b)fluoranthene results in increased expression of ADAM15 mRNA

NCBI chr 2:177,052,363...177,062,879
Ensembl chr 2:174,754,633...174,765,113

G

ADAM-like, decysin 1

increases expression

benzo(b)fluoranthene results in increased expression of ADAMDEC1 mRNA

NCBI chr15:47,076,011...47,097,065
Ensembl chr15:42,900,636...42,921,712

G

ADAM metallopeptidase with thrombospondin type 1 motif, 14

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of ADAMTS14 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ADAMTS14 mRNA

PMID:26377693 PMID:27858113

NCBI chr20:29,685,876...29,762,685
Ensembl chr20:29,144,354...29,219,866

G

ADAM metallopeptidase with thrombospondin type 1 motif, 15

decreases expression

benzo(b)fluoranthene results in decreased expression of ADAMTS15 mRNA

NCBI chr 8:37,566,064...37,589,446
Ensembl chr 8:29,307,865...29,331,249

G

ADAM metallopeptidase with thrombospondin type 1 motif, 4

increases expression

benzo(b)fluoranthene results in increased expression of ADAMTS4 mRNA

NCBI chr13:86,203,011...86,212,500
Ensembl chr13:83,670,183...83,680,065

G

ADAMTS-like 2

increases expression

benzo(b)fluoranthene results in increased expression of ADAMTSL2 mRNA

NCBI chr 3:30,795,882...30,832,635
Ensembl chr 3:10,404,626...10,434,554

G

adenylate cyclase 4

increases expression

benzo(b)fluoranthene results in increased expression of ADCY4 mRNA

NCBI chr15:33,236,201...33,252,070
Ensembl chr15:29,266,287...29,282,108

G

adenylate cyclase 5

increases expression

benzo(b)fluoranthene results in increased expression of ADCY5 mRNA

NCBI chr11:78,976,861...79,123,343
Ensembl chr11:65,471,612...65,618,974

G

ADCYAP receptor type I

increases expression

benzo(b)fluoranthene results in increased expression of ADCYAP1R1 mRNA

NCBI chr 4:85,924,171...85,972,973
Ensembl chr 4:84,593,892...84,642,700

G

adducin 3

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of ADD3 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of ADD3 mRNA

PMID:26377693 PMID:27858113

NCBI chr 1:262,152,722...262,260,504
Ensembl chr 1:252,147,386...252,255,124

G

adhesion G protein-coupled receptor A3

increases expression

benzo(b)fluoranthene results in increased expression of ADGRA3 mRNA

NCBI chr14:65,085,418...65,188,949
Ensembl chr14:60,874,715...60,976,332

G

adhesion G protein-coupled receptor E4

decreases expression

benzo(b)fluoranthene results in decreased expression of ADGRE4 mRNA

NCBI chr 9:9,758,106...9,901,908
Ensembl chr 9:9,760,355...9,900,760

G

adhesion G protein-coupled receptor F1

increases expression

benzo(b)fluoranthene results in increased expression of ADGRF1 mRNA

NCBI chr 9:25,158,198...25,210,744
Ensembl chr 9:17,660,930...17,711,704

G

adhesion G protein-coupled receptor F5

increases expression

benzo(b)fluoranthene results in increased expression of ADGRF5 mRNA

NCBI chr 9:25,014,861...25,128,045
Ensembl chr 9:17,520,009...17,623,968

G

adhesion G protein-coupled receptor G3

increases expression

benzo(b)fluoranthene results in increased expression of ADGRG3 mRNA

NCBI chr19:9,972,425...10,001,118
Ensembl chr19:9,972,430...10,001,123

G

adhesion G protein-coupled receptor L1

increases expression

benzo(b)fluoranthene results in increased expression of ADGRL1 mRNA

NCBI chr19:41,107,162...41,148,752
Ensembl chr19:24,204,360...24,244,139

G

adhesion G protein-coupled receptor L2

increases expression

benzo(b)fluoranthene results in increased expression of ADGRL2 mRNA

NCBI chr 2:237,696,055...238,327,141
Ensembl chr 2:237,696,056...238,327,141

G

adhesion G protein-coupled receptor L4

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of ADGRL4 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of ADGRL4 mRNA

PMID:26377693 PMID:27858113

NCBI chr 2:240,354,909...240,457,231
Ensembl chr 2:240,354,941...240,457,225

G

adhesion G protein-coupled receptor V1

decreases expression

benzo(b)fluoranthene results in decreased expression of ADGRV1 mRNA

NCBI chr 2:13,067,149...13,647,407
Ensembl chr 2:11,331,442...11,911,688

G

alcohol dehydrogenase 4 (class II), pi polypeptide

decreases expression

benzo(b)fluoranthene results in decreased expression of ADH4 mRNA

NCBI chr 2:229,622,092...229,640,120
Ensembl chr 2:226,947,466...226,987,591

G

adipogenin

decreases expression

benzo(b)fluoranthene results in decreased expression of ADIG mRNA

NCBI chr 3:147,155,079...147,160,412
Ensembl chr 3:147,154,097...147,160,490
Ensembl chr 3:147,154,097...147,160,490

G

adiponectin, C1Q and collagen domain containing

decreases expression

benzo(b)fluoranthene results in decreased expression of ADIPOQ mRNA

NCBI chr11:91,226,524...91,240,244
Ensembl chr11:77,721,912...77,735,564

G

adrenomedullin

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of ADM mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ADM mRNA

PMID:26377693 PMID:27858113

NCBI chr 1:174,164,178...174,182,372
Ensembl chr 1:164,745,466...164,747,654

G

adenosine A3 receptor

increases expression

benzo(b)fluoranthene results in increased expression of ADORA3 mRNA

NCBI chr 2:196,077,042...196,080,686
Ensembl chr 2:193,388,713...193,392,357

G

adrenoceptor beta 3

increases expression

benzo(b)fluoranthene results in increased expression of ADRB3 mRNA

NCBI chr16:71,544,603...71,547,410
Ensembl chr16:64,841,788...64,844,552

G

apoptosis enhancing nuclease

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of AEN mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of AEN mRNA

PMID:26377693 PMID:27858113

NCBI chr 1:142,224,499...142,233,902
Ensembl chr 1:132,815,142...132,824,523

G

AGBL carboxypeptidase 2

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of AGBL2 mRNA

NCBI chr 3:97,220,654...97,255,905
Ensembl chr 3:76,764,238...76,800,214

G

argonaute RISC catalytic component 2

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of AGO2 mRNA

NCBI chr 7:106,907,209...106,994,124
Ensembl chr 7:105,029,120...105,104,974

G

1-acylglycerol-3-phosphate O-acyltransferase 2

decreases expression

benzo(b)fluoranthene results in decreased expression of AGPAT2 mRNA

NCBI chr 3:29,814,924...29,826,569
Ensembl chr 3:9,416,843...9,428,371

G

adenosylhomocysteinase

decreases expression

benzo(b)fluoranthene results in decreased expression of AHCY mRNA

NCBI chr 3:164,029,338...164,044,562
Ensembl chr 3:143,569,094...143,584,393

G

adenosylhomocysteinase-like 2

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of AHCYL2 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of AHCYL2 mRNA

PMID:26377693 PMID:27858113

NCBI chr 4:59,348,747...59,498,503
Ensembl chr 4:58,381,218...58,531,060

G

AHNAK nucleoprotein

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of AHNAK mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of AHNAK mRNA

PMID:26377693 PMID:27858113

NCBI chr 1:215,311,289...215,400,010
Ensembl chr 1:205,882,273...205,970,926

G

aryl hydrocarbon receptor

multiple interactions
affects response to substance
increases expression
increases response to substance
increases activity

AHR affects the reaction [benzo(b)fluoranthene results in increased activity of [CCNA2 protein binds to CDK2 protein]]; AHR affects the reaction [benzo(b)fluoranthene results in increased expression of CCNA2 protein]; AHR affects the reaction [benzo(b)fluoranthene results in increased expression of CYP1A1 mRNA]; benzo(b)fluoranthene binds to and results in increased activity of AHR protein
AHR affects the susceptibility to benzo(b)fluoranthene
benzo(b)fluoranthene results in increased expression of AHR protein
AHR results in increased susceptibility to benzo(b)fluoranthene
benzo(b)fluoranthene promotes the reaction [AHR protein results in increased expression of CYP1A1 mRNA]
benzo(b)fluoranthene results in increased activity of AHR protein

PMID:11525907 PMID:12117779 PMID:12371477 PMID:12850102 PMID:17141280 More...

NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:52,234,089...52,271,568

G

aryl-hydrocarbon receptor repressor

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of AHRR mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of AHRR mRNA

PMID:26377693 PMID:27858113

NCBI chr 1:30,822,219...30,917,251
Ensembl chr 1:28,993,634...29,088,673

G

allograft inflammatory factor 1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of AIF1 mRNA

NCBI chr20:3,651,435...3,657,341
Ensembl chr20:3,646,777...3,652,668

G

AIF family member 3

increases expression

benzo(b)fluoranthene results in increased expression of AIFM3 mRNA

NCBI chr11:97,009,100...97,030,601
Ensembl chr11:83,504,861...83,521,248

G

adenylate kinase 1

increases expression

benzo(b)fluoranthene results in increased expression of AK1 mRNA

NCBI chr 3:36,310,113...36,320,760
Ensembl chr 3:15,912,485...15,923,041

G

A-kinase anchoring protein 7

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of AKAP7 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of AKAP7 mRNA

PMID:26377693 PMID:27858113

NCBI chr 1:21,906,503...22,168,663
Ensembl chr 1:20,087,373...20,217,797

G

aldo-keto reductase family 1 member B1

multiple interactions

[Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of AKR1B1 mRNA

NCBI chr 4:63,899,222...63,913,315
Ensembl chr 4:62,932,031...62,946,157

G

aldo-keto reductase family 1, member C1

increases expression

benzo(b)fluoranthene results in increased expression of AKR1C1 mRNA

NCBI chr17:70,720,397...70,747,285
Ensembl chr17:65,810,475...65,837,326

G

5'-aminolevulinate synthase 1

decreases expression

benzo(b)fluoranthene results in decreased expression of ALAS1 mRNA

NCBI chr 8:115,755,238...115,768,642
Ensembl chr 8:106,876,514...106,889,917

G

5'-aminolevulinate synthase 2

decreases expression

benzo(b)fluoranthene results in decreased expression of ALAS2 mRNA

NCBI chr X:22,890,650...22,914,046
Ensembl chr X:19,463,171...19,486,519

G

aldehyde dehydrogenase 1 family, member A1

decreases expression

benzo(b)fluoranthene results in decreased expression of ALDH1A1 mRNA

NCBI chr 1:227,426,939...227,579,497
Ensembl chr 1:218,042,127...218,152,961

G

aldolase, fructose-bisphosphate B

multiple interactions

[Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of ALDOB mRNA

NCBI chr 5:68,684,541...68,697,582
Ensembl chr 5:63,889,046...63,902,116

G

alkB homolog 7

decreases expression

benzo(b)fluoranthene results in decreased expression of ALKBH7 mRNA

NCBI chr 9:1,838,886...1,841,044
Ensembl chr 9:1,838,811...1,841,044

G

arachidonate 5-lipoxygenase

increases expression

benzo(b)fluoranthene results in increased expression of ALOX5 mRNA

NCBI chr 4:151,203,948...151,251,126
Ensembl chr 4:149,531,515...149,578,743

G

angiomotin

increases expression

benzo(b)fluoranthene results in increased expression of AMOT mRNA

NCBI chr X:113,778,990...113,837,846
Ensembl chr X:108,984,022...109,041,272

G

anaphase promoting complex subunit 11

increases expression

benzo(b)fluoranthene results in increased expression of ANAPC11 mRNA

NCBI chr10:106,373,610...106,384,633

G

angiopoietin-like 4

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of ANGPTL4 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ANGPTL4 mRNA

PMID:26377693 PMID:27858113

NCBI chr 7:15,252,450...15,259,971
Ensembl chr 7:14,550,311...14,556,519

G

ankyrin 3

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ANK3 mRNA

NCBI chr20:18,601,307...19,224,790
Ensembl chr20:18,602,786...19,086,300

G

ankyrin repeat domain 12

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ANKRD12 mRNA

NCBI chr 9:113,030,127...113,134,816
Ensembl chr 9:105,584,065...105,687,911

G

ankyrin repeat domain 29

decreases expression

benzo(b)fluoranthene results in decreased expression of ANKRD29 mRNA

NCBI chr18:3,436,301...3,494,292
Ensembl chr18:3,436,303...3,494,296

G

ankyrin repeat domain 44

decreases expression

benzo(b)fluoranthene results in decreased expression of ANKRD44 mRNA

NCBI chr 9:56,126,746...56,427,661
Ensembl chr 9:56,126,747...56,427,508

G

ankyrin repeat domain 63

decreases expression

benzo(b)fluoranthene results in decreased expression of ANKRD63 mRNA

NCBI chr 3:105,675,148...105,679,970
Ensembl chr 3:105,663,638...105,682,404

G

anillin, actin binding protein

increases expression

benzo(b)fluoranthene results in increased expression of ANLN mRNA

NCBI chr 8:29,134,222...29,197,513
Ensembl chr 8:20,858,228...20,921,538

G

acidic nuclear phosphoprotein 32 family member A

affects expression

benzo(b)fluoranthene affects the expression of ANP32A mRNA

NCBI chr 8:71,724,578...71,760,922
Ensembl chr 8:62,827,456...62,865,443

G

alanyl aminopeptidase, membrane

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ANPEP mRNA

NCBI chr 1:143,176,645...143,219,447
Ensembl chr 1:133,767,332...133,785,789

G

annexin A7

increases expression

benzo(b)fluoranthene results in increased expression of ANXA7 mRNA

NCBI chr15:3,869,180...3,897,827
Ensembl chr15:3,821,845...3,849,385

G

aldehyde oxidase 1

decreases expression

benzo(b)fluoranthene results in decreased expression of AOX1 mRNA

NCBI chr 9:67,073,831...67,152,980
Ensembl chr 9:59,579,649...59,658,770

G

adaptor related protein complex 4 subunit beta 1

increases expression

benzo(b)fluoranthene results in increased expression of AP4B1 mRNA

NCBI chr 2:194,006,926...194,018,971
Ensembl chr 2:191,318,482...191,330,531

G

APC down-regulated 1

increases expression

benzo(b)fluoranthene results in increased expression of APCDD1 mRNA

NCBI chr18:56,385,398...56,416,065
Ensembl chr18:56,385,264...56,416,070

G

apelin

decreases expression

benzo(b)fluoranthene results in decreased expression of APLN mRNA

NCBI chr X:132,058,739...132,091,518
Ensembl chr X:127,203,823...127,213,391

G

apelin receptor

decreases expression

benzo(b)fluoranthene results in decreased expression of APLNR mRNA

NCBI chr 3:90,624,055...90,627,700
Ensembl chr 3:70,217,385...70,221,050

G

apolipoprotein C3

multiple interactions

[Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of APOC3 mRNA

NCBI chr 8:55,428,172...55,430,352
Ensembl chr 8:46,531,478...46,533,583

G

apolipoprotein L9a

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of APOL9A mRNA

NCBI chr 7:109,140,871...109,149,799
Ensembl chr 7:109,140,871...109,147,649

G

androgen receptor

increases activity

benzo(b)fluoranthene results in increased activity of AR protein

NCBI chr X:67,135,317...67,304,476
Ensembl chr X:63,104,771...63,273,925

G

amphiregulin

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of AREG mRNA

NCBI chr14:17,256,384...17,265,641
Ensembl chr14:16,972,187...16,981,535

G

ARF GTPase activating protein 1

multiple interactions

[Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of ARFGAP1 mRNA

NCBI chr 3:168,084,560...168,099,948
Ensembl chr 3:168,084,614...168,099,933

G

arginine and glutamate rich 1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ARGLU1 mRNA

NCBI chr16:87,455,097...87,479,148
Ensembl chr16:80,753,315...80,777,349

G

Rho GTPase activating protein 17

decreases expression

benzo(b)fluoranthene results in decreased expression of ARHGAP17 mRNA

NCBI chr 1:187,238,675...187,328,093
Ensembl chr 1:177,807,583...177,896,854

G

Rho GTPase activating protein 20

decreases expression

benzo(b)fluoranthene results in decreased expression of ARHGAP20 mRNA

NCBI chr 8:60,970,480...61,055,199
Ensembl chr 8:52,074,158...52,155,739

G

Rho GTPase activating protein 22

decreases expression

benzo(b)fluoranthene results in decreased expression of ARHGAP22 mRNA

NCBI chr16:8,473,806...8,631,552
Ensembl chr16:8,476,306...8,631,548

G

Rho GTPase activating protein 23

decreases expression

benzo(b)fluoranthene results in decreased expression of ARHGAP23 mRNA

NCBI chr10:82,891,021...82,993,230
Ensembl chr10:82,394,648...82,496,504

G

Rho GTPase activating protein 40

increases expression

benzo(b)fluoranthene results in increased expression of ARHGAP40 mRNA

NCBI chr 3:147,165,781...147,206,552
Ensembl chr 3:147,165,729...147,207,203

G

Rho guanine nucleotide exchange factor 15

decreases expression

benzo(b)fluoranthene results in decreased expression of ARHGEF15 mRNA

NCBI chr10:53,650,521...53,663,269
Ensembl chr10:53,650,553...53,663,913

G

Rho guanine nucleotide exchange factor 16

increases expression

benzo(b)fluoranthene results in increased expression of ARHGEF16 mRNA

NCBI chr 5:170,126,573...170,148,624
Ensembl chr 5:164,844,161...164,866,212

G

Rho guanine nucleotide exchange factor 3

increases expression

benzo(b)fluoranthene results in increased expression of ARHGEF3 mRNA

NCBI chr16:2,308,311...2,588,634
Ensembl chr16:2,300,138...2,581,945

G

Rho guanine nucleotide exchange factor 38

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ARHGEF38 mRNA

NCBI chr 2:221,610,212...221,739,841
Ensembl chr 2:221,613,070...221,740,079

G

Rho guanine nucleotide exchange factor 40

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of ARHGEF40 mRNA

NCBI chr15:24,672,645...24,696,510
Ensembl chr15:24,672,763...24,696,510

G

armadillo repeat containing 6

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ARMC6 mRNA

NCBI chr16:19,191,106...19,201,528
Ensembl chr16:19,191,093...19,206,047

G

arrestin domain containing 4

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of ARRDC4 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ARRDC4 mRNA

PMID:26377693 PMID:27858113

NCBI chr 1:131,779,436...131,793,438
Ensembl chr 1:122,369,360...122,383,290

G

arylsulfatase family, member J

decreases expression

benzo(b)fluoranthene results in decreased expression of ARSJ mRNA

NCBI chr 2:214,774,631...214,854,614
Ensembl chr 2:214,774,654...214,854,612

G

ankyrin repeat and SOCS box-containing 2

decreases expression

benzo(b)fluoranthene results in decreased expression of ASB2 mRNA

NCBI chr 6:128,239,550...128,275,833
Ensembl chr 6:122,474,756...122,510,854

G

activating signal cointegrator 1 complex subunit 3

decreases expression

benzo(b)fluoranthene results in decreased expression of ASCC3 mRNA

NCBI chr20:55,089,430...55,372,374
Ensembl chr20:53,510,184...53,790,165

G

anti-silencing function 1B histone chaperone

increases expression

benzo(b)fluoranthene results in increased expression of ASF1B mRNA

NCBI chr19:41,085,786...41,100,352
Ensembl chr19:24,181,028...24,195,549

G

asialoglycoprotein receptor 1

decreases expression

benzo(b)fluoranthene results in decreased expression of ASGR1 mRNA

NCBI chr10:55,274,299...55,278,323
Ensembl chr10:54,776,024...54,779,631

G

asialoglycoprotein receptor 2

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of ASGR2 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ASGR2 mRNA

PMID:26377693 PMID:27858113

NCBI chr10:54,821,407...54,834,624
Ensembl chr10:54,821,438...54,834,617

G

argininosuccinate lyase

decreases expression

benzo(b)fluoranthene results in decreased expression of ASL mRNA

NCBI chr12:32,295,779...32,313,257
Ensembl chr12:26,659,565...26,679,662

G

aspartoacylase

increases expression

benzo(b)fluoranthene results in increased expression of ASPA mRNA

NCBI chr10:58,390,204...58,443,790
Ensembl chr10:57,892,104...57,945,272

G

asparaginase

increases expression

benzo(b)fluoranthene results in increased expression of ASPG mRNA

NCBI chr 6:136,997,832...137,017,417
Ensembl chr 6:131,176,874...131,196,268

G

aspartate-beta-hydroxylase

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ASPH mRNA

NCBI chr 5:27,398,933...27,611,519
Ensembl chr 5:22,603,486...22,813,876

G

assembly factor for spindle microtubules

increases expression

benzo(b)fluoranthene results in increased expression of ASPM mRNA

NCBI chr13:53,625,584...53,674,489
Ensembl chr13:51,074,849...51,123,755

G

argininosuccinate synthase 1

increases expression

benzo(b)fluoranthene results in increased expression of ASS1 mRNA

NCBI chr 3:35,144,765...35,194,632
Ensembl chr 3:14,747,368...14,796,903

G

ATPase family, AAA domain containing 2B

decreases expression

benzo(b)fluoranthene results in decreased expression of ATAD2B mRNA

NCBI chr 6:33,646,075...33,789,532
Ensembl chr 6:27,912,862...28,067,047

G

activating transcription factor 3

multiple interactions

[Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of ATF3 mRNA

NCBI chr13:105,274,103...105,331,653
Ensembl chr13:102,751,321...102,764,631

G

atonal bHLH transcription factor 8

decreases expression

benzo(b)fluoranthene results in decreased expression of ATOH8 mRNA

NCBI chr 4:105,818,203...105,850,379
Ensembl chr 4:104,259,992...104,292,168

G

atos homolog A

increases expression

benzo(b)fluoranthene results in increased expression of ATOSA mRNA

NCBI chr 8:84,575,360...84,653,103
Ensembl chr 8:75,695,022...75,772,549

G

atos homolog B

increases expression

benzo(b)fluoranthene results in increased expression of ATOSB mRNA

NCBI chr 5:62,056,654...62,070,338
Ensembl chr 5:57,260,841...57,268,892

G

ATPase 13A3

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ATP13A3 mRNA

NCBI chr11:70,364,998...70,442,005
Ensembl chr11:70,365,322...70,441,235

G

ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of ATP2A2 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ATP2A2 mRNA

PMID:26377693 PMID:27858113

NCBI chr12:39,733,519...39,782,942
Ensembl chr12:34,072,683...34,122,101

G

ATPase, class I, type 8B, member 5

increases expression

benzo(b)fluoranthene results in increased expression of ATP8B5 mRNA

NCBI chr 5:57,505,897...57,620,065
Ensembl chr 5:57,506,466...57,620,056

G

aurora kinase A and ninein interacting protein

increases expression

benzo(b)fluoranthene results in increased expression of AUNIP mRNA

NCBI chr 5:146,722,329...146,734,924
Ensembl chr 5:146,722,337...146,736,501

G

aurora kinase A

increases expression

benzo(b)fluoranthene results in increased expression of AURKA mRNA

NCBI chr 3:181,546,742...181,562,890
Ensembl chr 3:161,128,313...161,144,390

G

AVL9 cell migration associated

increases expression

benzo(b)fluoranthene results in increased expression of AVL9 mRNA

NCBI chr 4:85,961,493...86,008,347
Ensembl chr 4:85,961,635...86,008,791

G

arginine vasopressin-induced 1

increases expression

benzo(b)fluoranthene results in increased expression of AVPI1 mRNA

NCBI chr 1:240,930,236...240,936,154
Ensembl chr 1:240,930,236...240,936,154

G

UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5

increases expression

benzo(b)fluoranthene results in increased expression of B3GNT5 mRNA

NCBI chr11:81,141,102...81,153,206
Ensembl chr11:81,140,599...81,156,166

G

beta-1,4-galactosyltransferase 1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of B4GALT1 mRNA

NCBI chr 5:60,731,601...60,778,456
Ensembl chr 5:55,935,615...55,982,461

G

beta-1,4-galactosyltransferase 5

increases expression

benzo(b)fluoranthene results in increased expression of B4GALT5 mRNA

NCBI chr 3:176,437,073...176,453,001
Ensembl chr 3:156,018,053...156,070,074

G

beta-secretase 2

increases expression

benzo(b)fluoranthene results in increased expression of BACE2 mRNA

NCBI chr11:50,176,852...50,258,948
Ensembl chr11:36,707,458...36,789,546

G

BCL2-associated agonist of cell death

increases expression

benzo(b)fluoranthene results in increased expression of BAD protein

NCBI chr 1:213,562,719...213,572,034
Ensembl chr 1:204,131,501...204,142,823

G

B-cell scaffold protein with ankyrin repeats 1

increases expression

benzo(b)fluoranthene results in increased expression of BANK1 mRNA

NCBI chr 2:227,203,998...227,474,008
Ensembl chr 2:224,530,475...224,800,405

G

BRCA1 associated RING domain 1

increases expression

benzo(b)fluoranthene results in increased expression of BARD1 mRNA

NCBI chr 9:80,069,960...80,144,167
Ensembl chr 9:72,623,155...72,694,265

G

basic leucine zipper ATF-like transcription factor

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of BATF mRNA

NCBI chr 6:111,084,717...111,107,052
Ensembl chr 6:105,353,715...105,376,051

G

basic leucine zipper ATF-like transcription factor 2

increases expression

benzo(b)fluoranthene results in increased expression of BATF2 mRNA

NCBI chr 1:203,467,291...203,479,428
Ensembl chr 1:203,468,097...203,475,889

G

BCL2 associated X, apoptosis regulator

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of BAX mRNA; benzo(b)fluoranthene results in increased expression of BAX protein
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of BAX mRNA

PMID:21392559 PMID:26377693 PMID:27858113

NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368

G

butyrylcholinesterase

increases expression

benzo(b)fluoranthene results in increased expression of BCHE mRNA

NCBI chr 2:160,607,289...160,699,760
Ensembl chr 2:158,307,584...158,401,148

G

BCL2, apoptosis regulator

increases expression

benzo(b)fluoranthene results in increased expression of BCL2 protein

NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743
Ensembl chr13:22,684,989...22,853,743

G

Bcl2-like 1

increases expression

benzo(b)fluoranthene results in increased expression of BCL2L1 protein

NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:141,253,523...141,303,479
Ensembl chr 1:141,253,523...141,303,479

G

Bcl2-like 11

increases expression

benzo(b)fluoranthene results in increased expression of BCL2L11 protein

NCBI chr 3:135,820,042...135,857,330
Ensembl chr 3:115,366,646...115,404,068

G

BCL3, transcription coactivator

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of BCL3 mRNA

NCBI chr 1:88,599,321...88,613,555
Ensembl chr 1:79,471,369...79,485,607

G

BCL6B, transcription repressor

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of BCL6B mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of BCL6B mRNA

PMID:26377693 PMID:27858113

NCBI chr10:54,940,908...54,947,022
Ensembl chr10:54,940,909...54,945,974

G

BAF chromatin remodeling complex subunit BCL7B

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of BCL7B mRNA

NCBI chr12:21,496,860...21,510,079
Ensembl chr12:21,496,856...21,510,202

G

brain expressed, associated with NEDD4, 1

increases expression

benzo(b)fluoranthene results in increased expression of BEAN1 mRNA

NCBI chr19:745,993...792,853
Ensembl chr19:739,551...787,537

G

brain expressed X-linked 1

increases expression

benzo(b)fluoranthene results in increased expression of BEX2 mRNA

NCBI chr X:99,219,014...99,220,518
Ensembl chr X:99,219,014...99,220,958

G

beaded filament structural protein 1

increases expression

benzo(b)fluoranthene results in increased expression of BFSP1 mRNA

NCBI chr 3:131,195,087...131,252,668
Ensembl chr 3:131,195,087...131,229,337

G

beaded filament structural protein 2

increases expression

benzo(b)fluoranthene results in increased expression of BFSP2 mRNA

NCBI chr 8:104,006,226...104,063,399
Ensembl chr 8:104,006,226...104,063,399

G

basic helix-loop-helix family, member e40

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of BHLHE40 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of BHLHE40 mRNA

PMID:26377693 PMID:27858113

NCBI chr 4:143,174,450...143,180,150
Ensembl chr 4:141,618,476...141,624,774

G

betaine-homocysteine S-methyltransferase

decreases expression

benzo(b)fluoranthene results in decreased expression of BHMT mRNA

NCBI chr 2:26,594,852...26,614,429
Ensembl chr 2:24,859,873...24,879,742

G

bridging integrator 1

increases expression

benzo(b)fluoranthene results in increased expression of BIN1 mRNA

NCBI chr18:24,282,840...24,341,461
Ensembl chr18:24,009,653...24,067,263

G

baculoviral IAP repeat-containing 5

multiple interactions
increases expression

benzo(b)fluoranthene affects the localization of and results in increased expression of BIRC5 protein
benzo(b)fluoranthene results in increased expression of BIRC5 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of BIRC5 mRNA

PMID:21776270 PMID:26377693 PMID:27858113

NCBI chr10:103,567,369...103,580,069
Ensembl chr10:103,073,408...103,081,380

G

biogenesis of lysosomal organelles complex-1, subunit 2

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of BLOC1S2 mRNA

NCBI chr 1:252,973,818...252,980,873
Ensembl chr 1:243,024,614...243,031,653

G

biogenesis of lysosomal organelles complex 1 subunit 6

increases expression

benzo(b)fluoranthene results in increased expression of BLOC1S6 mRNA

NCBI chr 3:130,269,979...130,280,109
Ensembl chr 3:109,816,366...109,828,308

G

basic helix-loop-helix ARNT like 1

multiple interactions
decreases expression

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of BMAL1 mRNA
benzo(b)fluoranthene results in decreased expression of BMAL1 mRNA

PMID:26377693 PMID:27858113

NCBI chr 1:176,766,222...176,864,741
Ensembl chr 1:167,331,633...167,430,231

G

bone morphogenetic protein 6

decreases expression

benzo(b)fluoranthene results in decreased expression of BMP6 mRNA

NCBI chr17:26,523,704...26,785,558
Ensembl chr17:26,318,569...26,470,365

G

bone morphogenetic protein receptor type 2

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of BMPR2 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of BMPR2 mRNA

PMID:26377693 PMID:27858113

NCBI chr 9:68,685,942...68,801,353
Ensembl chr 9:61,190,566...61,301,809

G

BMP/retinoic acid inducible neural specific 1

increases expression

benzo(b)fluoranthene results in increased expression of BRINP1 mRNA

NCBI chr 5:87,363,621...87,565,580
Ensembl chr 5:82,348,930...82,493,150

G

bromodomain and WD repeat domain containing 1

decreases expression

benzo(b)fluoranthene results in decreased expression of BRWD1 mRNA

NCBI chr11:35,286,364...35,378,768
Ensembl chr11:35,288,313...35,378,768

G

BSCL2 lipid droplet biogenesis associated, seipin

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of BSCL2 mRNA

NCBI chr 1:215,160,764...215,172,540
Ensembl chr 1:205,733,872...205,743,421

G

bone marrow stromal cell antigen 1

increases expression

benzo(b)fluoranthene results in increased expression of BST1 mRNA

NCBI chr14:71,466,179...71,482,671
Ensembl chr14:67,252,998...67,270,180

G

B and T lymphocyte associated

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of BTLA mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of BTLA mRNA

PMID:26377693 PMID:27858113

NCBI chr11:69,069,734...69,099,331
Ensembl chr11:55,564,899...55,587,181

G

butyrophilin-like 9

increases expression

benzo(b)fluoranthene results in increased expression of BTNL9 mRNA

NCBI chr10:33,466,059...33,489,229
Ensembl chr10:33,470,536...33,489,025

G

C1q and TNF related 5

increases expression

benzo(b)fluoranthene results in increased expression of C1QTNF5 mRNA

NCBI chr 8:44,450,934...44,453,075
Ensembl chr 8:44,451,154...44,453,074

G

complement C1s

increases expression

benzo(b)fluoranthene results in increased expression of C1S mRNA

NCBI chr 4:159,116,549...159,128,736
Ensembl chr 4:157,430,117...157,442,303

G

C2 domain containing 3 centriole elongation regulator

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of C2CD3 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of C2CD3 mRNA

PMID:26377693 PMID:27858113

NCBI chr 1:164,127,304...164,225,088
Ensembl chr 1:154,715,310...154,812,520

G

complement C3

increases expression

benzo(b)fluoranthene results in increased expression of C3 mRNA

NCBI chr 9:2,174,412...2,201,339
Ensembl chr 9:2,087,437...2,114,429

G

complement C4B

increases expression

benzo(b)fluoranthene results in increased expression of C4B mRNA

NCBI chr20:4,201,979...4,216,292
Ensembl chr20:4,197,366...4,211,681

G

complement C5

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of HC mRNA

NCBI chr 3:38,668,174...38,759,468
Ensembl chr 3:18,270,696...18,361,994

G

complement C5a receptor 2

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of C5AR2 mRNA

NCBI chr 1:86,058,557...86,073,583
Ensembl chr 1:76,930,383...76,959,517

G

complement C7

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of C7 mRNA

NCBI chr 2:55,815,687...55,892,605
Ensembl chr 2:54,088,116...54,158,535

G

Cdk5 and Abl enzyme substrate 1

increases expression

benzo(b)fluoranthene results in increased expression of CABLES1 mRNA

NCBI chr18:3,349,681...3,455,956
Ensembl chr18:3,075,524...3,181,181

G

calcium binding protein 5

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CABP5 mRNA

NCBI chr 1:83,486,396...83,499,421
Ensembl chr 1:74,350,811...74,363,830

G

calcitonin receptor

increases expression

benzo(b)fluoranthene results in increased expression of CALCR mRNA

NCBI chr 4:32,615,955...32,691,075
Ensembl chr 4:31,661,273...31,736,392

G

calcium/calmodulin-dependent protein kinase II gamma

increases expression

benzo(b)fluoranthene results in increased expression of CAMK2G mRNA

NCBI chr15:3,553,238...3,612,310
Ensembl chr15:3,504,085...3,563,050

G

calpain 5

increases expression

benzo(b)fluoranthene results in increased expression of CAPN5 mRNA

NCBI chr 1:161,827,474...161,884,142
Ensembl chr 1:152,416,252...152,472,923

G

carbonic anhydrase 14

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of CAR14 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CAR14 mRNA

PMID:26377693 PMID:27858113

NCBI chr 2:186,131,196...186,138,164
Ensembl chr 2:183,441,667...183,449,693

G

carbonic anhydrase 2

increases expression

benzo(b)fluoranthene results in increased expression of CAR2 mRNA

NCBI chr 2:88,462,883...88,478,012
Ensembl chr 2:86,741,626...86,756,818

G

carbonic anhydrase 3

multiple interactions
decreases expression

[Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of CA3 mRNA
benzo(b)fluoranthene results in decreased expression of CAR3 mRNA

PMID:17690111 PMID:26377693

NCBI chr 2:88,491,666...88,501,299
Ensembl chr 2:86,770,420...86,784,280

G

carbonic anhydrase 8

increases expression

benzo(b)fluoranthene results in increased expression of CAR8 mRNA

NCBI chr 5:21,302,940...21,402,395
Ensembl chr 5:21,305,383...21,402,374

G

caspase recruitment domain family, member 19

increases expression

benzo(b)fluoranthene results in increased expression of CARD19 mRNA

NCBI chr17:15,638,973...15,651,720
Ensembl chr17:15,432,612...15,445,318

G

calcium regulated heat stable protein 1

increases expression

benzo(b)fluoranthene results in increased expression of CARHSP1 mRNA

NCBI chr10:6,946,036...6,960,556
Ensembl chr10:6,946,959...7,020,019

G

castor zinc finger 1

decreases expression

benzo(b)fluoranthene results in decreased expression of CASZ1 mRNA

NCBI chr 5:164,527,083...164,677,037
Ensembl chr 5:159,243,995...159,393,400

G

caveolin 1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CAV1 mRNA

NCBI chr 4:46,606,538...46,639,616
Ensembl chr 4:45,634,918...45,673,705

G

caveolin 3

increases expression

benzo(b)fluoranthene results in increased expression of CAV3 mRNA

NCBI chr 4:147,137,993...147,153,967
Ensembl chr 4:145,582,060...145,598,137

G

CBFA2/RUNX1 partner transcriptional co-repressor 3

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CBFA2T3 mRNA

NCBI chr19:67,584,319...67,658,533
Ensembl chr19:50,680,729...50,749,610

G

collagen and calcium binding EGF domains 1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CCBE1 mRNA

NCBI chr18:61,849,821...62,093,876
Ensembl chr18:59,580,768...59,824,400

G

coiled-coil domain containing 122

increases expression

benzo(b)fluoranthene results in increased expression of CCDC122 mRNA

NCBI chr15:52,407,717...52,470,163
Ensembl chr15:52,407,717...52,470,163

G

coiled-coil domain containing 184

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of CCDC184 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CCDC184 mRNA

PMID:26377693 PMID:27858113

NCBI chr 7:129,297,635...129,301,961
Ensembl chr 7:129,298,212...129,304,494

G

coiled-coil domain containing 30

decreases expression

benzo(b)fluoranthene results in decreased expression of CCDC30 mRNA

NCBI chr 5:138,212,067...138,305,465
Ensembl chr 5:132,926,615...133,019,659

G

coiled-coil domain containing 68

increases expression

benzo(b)fluoranthene results in increased expression of CCDC68 mRNA

NCBI chr18:63,541,828...63,584,122
Ensembl chr18:63,541,896...63,584,119

G

C-C motif chemokine ligand 4

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of CCL4 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CCL4 mRNA

PMID:26377693 PMID:27858113

NCBI chr10:68,963,893...68,965,728
Ensembl chr10:68,452,052...68,468,231

G

C-C motif chemokine ligand 5

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of CCL5 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CCL5 mRNA

PMID:26377693 PMID:27858113

NCBI chr10:68,820,330...68,824,906
Ensembl chr10:68,322,829...68,327,377

G

C-C motif chemokine ligand 9

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CCL6 mRNA

NCBI chr10:68,863,994...68,868,928
Ensembl chr10:68,366,487...68,371,369

G

CCM2 like scaffold protein

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of CCM2L mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CCM2L mRNA

PMID:26377693 PMID:27858113

NCBI chr 3:161,993,717...162,009,372
Ensembl chr 3:141,533,511...141,549,140

G

cellular communication network factor 1

increases expression

benzo(b)fluoranthene results in increased expression of CCN1 mRNA

NCBI chr 2:237,222,730...237,225,689
Ensembl chr 2:234,562,408...234,565,484

G

cellular communication network factor 4

increases expression

benzo(b)fluoranthene results in increased expression of CCN4 mRNA

NCBI chr 7:100,534,578...100,566,287
Ensembl chr 7:98,645,182...98,677,248

G

cyclin A2

multiple interactions
increases expression
decreases expression

AHR affects the reaction [benzo(b)fluoranthene results in increased activity of [CCNA2 protein binds to CDK2 protein]]; AHR affects the reaction [benzo(b)fluoranthene results in increased expression of CCNA2 protein]; benzo(b)fluoranthene results in increased activity of [CCNA2 protein binds to CDK2 protein]
benzo(b)fluoranthene results in decreased expression of CCNA2 mRNA
benzo(b)fluoranthene results in increased expression of CCNA2 mRNA

PMID:16269432 PMID:17141280 PMID:26377693

NCBI chr 2:121,355,363...121,361,762
Ensembl chr 2:119,426,089...119,433,577

G

cyclin B1

increases expression

benzo(b)fluoranthene results in increased expression of CCNB1 mRNA

NCBI chr 2:33,646,252...33,655,225
Ensembl chr 2:31,912,193...31,921,172

G

cyclin B2

increases expression

benzo(b)fluoranthene results in increased expression of CCNB2 mRNA

NCBI chr 8:79,968,459...79,981,717
Ensembl chr 8:71,087,595...71,100,874

G

cyclin D1

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of CCND1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CCND1 mRNA

PMID:26377693 PMID:27858113

NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:200,089,002...200,098,602

G

cyclin D2

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of CCND2 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CCND2 mRNA

PMID:26377693 PMID:27858113

NCBI chr 4:161,653,048...161,675,422
Ensembl chr 4:159,962,363...159,989,495

G

cyclin D3

increases expression

benzo(b)fluoranthene results in increased expression of CCND3 mRNA

NCBI chr 9:20,891,696...20,987,199
Ensembl chr 9:13,394,169...13,489,371

G

cyclin F

increases expression

benzo(b)fluoranthene results in increased expression of CCNF mRNA

NCBI chr10:13,757,884...13,783,669
Ensembl chr10:13,253,380...13,279,101

G

cyclin G1

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of CCNG1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CCNG1 mRNA

PMID:26377693 PMID:27858113

NCBI chr10:25,678,503...25,684,876
Ensembl chr10:25,176,234...25,181,641

G

cyclin J-like

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of CCNJL mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CCNJL mRNA

PMID:26377693 PMID:27858113

NCBI chr10:28,497,144...28,554,877
Ensembl chr10:27,995,679...28,053,426

G

cyclin L1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CCNL1 mRNA

NCBI chr 2:150,184,865...150,199,524
Ensembl chr 2:150,184,798...150,197,368

G

cyclin L2

increases expression

benzo(b)fluoranthene results in increased expression of CCNL2 mRNA

NCBI chr 5:171,698,951...171,711,037
Ensembl chr 5:166,417,508...166,436,882

G

cyclin O

increases expression

benzo(b)fluoranthene results in increased expression of CCNO mRNA

NCBI chr 2:46,364,074...46,367,113
Ensembl chr 2:44,626,369...44,633,914

G

C-C motif chemokine receptor 2

multiple interactions

[Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of CCR2 mRNA

NCBI chr 8:132,611,883...132,619,106
Ensembl chr 8:123,734,430...123,742,100

G

C-C motif chemokine receptor 7

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of CCR7 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CCR7 mRNA

PMID:26377693 PMID:27858113

NCBI chr10:84,594,399...84,604,514
Ensembl chr10:84,097,381...84,108,309

G

CD151 molecule (Raph blood group)

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of CD151 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CD151 mRNA

PMID:26377693 PMID:27858113

NCBI chr 1:205,994,300...205,998,307
Ensembl chr 1:196,565,181...196,568,753

G

CD164 molecule like 2

increases expression

benzo(b)fluoranthene results in increased expression of CD164L2 mRNA

NCBI chr 5:145,414,805...145,427,747
Ensembl chr 5:145,423,892...145,427,720

G

CD19 molecule

increases expression

benzo(b)fluoranthene results in increased expression of CD19 mRNA

NCBI chr 1:190,417,853...190,424,494
Ensembl chr 1:180,987,286...180,993,975

G

CD1d1 molecule

decreases expression

benzo(b)fluoranthene results in decreased expression of CD1D1 mRNA

NCBI chr 2:174,721,522...174,725,029
Ensembl chr 2:172,423,582...172,427,089

G

Cd200 molecule

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of CD200 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CD200 mRNA

PMID:26377693 PMID:27858113

NCBI chr11:68,916,200...68,943,570
Ensembl chr11:55,410,196...55,501,648

G

CD209d molecule

decreases expression

benzo(b)fluoranthene results in decreased expression of CD209D mRNA

NCBI chr12:6,689,002...6,695,452
Ensembl chr12:1,891,113...1,901,171

G

CD226 molecule

decreases expression

benzo(b)fluoranthene results in decreased expression of CD226 mRNA

NCBI chr18:84,723,330...84,819,836
Ensembl chr18:82,450,568...82,543,051

G

Cd300e molecule

decreases expression

benzo(b)fluoranthene results in decreased expression of CD300E mRNA

NCBI chr10:100,784,452...100,808,988
Ensembl chr10:100,291,437...100,299,311

G

Cd300 molecule-like family member F

increases expression

benzo(b)fluoranthene results in increased expression of CD300LF mRNA

NCBI chr10:100,858,924...100,875,111
Ensembl chr10:100,359,943...100,376,041

G

CD34 molecule

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of CD34 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CD34 mRNA

PMID:26377693 PMID:27858113

NCBI chr13:109,008,786...109,029,317
Ensembl chr13:106,480,043...106,499,832

G

CD36 molecule

increases expression

benzo(b)fluoranthene results in increased expression of CD36 mRNA

NCBI chr 4:18,209,088...18,302,142
Ensembl chr 4:17,354,466...17,513,903

G

CD37 molecule

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CD37 mRNA

NCBI chr 1:104,855,622...104,861,111
Ensembl chr 1:95,719,190...95,724,648

G

CD38 molecule

increases expression

benzo(b)fluoranthene results in increased expression of CD38 mRNA

NCBI chr14:71,384,532...71,424,794
Ensembl chr14:67,172,063...67,211,986

G

CD3 delta subunit of T-cell receptor complex

increases expression

benzo(b)fluoranthene results in increased expression of CD3D mRNA

NCBI chr 8:45,287,803...45,293,342
Ensembl chr 8:45,288,749...45,301,809

G

Cd48 molecule

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CD48 mRNA

NCBI chr13:84,184,884...84,209,144
Ensembl chr13:84,185,532...84,209,142

G

Cd69 molecule

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of CD69 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CD69 mRNA

PMID:26377693 PMID:27858113

NCBI chr 4:164,411,485...164,419,403
Ensembl chr 4:162,725,446...162,733,542

G

CD74 molecule

increases expression

benzo(b)fluoranthene results in increased expression of CD74 mRNA

NCBI chr18:56,527,071...56,536,406
Ensembl chr18:54,256,778...54,266,003

G

CD79b molecule

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of CD79B mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CD79B mRNA

PMID:26377693 PMID:27858113

NCBI chr10:91,739,134...91,742,312
Ensembl chr10:91,239,356...91,242,625

G

CD93 molecule

increases expression

benzo(b)fluoranthene results in increased expression of CD93 mRNA

NCBI chr 3:156,345,019...156,351,537
Ensembl chr 3:135,891,859...135,898,378

G

CD99 molecule (Xg blood group)

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of CD99 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CD99 mRNA

PMID:26377693 PMID:27858113

NCBI chr20:54,418,239...54,422,882

G

cell division cycle 20

increases expression

benzo(b)fluoranthene results in increased expression of CDC20 mRNA

NCBI chr 5:137,251,596...137,255,799
Ensembl chr 5:131,966,215...131,970,512

G

cell division cycle 25A

increases expression

benzo(b)fluoranthene results in increased expression of CDC25A mRNA

NCBI chr 8:118,742,824...118,761,190
Ensembl chr 8:109,864,478...109,882,701

G

cell division cycle 40

decreases expression

benzo(b)fluoranthene results in decreased expression of CDC40 mRNA

NCBI chr20:44,273,080...44,325,605
Ensembl chr20:44,273,089...44,325,358

G

cell division cycle associated 3

increases expression

benzo(b)fluoranthene results in increased expression of CDCA3 mRNA

NCBI chr 4:159,321,203...159,325,072
Ensembl chr 4:157,634,928...157,638,799

G

cell division cycle associated 5

increases expression

benzo(b)fluoranthene results in increased expression of CDCA5 mRNA

NCBI chr 1:212,807,863...212,821,313
Ensembl chr 1:203,378,577...203,392,023

G

cell division cycle associated 8

increases expression

benzo(b)fluoranthene results in increased expression of CDCA8 mRNA

NCBI chr 5:142,461,082...142,483,336
Ensembl chr 5:137,176,417...137,198,629

G

cadherin 1

multiple interactions

[Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of CDH1 mRNA

NCBI chr19:51,402,178...51,471,572
Ensembl chr19:34,492,371...34,561,775

G

cadherin 16

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CDH16 mRNA

NCBI chr19:367,202...377,710
Ensembl chr19:360,824...371,007

G

cadherin 22

decreases expression

benzo(b)fluoranthene results in decreased expression of CDH22 mRNA

NCBI chr 3:174,264,869...174,389,940
Ensembl chr 3:153,845,787...153,970,588

G

cadherin 5

increases expression

benzo(b)fluoranthene results in increased expression of CDH5 mRNA

NCBI chr19:821,875...860,931
Ensembl chr19:815,411...854,368

G

cadherin-related family member 4

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CDHR4 mRNA

NCBI chr 8:117,561,206...117,594,456
Ensembl chr 8:108,682,613...108,690,367

G

cyclin-dependent kinase 1

increases expression

benzo(b)fluoranthene results in increased expression of CDK1 mRNA

NCBI chr20:19,265,252...19,280,456
Ensembl chr20:19,266,248...19,281,408

G

cyclin dependent kinase 2

multiple interactions

AHR affects the reaction [benzo(b)fluoranthene results in increased activity of [CCNA2 protein binds to CDK2 protein]]; benzo(b)fluoranthene results in increased activity of [CCNA2 protein binds to CDK2 protein]

NCBI chr 7:1,714,392...1,721,964
Ensembl chr 7:1,129,811...1,137,403

G

cyclin-dependent kinase inhibitor 1A

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of CDKN1A mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CDKN1A mRNA

PMID:26377693 PMID:27858113

NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,149,217...7,159,585

G

cyclin-dependent kinase inhibitor 1C

decreases expression

benzo(b)fluoranthene results in decreased expression of CDKN1C mRNA

NCBI chr 1:208,084,801...208,087,680
Ensembl chr 1:198,655,407...198,658,048

G

cyclin-dependent kinase inhibitor 2A

decreases expression

benzo(b)fluoranthene results in decreased expression of CDKN2A mRNA

NCBI chr 5:109,100,763...109,114,448
Ensembl chr 5:103,984,949...104,003,149

G

cyclin-dependent kinase inhibitor 2C

increases expression

benzo(b)fluoranthene results in increased expression of CDKN2C mRNA

NCBI chr 5:129,639,736...129,645,564
Ensembl chr 5:124,411,124...124,416,278

G

cyclin-dependent kinase inhibitor 3

increases expression

benzo(b)fluoranthene results in increased expression of CDKN3 mRNA

NCBI chr15:22,502,299...22,513,725
Ensembl chr15:20,022,664...20,033,945

G

chromatin licensing and DNA replication factor 1

increases expression

benzo(b)fluoranthene results in increased expression of CDT1 mRNA

NCBI chr19:67,529,249...67,534,195
Ensembl chr19:50,620,713...50,625,659

G

CUGBP, Elav-like family member 5

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of CELF5 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CELF5 mRNA

PMID:26377693 PMID:27858113

NCBI chr 7:8,225,787...8,250,322
Ensembl chr 7:8,225,825...8,250,322

G

cadherin, EGF LAG seven-pass G-type receptor 1

decreases expression

benzo(b)fluoranthene results in decreased expression of CELSR1 mRNA

NCBI chr 7:118,867,450...119,004,859
Ensembl chr 7:116,987,605...117,125,164

G

centromere protein A

increases expression

benzo(b)fluoranthene results in increased expression of CENPA mRNA

NCBI chr 6:31,420,062...31,431,703
Ensembl chr 6:25,700,142...25,711,675

G

centromere protein E

increases expression

benzo(b)fluoranthene results in increased expression of CENPE mRNA

NCBI chr 2:226,310,970...226,369,636
Ensembl chr 2:223,636,998...223,695,669

G

centromere protein K

increases expression

benzo(b)fluoranthene results in increased expression of CENPK mRNA

NCBI chr 2:37,094,163...37,155,158
Ensembl chr 2:35,360,132...35,385,706

G

centromere protein P

increases expression

benzo(b)fluoranthene results in increased expression of CENPP mRNA

NCBI chr17:15,014,087...15,189,312
Ensembl chr17:15,014,058...15,189,304

G

centrosomal protein 162

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CEP162 mRNA

NCBI chr 8:88,149,726...88,208,249
Ensembl chr 8:88,149,726...88,206,830

G

centrosomal protein 164

increases expression

benzo(b)fluoranthene results in increased expression of CEP164 mRNA

NCBI chr 8:54,967,621...55,031,264
Ensembl chr 8:46,071,076...46,134,336

G

centrosomal protein 250

increases expression

benzo(b)fluoranthene results in increased expression of CEP250 mRNA

NCBI chr 3:144,470,946...144,516,125
Ensembl chr 3:144,471,214...144,516,125

G

centrosomal protein 295

increases expression

benzo(b)fluoranthene results in increased expression of CEP295 mRNA

NCBI chr 8:12,156,568...12,194,542
Ensembl chr 8:12,156,554...12,194,552

G

centrosomal protein 95

increases expression

benzo(b)fluoranthene results in increased expression of CEP95 mRNA

NCBI chr10:91,732,111...91,760,095
Ensembl chr10:91,732,111...91,760,092

G

carboxylesterase 2C

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CES2C mRNA

NCBI chr 1:270,377,201...270,384,768
Ensembl chr 1:260,388,902...260,398,790

G

carboxylesterase 2E

multiple interactions
increases expression

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CES2E mRNA
benzo(b)fluoranthene results in increased expression of CES2E mRNA

PMID:26377693 PMID:27858113

NCBI chr19:163,899...179,274
Ensembl chr19:157,407...172,856

G

carboxylesterase 2H

increases expression

benzo(b)fluoranthene results in increased expression of CES2 mRNA

NCBI chr19:49,884,164...49,898,764
Ensembl chr19:32,974,242...32,988,830

G

cilia and flagella associated protein 126

increases expression

benzo(b)fluoranthene results in increased expression of CFAP126 mRNA

NCBI chr13:86,059,142...86,075,034
Ensembl chr13:83,526,657...83,542,552

G

complement factor B

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CFB mRNA

NCBI chr20:3,975,271...3,981,138
Ensembl chr20:3,951,474...3,976,505

G

complement factor D

decreases expression

benzo(b)fluoranthene results in decreased expression of CFD mRNA

NCBI chr 7:10,463,773...10,465,496
Ensembl chr 7:9,813,150...9,815,053

G

complement factor properdin

increases expression

benzo(b)fluoranthene results in increased expression of CFP mRNA

NCBI chr X:3,715,551...3,721,113
Ensembl chr X:1,161,979...1,167,573

G

cyclic GMP-AMP synthase

increases expression

benzo(b)fluoranthene results in increased expression of CGAS mRNA

NCBI chr 8:88,172,559...88,187,538
Ensembl chr 8:79,294,511...79,305,496

G

cell growth regulator with EF hand domain 1

increases expression

benzo(b)fluoranthene results in increased expression of CGREF1 mRNA

NCBI chr 6:31,151,795...31,163,801
Ensembl chr 6:25,431,799...25,443,852

G

chromatin assembly factor 1 subunit A

increases expression

benzo(b)fluoranthene results in increased expression of CHAF1A mRNA

NCBI chr 9:873,953...900,701
Ensembl chr 9:874,051...900,654

G

chromatin assembly factor 1 subunit B

increases expression

benzo(b)fluoranthene results in increased expression of CHAF1B mRNA

NCBI chr11:46,670,560...46,690,739
Ensembl chr11:33,200,981...33,221,070

G

chromodomain helicase DNA binding protein 2

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of CHD2 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CHD2 mRNA

PMID:26377693 PMID:27858113

NCBI chr 1:136,597,993...136,726,874
Ensembl chr 1:127,190,059...127,300,502

G

chromodomain helicase DNA binding protein 6

decreases expression

benzo(b)fluoranthene results in decreased expression of CHD6 mRNA

NCBI chr 3:149,596,509...149,757,765
Ensembl chr 3:149,596,509...149,757,755

G

chitinase, acidic

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CHIA mRNA

NCBI chr 2:196,302,687...196,344,849
Ensembl chr 2:193,614,114...193,656,533

G

choline kinase alpha

decreases expression

benzo(b)fluoranthene results in decreased expression of CHKA mRNA

NCBI chr 1:210,506,069...210,554,753
Ensembl chr 1:201,076,860...201,125,516

G

chondroitin polymerizing factor 2

increases expression

benzo(b)fluoranthene results in increased expression of CHPF2 mRNA

NCBI chr 4:10,578,470...10,585,940
Ensembl chr 4:10,580,462...10,585,916

G

carbohydrate sulfotransferase 1

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of CHST1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CHST1 mRNA

PMID:26377693 PMID:27858113

NCBI chr 3:99,003,987...99,030,214
Ensembl chr 3:78,548,525...78,574,883

G

carbohydrate sulfotransferase 3

increases expression

benzo(b)fluoranthene results in increased expression of CHST3 mRNA

NCBI chr20:28,657,308...28,694,976
Ensembl chr20:28,114,404...28,121,807

G

carbohydrate sulfotransferase 7

decreases expression

benzo(b)fluoranthene results in decreased expression of CHST7 mRNA

NCBI chr X:4,949,810...4,986,372
Ensembl chr X:2,393,874...2,432,840

G

circadian associated repressor of transcription

increases expression

benzo(b)fluoranthene results in increased expression of CIART mRNA

NCBI chr 2:183,419,819...183,424,845
Ensembl chr 2:183,419,819...183,423,313

G

cell death-inducing DFFA-like effector c

decreases expression

benzo(b)fluoranthene results in decreased expression of CIDEC mRNA

NCBI chr 4:148,124,924...148,137,806
Ensembl chr 4:146,569,289...146,582,173

G

cold inducible RNA binding protein

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CIRBP mRNA

NCBI chr 7:10,184,515...10,189,623
Ensembl chr 7:9,424,178...9,538,818

G

cytokine inducible SH2-containing protein

increases expression

benzo(b)fluoranthene results in increased expression of CISH mRNA

NCBI chr 8:107,972,306...107,977,254
Ensembl chr 8:107,972,306...107,977,250

G

Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CITED2 mRNA

NCBI chr 1:14,132,303...14,134,746
Ensembl chr 1:12,312,160...12,314,897

G

cytoskeleton associated protein 2

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of CKAP2 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CKAP2 mRNA

PMID:26377693 PMID:27858113

NCBI chr16:76,542,114...76,567,297
Ensembl chr16:69,839,630...69,864,913

G

cytoskeleton associated protein 2-like

increases expression

benzo(b)fluoranthene results in increased expression of CKAP2L mRNA

NCBI chr 3:136,950,390...136,977,503
Ensembl chr 3:116,498,022...116,524,366

G

CDC28 protein kinase regulatory subunit 1B

increases expression

benzo(b)fluoranthene results in increased expression of CKS1B mRNA

NCBI chr 2:177,130,751...177,135,333
Ensembl chr 2:174,833,050...174,837,636

G

chloride channel accessory 2

increases expression

benzo(b)fluoranthene results in increased expression of CLCA2 mRNA

NCBI chr 2:236,655,419...236,682,669
Ensembl chr 2:233,995,078...234,022,199

G

claudin 14

increases expression

benzo(b)fluoranthene results in increased expression of CLDN14 mRNA

NCBI chr11:46,701,940...46,799,049
Ensembl chr11:33,232,220...33,329,171

G

C-type lectin domain containing 14A

decreases expression

benzo(b)fluoranthene results in decreased expression of CLEC14A mRNA

NCBI chr 6:81,616,414...81,619,556
Ensembl chr 6:75,881,473...75,884,612

G

C-type lectin domain family 1, member A

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CLEC1A mRNA

NCBI chr 4:162,875,360...162,902,571
Ensembl chr 4:162,877,346...162,901,247

G

C-type lectin domain family 1, member B

decreases expression

benzo(b)fluoranthene results in decreased expression of CLEC1B mRNA

NCBI chr 4:164,533,987...164,542,320
Ensembl chr 4:162,848,010...162,856,291

G

C-type lectin domain family 4, member A

increases expression

benzo(b)fluoranthene results in increased expression of CLEC4N mRNA

NCBI chr 4:158,026,138...158,119,904
Ensembl chr 4:156,414,688...156,432,402

G

C-type lectin domain family 4, member A1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CLEC4A1 mRNA

NCBI chr 4:156,173,894...156,186,009
Ensembl chr 4:156,173,894...156,186,008

G

C-type lectin domain family 4, member D

increases expression

benzo(b)fluoranthene results in increased expression of CLEC4D mRNA

NCBI chr 4:156,589,591...156,599,279
Ensembl chr 4:156,589,792...156,598,848

G

C-type lectin domain family 4, member G

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of CLEC4G mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CLEC4G mRNA

PMID:26377693 PMID:27858113

NCBI chr12:6,578,266...6,582,913
Ensembl chr12:1,780,371...1,784,985

G

chloride intracellular channel 1

increases expression

benzo(b)fluoranthene results in increased expression of CLIC1 mRNA

NCBI chr20:3,769,522...3,778,367
Ensembl chr20:3,761,461...3,773,712

G

clock circadian regulator

decreases expression

benzo(b)fluoranthene results in decreased expression of CLOCK mRNA

NCBI chr14:32,262,747...32,346,872
Ensembl chr14:31,908,566...31,990,400

G

calsyntenin 2

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CLSTN2 mRNA

NCBI chr 8:106,899,894...107,516,402
Ensembl chr 8:98,021,666...98,637,731

G

clathrin, light chain B

increases expression

benzo(b)fluoranthene results in increased expression of CLTB mRNA

NCBI chr17:10,006,416...10,024,278
Ensembl chr17:10,001,513...10,019,169

G

cytidine/uridine monophosphate kinase 2

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CMPK2 mRNA

NCBI chr 6:48,802,150...48,813,652
Ensembl chr 6:43,073,796...43,085,183

G

cardiomyopathy associated 5

decreases expression

benzo(b)fluoranthene results in decreased expression of CMYA5 mRNA

NCBI chr 2:26,014,545...26,113,273
Ensembl chr 2:24,279,528...24,378,364

G

cornifelin

decreases expression

benzo(b)fluoranthene results in decreased expression of CNFN mRNA

NCBI chr 1:80,949,699...80,953,747
Ensembl chr 1:80,951,600...80,953,747

G

cyclic nucleotide gated channel subunit beta 1

increases expression

benzo(b)fluoranthene results in increased expression of CNGB1 mRNA

NCBI chr19:9,732,646...9,798,864
Ensembl chr19:9,726,595...9,791,173

G

cytochrome c oxidase assembly factor 8

decreases expression

benzo(b)fluoranthene results in decreased expression of COA8 mRNA

NCBI chr 6:136,593,399...136,618,237
Ensembl chr 6:130,771,199...130,797,081

G

cordon-bleu WH2 repeat protein

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of COBL mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of COBL mRNA

PMID:26377693 PMID:27858113

NCBI chr14:86,828,137...87,060,682
Ensembl chr14:86,828,139...87,060,800

G

collagen type XIV alpha 1 chain

increases expression

benzo(b)fluoranthene results in increased expression of COL14A1 mRNA

NCBI chr 7:88,611,827...88,826,939
Ensembl chr 7:86,722,094...86,937,214

G

collagen type XVIII alpha 1 chain

increases expression

benzo(b)fluoranthene results in increased expression of COL18A1 mRNA

NCBI chr20:11,473,645...11,582,111
Ensembl chr20:11,474,104...11,582,593

G

collagen type I alpha 1 chain

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of COL1A1 mRNA

NCBI chr10:80,380,458...80,397,461
Ensembl chr10:79,883,622...79,900,624

G

collagen type I alpha 2 chain

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of COL1A2 mRNA

NCBI chr 4:33,518,557...33,553,484
Ensembl chr 4:32,563,381...32,598,867

G

collagen type XX alpha 1 chain

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of COL20A1 mRNA

NCBI chr 3:168,102,475...168,134,759
Ensembl chr 3:168,084,560...168,135,309

G

collagen type III alpha 1 chain

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of COL3A1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of COL3A1 mRNA

PMID:26377693 PMID:27858113

NCBI chr 9:54,866,646...54,902,578
Ensembl chr 9:47,374,593...47,410,547

G

collagen type IV alpha 1 chain

increases expression

benzo(b)fluoranthene results in increased expression of COL4A1 mRNA

NCBI chr16:84,885,597...84,996,482
Ensembl chr16:78,183,533...78,294,412

G

collagen type IV alpha 2 chain

increases expression

benzo(b)fluoranthene results in increased expression of COL4A2 mRNA

NCBI chr16:84,749,672...84,885,520
Ensembl chr16:78,047,602...78,183,839

G

collagen type IV alpha 4 chain

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of COL4A4 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of COL4A4 mRNA

PMID:26377693 PMID:27858113

NCBI chr 9:91,281,324...91,323,577
Ensembl chr 9:83,755,515...83,875,876

G

collagen type V alpha 3 chain

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of COL5A3 mRNA

NCBI chr 8:19,304,564...19,349,809
Ensembl chr 8:19,304,571...19,349,853

G

COMM domain containing 3

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of COMMD3 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of COMMD3 mRNA

PMID:26377693 PMID:27858113

NCBI chr17:81,327,444...81,331,191
Ensembl chr17:81,327,405...81,331,177

G

COMM domain containing 4

increases expression

benzo(b)fluoranthene results in increased expression of COMMD4 mRNA

NCBI chr 8:66,462,188...66,465,700
Ensembl chr 8:57,566,236...57,569,760

G

coenzyme Q10B

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of COQ10B mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of COQ10B mRNA

PMID:26377693 PMID:27858113

NCBI chr 9:64,048,168...64,068,082
Ensembl chr 9:56,553,758...56,573,663

G

coenzyme Q8A

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of COQ8A mRNA

NCBI chr13:94,436,680...94,465,535
Ensembl chr13:91,904,739...91,931,431

G

coronin 2A

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CORO2A mRNA

NCBI chr 5:60,825,630...60,881,917
Ensembl chr 5:60,828,247...60,859,035

G

cytochrome c oxidase subunit 6B2

increases expression

benzo(b)fluoranthene results in increased expression of COX6B2 mRNA

NCBI chr 1:69,094,009...69,095,312

G

cytochrome c oxidase subunit 7A1

decreases expression

benzo(b)fluoranthene results in decreased expression of COX7A1 mRNA

NCBI chr 1:94,549,663...94,572,330
Ensembl chr 1:85,441,871...85,445,151

G

ceruloplasmin

increases expression

benzo(b)fluoranthene results in increased expression of CP mRNA

NCBI chr 2:104,368,336...104,427,119
Ensembl chr 2:102,439,624...102,498,075

G

complexin 2

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CPLX2 mRNA

NCBI chr17:10,219,577...10,292,835
Ensembl chr17:10,222,347...10,293,855

G

carboxypeptidase M

decreases expression

benzo(b)fluoranthene results in decreased expression of CPM mRNA

NCBI chr 7:55,111,599...55,172,114
Ensembl chr 7:53,225,696...53,286,220

G

copine 4

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CPNE4 mRNA

NCBI chr 8:114,056,152...114,531,855
Ensembl chr 8:105,177,376...105,653,068

G

copine 5

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CPNE5 mRNA

NCBI chr20:7,206,742...7,289,309
Ensembl chr20:7,206,742...7,288,883

G

calcineurin-like phosphoesterase domain containing 1

increases expression

benzo(b)fluoranthene results in increased expression of CPPED1 mRNA

NCBI chr10:4,135,601...4,328,039
Ensembl chr10:3,701,459...3,821,054

G

carnitine palmitoyltransferase 1c

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CPT1C mRNA

NCBI chr 1:104,579,297...104,593,824
Ensembl chr 1:95,442,817...95,457,342

G

complement C3d receptor 2

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of CR2 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CR2 mRNA

PMID:26377693 PMID:27858113

NCBI chr13:109,207,034...109,244,980
Ensembl chr13:106,685,413...106,716,235

G

CREB3 regulatory factor

increases expression

benzo(b)fluoranthene results in increased expression of CREBRF mRNA

NCBI chr10:16,903,607...16,967,450
Ensembl chr10:16,404,596...16,461,999

G

CREB/ATF bZIP transcription factor

increases expression

benzo(b)fluoranthene results in increased expression of CREBZF mRNA

NCBI chr 1:144,416,864...144,423,540
Ensembl chr 1:144,417,446...144,428,553

G

cellular repressor of E1A-stimulated genes 1

increases expression

benzo(b)fluoranthene results in increased expression of CREG1 mRNA

NCBI chr13:78,019,814...78,032,310
Ensembl chr13:78,019,843...78,032,308

G

cAMP responsive element modulator

increases expression

benzo(b)fluoranthene results in increased expression of CREM mRNA

NCBI chr17:58,932,011...59,001,160
Ensembl chr17:54,239,030...54,305,989

G

cysteine-rich secretory protein 3

increases expression

benzo(b)fluoranthene results in increased expression of CRISP3 mRNA

NCBI chr 9:20,432,051...20,472,663
Ensembl chr 9:20,450,908...20,472,658

G

CRK proto-oncogene, adaptor protein

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CRK mRNA

NCBI chr10:61,028,736...61,054,971
Ensembl chr10:60,530,464...60,553,406

G

cytokine receptor-like factor 2

increases expression

benzo(b)fluoranthene results in increased expression of CRLF2 mRNA

NCBI chr14:118,932...123,632
Ensembl chr14:103,939...108,642

G

cysteine sulfinic acid decarboxylase

decreases expression

benzo(b)fluoranthene results in decreased expression of CSAD mRNA

NCBI chr 7:135,187,175...135,216,495
Ensembl chr 7:133,308,574...133,337,615

G

colony stimulating factor 1

decreases expression

benzo(b)fluoranthene results in decreased expression of CSF1 mRNA

NCBI chr 2:198,065,400...198,084,774
Ensembl chr 2:195,377,215...195,411,704

G

colony stimulating factor 2 receptor subunit alpha

increases expression

benzo(b)fluoranthene results in increased expression of CSF2RA mRNA

NCBI chr14:113,219...118,808
Ensembl chr14:89,172...103,128

G

cysteine and serine rich nuclear protein 1

increases expression

benzo(b)fluoranthene results in increased expression of CSRNP1 mRNA

NCBI chr 8:128,582,364...128,594,163
Ensembl chr 8:119,704,713...119,718,183

G

cystatin 8

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of CST8 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CST8 mRNA

PMID:26377693 PMID:27858113

NCBI chr 3:136,244,586...136,255,412
Ensembl chr 3:136,244,636...136,251,273

G

cystathionine gamma-lyase

decreases expression

benzo(b)fluoranthene results in decreased expression of CTH mRNA

NCBI chr 2:249,634,731...249,661,066
Ensembl chr 2:246,975,894...247,002,234

G

CTP synthase 2

increases expression

benzo(b)fluoranthene results in increased expression of CTPS2 mRNA

NCBI chr X:35,277,658...35,418,505
Ensembl chr X:31,645,873...31,786,733

G

cathepsin D

increases expression

benzo(b)fluoranthene results in increased expression of CTSD mRNA

NCBI chr 1:206,956,945...206,968,821
Ensembl chr 1:197,527,467...197,539,488

G

cathepsin H

increases expression

benzo(b)fluoranthene results in increased expression of CTSH mRNA

NCBI chr 8:99,488,756...99,507,639
Ensembl chr 8:90,608,941...90,627,824

G

cathepsin S

increases expression

benzo(b)fluoranthene results in increased expression of CTSS mRNA

NCBI chr 2:185,775,316...185,803,440
Ensembl chr 2:183,086,437...183,114,483

G

C-X3-C motif chemokine ligand 1

affects expression

benzo(b)fluoranthene affects the expression of CX3CL1 mRNA

NCBI chr19:10,233,326...10,244,856
Ensembl chr19:10,227,340...10,236,833

G

C-X3-C motif chemokine receptor 1

affects expression

benzo(b)fluoranthene affects the expression of CX3CR1 mRNA

NCBI chr 8:128,661,294...128,679,048
Ensembl chr 8:119,782,595...119,800,014

G

C-X-C motif chemokine ligand 10

increases expression

benzo(b)fluoranthene results in increased expression of CXCL10 mRNA

NCBI chr14:15,989,066...15,991,263
Ensembl chr14:15,704,758...15,706,975

G

C-X-C motif chemokine ligand 13

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CXCL13 mRNA

NCBI chr14:13,912,858...13,917,920
Ensembl chr14:13,608,902...13,613,933

G

C-X-C motif chemokine ligand 16

increases expression

benzo(b)fluoranthene results in increased expression of CXCL16 mRNA

NCBI chr10:55,665,355...55,669,950
Ensembl chr10:55,166,723...55,171,592

G

C-X-C motif chemokine ligand 3

decreases expression

benzo(b)fluoranthene results in decreased expression of CXCL1 mRNA

NCBI chr14:17,571,900...17,573,624
Ensembl chr14:17,270,146...17,289,511

G

C-X-C motif chemokine ligand 6

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of CXCL5 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CXCL5 mRNA

PMID:26377693 PMID:27858113

NCBI chr14:17,594,959...17,596,417
Ensembl chr14:17,310,426...17,313,093

G

C-X-C motif chemokine receptor 2

increases expression

benzo(b)fluoranthene results in increased expression of CXCR2 mRNA

NCBI chr 9:83,178,645...83,185,017
Ensembl chr 9:75,729,115...75,739,425

G

C-X-C motif chemokine receptor 5

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of CXCR5 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CXCR5 mRNA

PMID:26377693 PMID:27858113

NCBI chr 8:53,738,878...53,756,813
Ensembl chr 8:44,843,413...44,857,893

G

C-X-C motif chemokine receptor 6

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of CXCR6 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CXCR6 mRNA

PMID:26377693 PMID:27858113

NCBI chr 8:132,311,834...132,317,001
Ensembl chr 8:123,416,325...123,439,526

G

cytochrome b5 type A

increases expression

benzo(b)fluoranthene results in increased expression of CYB5A mRNA

NCBI chr18:80,487,923...80,520,544
Ensembl chr18:78,202,342...78,258,535
Ensembl chr18:78,202,342...78,258,535

G

CYLD lysine 63 deubiquitinase

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CYLD mRNA

NCBI chr19:34,487,491...34,547,311
Ensembl chr19:18,314,019...18,373,658

G

cytochrome P450, family 17, subfamily a, polypeptide 1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CYP17A1 mRNA

NCBI chr 1:255,476,861...255,484,547
Ensembl chr 1:245,535,462...245,541,573

G

cytochrome P450, family 1, subfamily a, polypeptide 1

multiple interactions
increases activity
increases expression
decreases expression
affects expression

[benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with Benzo(a)pyrene co-treated with chrysene] results in increased expression of CYP1A1 mRNA; [benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with Benzo(a)pyrene co-treated with chrysene] results in increased expression of CYP1A1 protein; [Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of CYP1A1 mRNA; [Docosahexaenoic Acids co-treated with benzo(b)fluoranthene] results in decreased expression of CYP1A1 mRNA; [phenanthrene co-treated with pyrene co-treated with Benzo(a)pyrene co-treated with benzo(k)fluoranthene co-treated with dibenzo(a,l)pyrene co-treated with benzo(b)fluoranthene] results in increased expression of CYP1A1 mRNA; [propiconazole co-treated with benzo(b)fluoranthene] results in increased expression of CYP1A1 mRNA; benzo(b)fluoranthene promotes the reaction [AHR protein results in increased expression of CYP1A1 mRNA]; Cadmium Chloride inhibits the reaction [benzo(b)fluoranthene results in increased activity of CYP1A1 protein]; lead nitrate inhibits the reaction [benzo(b)fluoranthene results in increased activity of CYP1A1 protein]; Mercuric Chloride inhibits the reaction [benzo(b)fluoranthene results in increased activity of CYP1A1 protein]; sodium arsenite inhibits the reaction [benzo(b)fluoranthene results in increased activity of CYP1A1 protein]
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CYP1A1 mRNA; [fluoranthene co-treated with pyrene co-treated with benz(a)anthracene co-treated with chrysene co-treated with benzo(b)fluoranthene co-treated with benzo(k)fluoranthene co-treated with Benzo(a)pyrene] results in increased expression of CYP1A1 mRNA
[chrysene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene] promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 mRNA]; [chrysene co-treated with Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene] results in increased expression of CYP1A1 mRNA; AHR affects the reaction [benzo(b)fluoranthene results in increased expression of CYP1A1 mRNA]; Benzo(a)pyrene promotes the reaction [benzo(b)fluoranthene results in increased expression of CYP1A1 mRNA]; benzo(b)fluoranthene affects the reaction [Benzo(a)pyrene affects the expression of CYP1A1 mRNA]; benzo(b)fluoranthene promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 mRNA]
benzo(b)fluoranthene results in increased expression of CYP1A1 mRNA; benzo(b)fluoranthene results in increased expression of CYP1A1 protein
benzo(b)fluoranthene results in decreased expression of CYP1A1 mRNA
benzo(b)fluoranthene affects the expression of CYP1A1 mRNA

PMID:7750161 PMID:10190573 PMID:11162773 PMID:11408366 PMID:12117779 More...

NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:58,096,077...58,102,125

G

cytochrome P450, family 1, subfamily a, polypeptide 2

increases expression
multiple interactions
decreases activity

benzo(b)fluoranthene results in increased expression of CYP1A2 mRNA
[fluoranthene co-treated with pyrene co-treated with benz(a)anthracene co-treated with chrysene co-treated with benzo(b)fluoranthene co-treated with benzo(k)fluoranthene co-treated with Benzo(a)pyrene] results in increased expression of CYP1A2 mRNA
benzo(b)fluoranthene results in decreased activity of CYP1A2 protein
[Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of CYP1A2 mRNA; [propiconazole co-treated with benzo(b)fluoranthene] results in increased expression of CYP1A2 mRNA
[Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of CYP1A2 mRNA; [chrysene co-treated with Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene] results in increased expression of CYP1A2 mRNA

PMID:7750161 PMID:11162773 PMID:12117779 PMID:16269432 PMID:17253728 More...

NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:58,075,367...58,082,312

G

cytochrome P450, family 1, subfamily b, polypeptide 1

multiple interactions
increases expression
affects expression

[benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with Benzo(a)pyrene co-treated with chrysene] results in increased expression of CYP1B1 mRNA; [benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with Benzo(a)pyrene co-treated with chrysene] results in increased expression of CYP1B1 protein; [phenanthrene co-treated with pyrene co-treated with Benzo(a)pyrene co-treated with benzo(k)fluoranthene co-treated with dibenzo(a,l)pyrene co-treated with benzo(b)fluoranthene] results in increased expression of CYP1B1 mRNA
benzo(b)fluoranthene results in increased expression of CYP1B1 mRNA
[benz(a)anthracene co-treated with benzo(b)fluoranthene] promotes the reaction [chrysene promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1B1 mRNA]]; [chrysene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene] promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1B1 mRNA]; [chrysene co-treated with Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene] results in increased expression of CYP1B1 mRNA; benzo(b)fluoranthene affects the reaction [Benzo(a)pyrene affects the expression of CYP1B1 mRNA]
benzo(b)fluoranthene affects the expression of CYP1B1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CYP1B1 mRNA

PMID:12117779 PMID:15566942 PMID:17961608 PMID:26377693 PMID:27099206 More...

NCBI chr 6:21,093,927...21,103,091
Ensembl chr 6:15,342,344...15,350,917

G

cytochrome P450, family 26, subfamily b, polypeptide 1

decreases expression

benzo(b)fluoranthene results in decreased expression of CYP26B1 mRNA

NCBI chr 4:118,599,356...118,616,176
Ensembl chr 4:117,041,808...117,058,628

G

cytochrome P450, family 2, subfamily b, polypeptide 2

increases expression

benzo(b)fluoranthene results in increased expression of CYP2B13 mRNA

NCBI chr 1:90,722,243...90,736,272
Ensembl chr 1:81,594,555...81,608,566

G

cytochrome P450, family 2, subfamily b, polypeptide 3

increases expression

benzo(b)fluoranthene results in increased expression of CYP2B10 mRNA

NCBI chr 1:90,780,468...90,859,852
Ensembl chr 1:81,652,787...81,732,143

G

cytochrome P450, family 2, subfamily d, polypeptide 4

increases expression

benzo(b)fluoranthene results in increased expression of CYP2D6 mRNA

NCBI chr 7:115,762,662...115,771,832
Ensembl chr 7:113,881,618...113,891,759

G

cytochrome P450, family 2, subfamily e, polypeptide 1

increases expression

benzo(b)fluoranthene results in increased expression of CYP2E1 mRNA

NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:195,840,058...195,864,023

G

cytochrome P450, family 2, subfamily g, polypeptide 1

increases expression

benzo(b)fluoranthene results in increased expression of CYP2G1 mRNA

NCBI chr 1:91,273,309...91,284,499
Ensembl chr 1:82,145,073...82,156,828

G

cytochrome P450, family 4, subfamily b, polypeptide 1

decreases expression

benzo(b)fluoranthene results in decreased expression of CYP4B1 mRNA

NCBI chr 5:134,375,807...134,413,635
Ensembl chr 5:129,139,038...129,156,348

G

cytochrome P450 family 7 subfamily B member 1

increases expression

benzo(b)fluoranthene results in increased expression of CYP7B1 mRNA

NCBI chr 2:102,419,011...102,586,047
Ensembl chr 2:100,502,791...100,669,698

G

cystin 1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CYS1 mRNA

NCBI chr 6:47,029,440...47,046,671
Ensembl chr 6:41,300,836...41,318,071

G

cytohesin 2

increases expression

benzo(b)fluoranthene results in increased expression of CYTH2 mRNA

NCBI chr 1:96,283,182...96,291,094
Ensembl chr 1:96,284,252...96,291,092

G

cytokine like 1

decreases expression

benzo(b)fluoranthene results in decreased expression of CYTL1 mRNA

NCBI chr14:77,278,635...77,283,645
Ensembl chr14:73,053,877...73,058,886

G

DAB adaptor protein 2

increases expression

benzo(b)fluoranthene results in increased expression of DAB2 mRNA

NCBI chr 2:57,241,947...57,294,893
Ensembl chr 2:55,514,700...55,567,476

G

dachshund family transcription factor 1

increases expression

benzo(b)fluoranthene results in increased expression of DACH1 mRNA

NCBI chr15:74,528,122...74,909,811
Ensembl chr15:74,529,208...74,909,922

G

differentiation antagonizing non-protein coding RNA

affects expression

benzo(b)fluoranthene affects the expression of DANCR mRNA

NCBI chr14:34,126,956...34,127,936

G

death associated protein-like 1

increases expression

benzo(b)fluoranthene results in increased expression of DAPL1 mRNA

NCBI chr 3:64,369,734...64,389,677
Ensembl chr 3:43,960,810...43,980,940

G

aspartyl-tRNA synthetase 1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of DARS1 mRNA

NCBI chr13:42,410,351...42,465,467
Ensembl chr13:39,857,936...39,913,116

G

diazepam binding inhibitor

decreases expression

benzo(b)fluoranthene results in decreased expression of DBI mRNA

NCBI chr13:33,794,231...33,802,632
Ensembl chr13:31,206,988...31,268,693

G

D-box binding PAR bZIP transcription factor

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of DBP mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of DBP mRNA

PMID:26377693 PMID:27858113

NCBI chr 1:105,312,256...105,317,205
Ensembl chr 1:96,175,440...96,180,745

G

DDB1 and CUL4 associated factor 12-like 2

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of DCAF12L2 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of DCAF12L2 mRNA

PMID:26377693 PMID:27858113

NCBI chr X:123,293,761...123,296,550
Ensembl chr X:123,294,744...123,296,156

G

DDB1 and CUL4 associated factor 4

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of DCAF4 mRNA

NCBI chr 6:103,154,847...103,180,992
Ensembl chr 6:103,154,867...103,180,982

G

DCC netrin 1 receptor

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of DCC mRNA

NCBI chr18:67,144,272...68,248,159
Ensembl chr18:64,873,898...65,972,740

G

decorin

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of DCN mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of DCN mRNA

PMID:26377693 PMID:27858113

NCBI chr 7:34,167,973...34,208,004
Ensembl chr 7:32,281,252...32,321,270

G

dimethylarginine dimethylaminohydrolase 1

affects expression
multiple interactions

benzo(b)fluoranthene affects the expression of DDAH1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of DDAH1 mRNA

PMID:26377693 PMID:27858113

NCBI chr 2:237,327,812...237,460,624
Ensembl chr 2:234,667,491...234,799,339

G

dopa decarboxylase

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of DDC mRNA

NCBI chr14:90,592,304...90,682,830
Ensembl chr14:86,378,685...86,469,208

G

DNA damage-induced apoptosis suppressor

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of DDIAS mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of DDIAS mRNA

PMID:26377693 PMID:27858113

NCBI chr 1:156,318,559...156,342,869
Ensembl chr 1:146,906,154...146,930,462

G

DNA-damage-inducible transcript 4-like

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of DDIT4L mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of DDIT4L mRNA

PMID:26377693 PMID:27858113

NCBI chr 2:228,800,831...228,804,478
Ensembl chr 2:226,128,276...226,131,375

G

DEAD-box helicase 25

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of DDX25 mRNA

NCBI chr 8:42,152,046...42,168,635
Ensembl chr 8:33,894,232...33,921,764

G

DEAD-box helicase 5

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of DDX5 mRNA

NCBI chr10:92,224,393...92,231,928
Ensembl chr10:91,723,508...91,732,283

G

DEF6 guanine nucleotide exchange factor

increases expression

benzo(b)fluoranthene results in increased expression of DEF6 mRNA

NCBI chr20:6,268,579...6,290,030
Ensembl chr20:6,268,601...6,289,961

G

DEP domain containing 1B

increases expression

benzo(b)fluoranthene results in increased expression of DEPDC1B mRNA

NCBI chr 2:41,605,686...41,697,207
Ensembl chr 2:39,891,481...39,963,779

G

diacylglycerol O-acyltransferase 2

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of DGAT2 mRNA

NCBI chr 1:162,866,237...162,896,655
Ensembl chr 1:153,454,080...153,484,428

G

24-dehydrocholesterol reductase

increases expression

benzo(b)fluoranthene results in increased expression of DHCR24 mRNA

NCBI chr 5:126,573,366...126,599,940
Ensembl chr 5:121,344,575...121,371,137

G

diaphanous-related formin 1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of DIAP1 mRNA

NCBI chr18:29,920,889...30,020,280
Ensembl chr18:29,669,659...29,769,172

G

diaphanous-related formin 3

increases expression

benzo(b)fluoranthene results in increased expression of DIAPH3 mRNA

NCBI chr15:68,951,992...69,421,623
Ensembl chr15:62,543,375...63,012,975

G

death inducer-obliterator 1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of DIDO1 mRNA

NCBI chr 3:167,772,535...167,825,894
Ensembl chr 3:167,772,770...167,817,218

G

iodothyronine deiodinase 1

decreases expression

benzo(b)fluoranthene results in decreased expression of DIO1 mRNA

NCBI chr 5:127,303,089...127,319,784
Ensembl chr 5:122,074,279...122,090,970

G

divergent protein kinase domain 1B

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of DIPK1B mRNA

NCBI chr 3:29,852,710...29,862,248
Ensembl chr 3:9,456,409...9,464,161

G

dispatched RND transporter family member 2

increases expression

benzo(b)fluoranthene results in increased expression of DISP2 mRNA

NCBI chr 3:105,762,303...105,777,826
Ensembl chr 3:105,762,305...105,777,800

G

dematin actin binding protein

increases expression

benzo(b)fluoranthene results in increased expression of DMTN mRNA

NCBI chr15:52,087,667...52,111,956
Ensembl chr15:45,677,977...45,705,601

G

dynein axonemal assembly factor 10

increases expression

benzo(b)fluoranthene results in increased expression of DNAAF10 mRNA

NCBI chr14:91,618,649...91,639,828
Ensembl chr14:91,636,157...91,639,831

G

dynein, axonemal, heavy chain 8

decreases expression

benzo(b)fluoranthene results in decreased expression of DNAH8 mRNA

NCBI chr20:8,694,371...8,948,849
Ensembl chr20:8,692,963...8,946,772

G

DnaJ heat shock protein family (Hsp40) member A1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of DNAJA1 mRNA

NCBI chr 5:60,638,404...60,649,315
Ensembl chr 5:55,842,426...55,853,967

G

DnaJ heat shock protein family (Hsp40) member B11

increases expression

benzo(b)fluoranthene results in increased expression of DNAJB11 mRNA

NCBI chr11:91,656,334...91,672,800
Ensembl chr11:78,150,429...78,180,407

G

DnaJ heat shock protein family (Hsp40) member B4

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of DNAJB4 mRNA

NCBI chr 2:243,790,296...243,819,042
Ensembl chr 2:241,130,340...241,159,089

G

DnaJ heat shock protein family (Hsp40) member C8

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of DNAJC8 mRNA

NCBI chr 5:144,745,055...144,763,106
Ensembl chr 5:144,745,036...144,763,108

G

deoxyribonuclease 1 like 2

increases expression

benzo(b)fluoranthene results in increased expression of DNASE1L2 mRNA

NCBI chr10:13,976,012...13,978,574
Ensembl chr10:13,471,479...13,473,763

G

DNA methyltransferase 3 alpha

increases expression

benzo(b)fluoranthene results in increased expression of DNMT3A mRNA

NCBI chr 6:32,507,316...32,621,678
Ensembl chr 6:26,822,609...26,896,687

G

docking protein 3

increases expression

benzo(b)fluoranthene results in increased expression of DOK3 mRNA

NCBI chr17:9,109,633...9,115,188
Ensembl chr17:9,109,597...9,115,188

G

dolichyl-phosphate N-acetylglucosaminephosphotransferase 1

increases expression

benzo(b)fluoranthene results in increased expression of DPAGT1 mRNA

NCBI chr 8:44,664,055...44,671,102
Ensembl chr 8:44,664,071...44,671,087

G

dipeptidase 2

increases expression

benzo(b)fluoranthene results in increased expression of DPEP2 mRNA

NCBI chr19:50,795,322...50,806,320
Ensembl chr19:33,885,478...33,891,954

G

dopamine receptor D1

multiple interactions

[Particulate Matter results in increased abundance of benzo(b)fluoranthene] which results in decreased expression of DRD1 mRNA

NCBI chr17:10,545,488...10,550,029
Ensembl chr17:10,540,558...10,545,002

G

denticleless E3 ubiquitin protein ligase homolog

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of DTL mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of DTL mRNA

PMID:26377693 PMID:27858113

NCBI chr13:105,646,908...105,685,921
Ensembl chr13:103,117,186...103,154,890

G

deltex E3 ubiquitin ligase 4

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of DTX4 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of DTX4 mRNA

PMID:26377693 PMID:27858113

NCBI chr 1:218,882,391...218,969,837
Ensembl chr 1:209,460,735...209,492,818

G

dishevelled segment polarity protein 3

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of DVL3 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of DVL3 mRNA

PMID:26377693 PMID:27858113

NCBI chr11:93,869,834...93,887,013
Ensembl chr11:80,366,117...80,382,462

G

dynein cytoplasmic 1 intermediate chain 1

increases expression

benzo(b)fluoranthene results in increased expression of DYNC1I1 mRNA

NCBI chr 4:34,819,313...35,132,647
Ensembl chr 4:33,852,927...34,166,149

G

dysferlin

increases expression

benzo(b)fluoranthene results in increased expression of DYSF mRNA

NCBI chr 4:118,048,460...118,248,273
Ensembl chr 4:116,490,616...116,690,709

G

DAZ interacting zinc finger protein 1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of DZIP1 mRNA

NCBI chr15:102,363,392...102,417,085
Ensembl chr15:95,956,398...96,010,066

G

E2F transcription factor 3

increases expression

benzo(b)fluoranthene results in increased expression of E2F3 mRNA

NCBI chr17:34,810,355...34,887,725
Ensembl chr17:34,601,830...34,676,253

G

E2F transcription factor 7

increases expression

benzo(b)fluoranthene results in increased expression of E2F7 mRNA

NCBI chr 7:46,150,533...46,192,739
Ensembl chr 7:46,151,293...46,192,734

G

E2F transcription factor 8

increases expression

benzo(b)fluoranthene results in increased expression of E2F8 mRNA

NCBI chr 1:107,701,985...107,720,538
Ensembl chr 1:98,565,717...98,584,098

G

endothelin converting enzyme 1

multiple interactions

[Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of ECE1 mRNA

NCBI chr 5:155,361,031...155,462,723
Ensembl chr 5:150,077,644...150,179,371

G

enoyl CoA hydratase domain containing 2

increases expression

benzo(b)fluoranthene results in increased expression of ECHDC2 mRNA

NCBI chr 5:122,915,874...122,934,860
Ensembl chr 5:122,916,134...122,934,859

G

extracellular matrix protein 1

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of ECM1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of ECM1 mRNA

PMID:26377693 PMID:27858113

NCBI chr 2:185,976,439...185,981,656
Ensembl chr 2:183,287,322...183,292,671

G

epithelial cell transforming 2

increases expression

benzo(b)fluoranthene results in increased expression of ECT2 mRNA

NCBI chr 2:111,904,522...111,966,786
Ensembl chr 2:109,975,813...110,037,911

G

EGF like repeats and discoidin domains 3

increases expression

benzo(b)fluoranthene results in increased expression of EDIL3 mRNA

NCBI chr 2:21,625,604...22,140,380
Ensembl chr 2:19,890,373...20,405,008

G

endothelin receptor type B

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of EDNRB mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of EDNRB mRNA

PMID:26377693 PMID:27858113

NCBI chr15:87,055,490...87,086,765
Ensembl chr15:80,643,043...80,672,115

G

EGF containing fibulin extracellular matrix protein 2

increases expression

benzo(b)fluoranthene results in increased expression of EFEMP2 mRNA

NCBI chr 1:212,211,057...212,218,739
Ensembl chr 1:202,781,665...202,789,414

G

ephrin A1

decreases expression

benzo(b)fluoranthene results in decreased expression of EFNA1 mRNA

NCBI chr 2:176,979,434...176,988,675
Ensembl chr 2:174,681,682...174,690,866

G

ephrin B1

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of EFNB1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of EFNB1 mRNA

PMID:26377693 PMID:27858113

NCBI chr X:68,297,529...68,310,335
Ensembl chr X:64,257,351...64,270,157

G

EGF-like-domain, multiple 7

increases expression

benzo(b)fluoranthene results in increased expression of EGFL7 mRNA

NCBI chr 3:29,802,481...29,814,966
Ensembl chr 3:9,407,520...9,416,879

G

epidermal growth factor receptor

multiple interactions
decreases expression

benzo(b)fluoranthene affects the localization of and results in increased expression of EGFR protein
benzo(b)fluoranthene results in decreased expression of EGFR mRNA

PMID:21776270 PMID:26377693

NCBI chr14:95,378,626...95,551,358
Ensembl chr14:91,177,067...91,344,382

G

early growth response 1

increases expression

benzo(b)fluoranthene results in increased expression of EGR1 mRNA
benzo(b)fluoranthene results in increased expression of EGR1 mRNA; benzo(b)fluoranthene results in increased expression of EGR1 protein

PMID:26377693 PMID:29787794

NCBI chr18:26,737,078...26,740,877
Ensembl chr18:26,462,981...26,466,766

G

EH domain binding protein 1

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of EHBP1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of EHBP1 mRNA

PMID:26377693 PMID:27858113

NCBI chr14:100,294,585...100,581,764
Ensembl chr14:96,093,327...96,345,332

G

EH-domain containing 1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of EHD1 mRNA

NCBI chr 1:213,009,113...213,031,488
Ensembl chr 1:203,579,869...203,602,212

G

EH-domain containing 3

increases expression

benzo(b)fluoranthene results in increased expression of EHD3 mRNA

NCBI chr 6:27,392,709...27,417,445
Ensembl chr 6:21,639,290...21,665,236

G

EH-domain containing 4

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of EHD4 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of EHD4 mRNA

PMID:26377693 PMID:27858113

NCBI chr 3:127,511,973...127,575,856
Ensembl chr 3:107,058,958...107,122,002

G

ets homologous factor

decreases expression

benzo(b)fluoranthene results in decreased expression of EHF mRNA

NCBI chr 3:110,094,770...110,134,991
Ensembl chr 3:89,641,833...89,679,997

G

EP300 interacting inhibitor of differentiation 1

increases expression

benzo(b)fluoranthene results in increased expression of EID1 mRNA

NCBI chr 3:133,376,389...133,378,108
Ensembl chr 3:112,922,668...112,924,752

G

ELOVL fatty acid elongase 1

increases expression

benzo(b)fluoranthene results in increased expression of ELOVL1 mRNA

NCBI chr 5:137,246,781...137,251,351
Ensembl chr 5:131,961,322...131,965,958

G

endomucin

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of EMCN mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of EMCN mRNA

PMID:26377693 PMID:27858113

NCBI chr 2:228,564,445...228,644,370
Ensembl chr 2:225,891,100...225,970,929

G

EMI domain containing 1

increases expression

benzo(b)fluoranthene results in increased expression of EMID1 mRNA

NCBI chr14:84,214,530...84,257,628
Ensembl chr14:80,000,486...80,043,620

G

EMAP like 1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of EML1 mRNA

NCBI chr 6:133,048,271...133,221,642
Ensembl chr 6:127,284,029...127,457,246

G

epithelial membrane protein 1

increases expression

benzo(b)fluoranthene results in increased expression of EMP1 mRNA

NCBI chr 4:169,931,537...169,964,366
Ensembl chr 4:168,212,861...168,232,904

G

endonuclease, poly(U)-specific

increases expression

benzo(b)fluoranthene results in increased expression of ENDOU mRNA

NCBI chr 7:130,723,972...130,745,672
Ensembl chr 7:128,844,862...128,866,596

G

enolase 3

decreases expression

benzo(b)fluoranthene results in decreased expression of ENO3 mRNA

NCBI chr10:55,868,880...55,876,099
Ensembl chr10:55,366,975...55,375,921

G

ectonucleoside triphosphate diphosphohydrolase 2

increases expression

benzo(b)fluoranthene results in increased expression of ENTPD2 mRNA

NCBI chr 3:28,611,722...28,617,237
Ensembl chr 3:8,213,663...8,226,866

G

endosomal transmembrane epsin interactor 3

increases expression

benzo(b)fluoranthene results in increased expression of ENTREP3 mRNA

NCBI chr 2:176,886,903...176,893,047
Ensembl chr 2:174,589,337...174,595,281

G

erythrocyte membrane protein band 4.1

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of EPB41 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of EPB41 mRNA

PMID:26377693 PMID:27858113

NCBI chr 5:149,394,080...149,548,178
Ensembl chr 5:144,111,906...144,237,821

G

Eph receptor A1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of EPHA1 mRNA

NCBI chr 4:72,213,022...72,227,543
Ensembl chr 4:71,246,409...71,260,846

G

Eph receptor A2

increases expression

benzo(b)fluoranthene results in increased expression of EPHA2 mRNA

NCBI chr 5:158,888,629...158,917,100
Ensembl chr 5:153,605,644...153,634,117

G

epoxide hydrolase 1

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of EPHX1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of EPHX1 mRNA

PMID:26377693 PMID:27858113

NCBI chr13:95,246,079...95,275,852
Ensembl chr13:92,714,315...92,790,235

G

epsin 2

decreases expression

benzo(b)fluoranthene results in decreased expression of EPN2 mRNA

NCBI chr10:46,697,238...46,759,128
Ensembl chr10:46,197,785...46,259,642

G

erythropoietin receptor

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of EPOR mRNA

NCBI chr 8:28,765,738...28,770,371
Ensembl chr 8:20,489,678...20,494,257

G

Ets2 repressor factor

increases expression

benzo(b)fluoranthene results in increased expression of ERF mRNA

NCBI chr 1:89,957,760...89,966,213
Ensembl chr 1:80,829,935...80,838,388

G

ermin

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ERMN mRNA

NCBI chr 3:63,037,001...63,042,657
Ensembl chr 3:42,626,309...42,633,744

G

endothelial cell adhesion molecule

increases expression

benzo(b)fluoranthene results in increased expression of ESAM mRNA

NCBI chr 8:45,426,985...45,437,976
Ensembl chr 8:37,238,287...37,249,215

G

endothelial cell-specific molecule 1

decreases expression

benzo(b)fluoranthene results in decreased expression of ESM1 mRNA

NCBI chr 2:46,609,253...46,617,991
Ensembl chr 2:44,876,067...44,884,804

G

estrogen receptor 1

increases expression
increases activity

benzo(b)fluoranthene results in increased expression of ESR1 protein
benzo(b)fluoranthene results in increased activity of ESR1 protein

PMID:21392559 PMID:28728110

NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:41,210,475...41,495,002

G

ETHE1, persulfide dioxygenase

decreases expression

benzo(b)fluoranthene results in decreased expression of ETHE1 mRNA

NCBI chr 1:89,311,948...89,327,000
Ensembl chr 1:80,183,894...80,199,052

G

eva-1 homolog A, regulator of programmed cell death

increases expression

benzo(b)fluoranthene results in increased expression of EVA1A mRNA

NCBI chr 4:116,151,595...116,200,827
Ensembl chr 4:114,593,341...114,643,011

G

exonuclease 1

increases expression

benzo(b)fluoranthene results in increased expression of EXO1 mRNA

NCBI chr13:90,341,947...90,366,861
Ensembl chr13:87,809,810...87,834,654

G

exocyst complex component 3-like 2

increases expression

benzo(b)fluoranthene results in increased expression of EXOC3L2 mRNA

NCBI chr 1:79,113,784...79,145,359
Ensembl chr 1:79,112,506...79,145,465

G

exocyst complex component 4

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of EXOC4 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of EXOC4 mRNA

PMID:26377693 PMID:27858113

NCBI chr 4:62,774,896...63,551,541
Ensembl chr 4:61,807,761...62,585,723

G

coagulation factor XIII A1 chain

increases expression

benzo(b)fluoranthene results in increased expression of F13A1 mRNA

NCBI chr17:28,021,197...28,197,960
Ensembl chr17:27,815,702...27,992,700

G

coagulation factor III, tissue factor

increases expression

benzo(b)fluoranthene results in increased expression of F3 protein

NCBI chr 2:212,511,675...212,523,375
Ensembl chr 2:209,826,959...209,838,668

G

fatty acid binding protein 1

multiple interactions

[Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of FABP1 mRNA

NCBI chr 4:104,744,302...104,753,119
Ensembl chr 4:103,191,006...103,194,788

G

fatty acid binding protein 12

increases expression

benzo(b)fluoranthene results in increased expression of FABP12 mRNA

NCBI chr 2:93,446,966...93,462,393
Ensembl chr 2:91,500,539...91,554,996

G

fatty acid binding protein 3

decreases expression

benzo(b)fluoranthene results in decreased expression of FABP3 mRNA

NCBI chr 5:147,936,027...147,942,870
Ensembl chr 5:142,651,956...142,658,718

G

fatty acid binding protein 4

decreases expression

benzo(b)fluoranthene results in decreased expression of FABP4 mRNA

NCBI chr 2:93,488,251...93,492,961
Ensembl chr 2:91,580,885...91,585,578

G

fatty acid binding protein 5

increases expression

benzo(b)fluoranthene results in increased expression of FABP5 mRNA

NCBI chr 2:93,672,451...93,676,186
Ensembl chr 2:91,765,056...91,853,773

G

family with sequence similarity 107, member A

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of FAM107A mRNA

NCBI chr15:19,038,726...19,060,644
Ensembl chr15:16,607,205...16,630,396

G

family with sequence similarity 110, member D

multiple interactions
decreases expression

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FAM110D mRNA
benzo(b)fluoranthene results in decreased expression of FAM110D mRNA

PMID:26377693 PMID:27858113

NCBI chr 5:146,471,048...146,474,019
Ensembl chr 5:146,471,049...146,474,056

G

FAM111 trypsin like peptidase A

increases expression

benzo(b)fluoranthene results in increased expression of FAM111A mRNA

NCBI chr 1:219,065,542...219,081,213
Ensembl chr 1:209,640,953...209,656,547

G

family with sequence similarity 133, member B

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of FAM133B mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FAM133B mRNA

PMID:26377693 PMID:27858113

NCBI chr 4:30,589,646...30,616,291
Ensembl chr 4:30,589,635...30,616,040

G

family with sequence similarity 13, member A

increases expression

benzo(b)fluoranthene results in increased expression of FAM13A mRNA

NCBI chr 4:89,386,685...89,485,940
Ensembl chr 4:88,058,403...88,155,860

G

family with sequence similarity 13, member C

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FAM13C mRNA

NCBI chr20:18,064,706...18,186,888
Ensembl chr20:18,065,628...18,187,592

G

family with sequence similarity 193, member B

increases expression

benzo(b)fluoranthene results in increased expression of FAM193B mRNA

NCBI chr17:9,066,818...9,099,511
Ensembl chr17:9,066,707...9,099,508

G

FAM20B, glycosaminoglycan xylosylkinase

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FAM20B mRNA

NCBI chr13:68,801,663...68,839,979
Ensembl chr13:68,801,669...68,839,915

G

family with sequence similarity 43, member A

increases expression

benzo(b)fluoranthene results in increased expression of FAM43A mRNA

NCBI chr11:70,128,253...70,131,401
Ensembl chr11:70,128,253...70,131,401

G

FA complementation group B

decreases expression

benzo(b)fluoranthene results in decreased expression of FANCB mRNA

NCBI chr X:33,035,387...33,051,993
Ensembl chr X:29,403,771...29,420,192

G

FERM, ARH/RhoGEF and pleckstrin domain protein 1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FARP1 mRNA

NCBI chr15:104,531,196...104,770,148
Ensembl chr15:98,182,329...98,363,299

G

fatty acid synthase

multiple interactions

[Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of FASN mRNA

NCBI chr10:106,570,415...106,588,581
Ensembl chr10:106,072,091...106,090,261

G

Fas-activated serine/threonine kinase

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FASTK mRNA

NCBI chr 4:11,624,697...11,628,769
Ensembl chr 4:10,732,256...10,737,430

G

F-box and leucine-rich repeat protein 4

increases expression

benzo(b)fluoranthene results in increased expression of FBXL4 mRNA

NCBI chr 5:40,752,513...40,826,154
Ensembl chr 5:35,955,812...36,029,443

G

F-box protein 5

increases expression

benzo(b)fluoranthene results in increased expression of FBXO5 mRNA

NCBI chr 1:44,601,412...44,607,781
Ensembl chr 1:42,196,068...42,202,437

G

Fc epsilon receptor II

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of FCER2A mRNA

NCBI chr12:6,540,697...6,552,364
Ensembl chr12:1,742,815...1,754,476

G

FCH and double SH3 domains 2

increases expression

benzo(b)fluoranthene results in increased expression of FCHSD2 mRNA

NCBI chr 1:155,444,471...155,685,350
Ensembl chr 1:155,444,460...155,685,539

G

Fc mu receptor

increases expression

benzo(b)fluoranthene results in increased expression of FCMR mRNA

NCBI chr13:44,889,628...44,903,926
Ensembl chr13:42,337,414...42,351,653

G

Fc receptor-like A

increases expression

benzo(b)fluoranthene results in increased expression of FCRLA mRNA

NCBI chr13:83,160,453...83,170,170
Ensembl chr13:83,160,398...83,170,762

G

FES proto-oncogene, tyrosine kinase

increases expression

benzo(b)fluoranthene results in increased expression of FES mRNA

NCBI chr 1:143,746,945...143,756,181
Ensembl chr 1:134,337,698...134,346,934

G

fasciculation and elongation protein zeta 2

increases expression

benzo(b)fluoranthene results in increased expression of FEZ2 mRNA

NCBI chr 6:22,406,685...22,446,745
Ensembl chr 6:16,654,614...16,694,626

G

fibrinogen alpha chain

multiple interactions

[Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of FGA mRNA

NCBI chr 2:170,672,169...170,679,572
Ensembl chr 2:168,374,120...168,381,528

G

FYVE, RhoGEF and PH domain containing 5

increases expression

benzo(b)fluoranthene results in increased expression of FGD5 mRNA

NCBI chr 4:124,497,061...124,594,564
Ensembl chr 4:124,497,068...124,594,563

G

fibroblast growth factor 1

decreases expression

benzo(b)fluoranthene results in decreased expression of FGF1 mRNA

NCBI chr18:30,937,670...31,023,786
Ensembl chr18:30,686,581...30,772,357

G

fibroblast growth factor 9

increases expression

benzo(b)fluoranthene results in increased expression of FGF9 mRNA

NCBI chr15:36,325,552...36,369,995
Ensembl chr15:32,210,074...32,253,309

G

FGFR1 oncogene partner 2

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of FGFR1OP2 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FGFR1OP2 mRNA

PMID:26377693 PMID:27858113

NCBI chr 4:179,491,602...179,512,630
Ensembl chr 4:179,491,599...179,512,630

G

fibroblast growth factor receptor 3

increases expression

benzo(b)fluoranthene results in increased expression of FGFR3 mRNA

NCBI chr14:81,211,800...81,227,215
Ensembl chr14:76,987,993...77,003,341

G

fibrinogen gamma chain

multiple interactions

[Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of FGG mRNA

NCBI chr 2:170,652,929...170,660,372
Ensembl chr 2:168,355,013...168,362,322

G

fibrinogen-like 1

increases expression

benzo(b)fluoranthene results in increased expression of FGL1 mRNA

NCBI chr16:57,824,127...57,854,413
Ensembl chr16:51,120,694...51,151,093

G

four and a half LIM domains 2

decreases expression

benzo(b)fluoranthene results in decreased expression of FHL2 mRNA

NCBI chr 9:52,881,091...52,954,540
Ensembl chr 9:45,388,981...45,431,192

G

formin homology 2 domain containing 3

decreases expression

benzo(b)fluoranthene results in decreased expression of FHOD3 mRNA

NCBI chr18:16,267,830...16,700,508
Ensembl chr18:15,993,324...16,425,796

G

fin bud initiation factor homolog

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of FIBIN mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FIBIN mRNA

PMID:26377693 PMID:27858113

NCBI chr 3:96,942,405...96,944,676
Ensembl chr 3:96,942,406...96,944,676

G

FIG4 phosphoinositide 5-phosphatase

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of FIG4 mRNA

NCBI chr20:46,183,225...46,306,686
Ensembl chr20:44,600,603...44,723,844

G

fidgetin, microtubule severing factor

decreases expression

benzo(b)fluoranthene results in decreased expression of FIGN mRNA

NCBI chr 3:69,045,918...69,169,148
Ensembl chr 3:48,642,496...48,760,787

G

fidgetin-like 1

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of FIGNL1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of FIGNL1 mRNA

PMID:26377693 PMID:27858113

NCBI chr14:90,573,090...90,595,342
Ensembl chr14:86,368,675...86,377,455

G

filamin A interacting protein 1-like

increases expression

benzo(b)fluoranthene results in increased expression of FILIP1L mRNA

NCBI chr11:56,403,467...56,646,422
Ensembl chr11:42,940,467...43,177,415

G

four-jointed box kinase 1

increases expression

benzo(b)fluoranthene results in increased expression of FJX1 mRNA

NCBI chr 3:109,229,223...109,231,324
Ensembl chr 3:88,774,220...88,776,321

G

FKBP prolyl isomerase 14

increases expression

benzo(b)fluoranthene results in increased expression of FKBP14 mRNA

NCBI chr 4:85,035,840...85,051,917
Ensembl chr 4:83,705,652...83,721,528

G

FKBP prolyl isomerase 1A

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FKBP1A mRNA

NCBI chr 3:160,500,748...160,520,492
Ensembl chr 3:140,040,278...140,060,743

G

folliculin

increases expression

benzo(b)fluoranthene results in increased expression of FLCN mRNA

NCBI chr10:45,088,164...45,107,581
Ensembl chr10:44,588,624...44,607,769

G

FLII, actin remodeling protein

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FLII mRNA

NCBI chr10:45,893,566...45,907,547
Ensembl chr10:45,394,032...45,407,970

G

filamin B

increases expression

benzo(b)fluoranthene results in increased expression of FLNB mRNA

NCBI chr15:19,392,212...19,525,278
Ensembl chr15:16,962,003...17,095,006

G

fibronectin leucine rich transmembrane protein 3

decreases expression

benzo(b)fluoranthene results in decreased expression of FLRT3 mRNA

NCBI chr 3:148,448,115...148,461,458
Ensembl chr 3:127,994,226...128,007,841

G

FLVCR choline and putative heme transporter 2

decreases expression

benzo(b)fluoranthene results in decreased expression of FLVCR2 mRNA

NCBI chr 6:105,408,355...105,472,355
Ensembl chr 6:105,408,339...105,472,353

G

formin 2

increases expression

benzo(b)fluoranthene results in increased expression of FMN2 mRNA

NCBI chr13:86,454,256...86,771,437
Ensembl chr13:86,453,926...86,771,411

G

flavin containing dimethylaniline monoxygenase 1

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of FMO1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FMO1 mRNA

PMID:26377693 PMID:27858113

NCBI chr13:77,715,405...77,747,666
Ensembl chr13:75,182,176...75,214,647

G

flavin containing dimethylaniline monoxygenase 3

increases expression

benzo(b)fluoranthene results in increased expression of FMO3 mRNA

NCBI chr13:77,838,899...77,868,869
Ensembl chr13:75,309,374...75,328,028

G

flavin containing dimethylaniline monoxygenase 5

multiple interactions

[Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of FMO5 mRNA

NCBI chr 2:187,885,741...187,938,468
Ensembl chr 2:185,222,204...185,249,693

G

fragile X messenger ribonucleoprotein 1

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of FMR1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FMR1 mRNA

PMID:26377693 PMID:27858113

NCBI chr X:152,284,857...152,322,686
Ensembl chr X:147,240,301...147,278,050

G

fibronectin type III domain containing 1

affects expression
multiple interactions

benzo(b)fluoranthene affects the expression of FNDC1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FNDC1 mRNA

PMID:26377693 PMID:27858113

NCBI chr 1:49,686,856...49,769,263
Ensembl chr 1:47,281,844...47,364,259

G

forkhead box A1

decreases expression

benzo(b)fluoranthene results in decreased expression of FOXA1 mRNA

NCBI chr 6:80,838,380...80,871,195
Ensembl chr 6:75,103,503...75,136,188

G

forkhead box A3

increases expression

benzo(b)fluoranthene results in increased expression of FOXA3 mRNA

NCBI chr 1:87,790,111...87,800,259
Ensembl chr 1:78,662,431...78,672,155

G

forkhead box F1

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of FOXF1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of FOXF1 mRNA

PMID:26377693 PMID:27858113

NCBI chr19:66,062,635...66,066,427
Ensembl chr19:49,153,699...49,157,738

G

forkhead box Q1

increases expression

benzo(b)fluoranthene results in increased expression of FOXQ1 mRNA

NCBI chr17:33,121,454...33,124,087
Ensembl chr17:32,912,744...32,915,377
Ensembl chr17:32,912,744...32,915,377

G

forkhead box S1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FOXS1 mRNA

NCBI chr 3:161,857,264...161,858,548
Ensembl chr 3:141,397,016...141,398,281

G

FSHD region gene 1

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of FRG1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FRG1 mRNA

PMID:26377693 PMID:27858113

NCBI chr16:57,629,221...57,650,188
Ensembl chr16:50,925,803...50,946,661

G

FERM domain containing 4B

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FRMD4B mRNA

NCBI chr 4:129,895,401...130,222,070
Ensembl chr 4:129,895,708...130,084,197

G

fascin actin-bundling protein 3

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FSCN3 mRNA

NCBI chr 4:58,008,124...58,017,674
Ensembl chr 4:57,042,797...57,052,404

G

FXYD domain-containing ion transport regulator 5

increases expression

benzo(b)fluoranthene results in increased expression of FXYD5 mRNA

NCBI chr 1:95,395,327...95,404,722
Ensembl chr 1:86,267,406...86,277,519

G

frizzled class receptor 4

decreases expression

benzo(b)fluoranthene results in decreased expression of FZD4 mRNA

NCBI chr 1:152,692,507...152,701,372
Ensembl chr 1:143,280,065...143,285,724

G

glucose-6-phosphate dehydrogenase

multiple interactions

[Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of G6PD mRNA

NCBI chr X:157,352,364...157,372,144
Ensembl chr X:152,201,098...152,220,801

G

alpha glucosidase

increases expression

benzo(b)fluoranthene results in increased expression of GAA mRNA

NCBI chr10:105,028,106...105,045,365
Ensembl chr10:104,529,747...104,546,836

G

gamma-aminobutyric acid type A receptor subunit pi

decreases expression

benzo(b)fluoranthene results in decreased expression of GABRP mRNA

NCBI chr10:18,143,031...18,169,595
Ensembl chr10:18,143,038...18,169,516

G

growth arrest and DNA-damage-inducible, alpha

multiple interactions

[Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of GADD45A mRNA

NCBI chr 4:97,484,497...97,486,799
Ensembl chr 4:96,154,789...96,157,115

G

growth arrest and DNA-damage-inducible, gamma

increases expression

benzo(b)fluoranthene results in increased expression of GADD45G mRNA

NCBI chr17:13,528,606...13,530,351
Ensembl chr17:13,376,839...13,378,610

G

galactose-3-O-sulfotransferase 2

increases expression

benzo(b)fluoranthene results in increased expression of GAL3ST2 mRNA

NCBI chr 9:101,823,815...101,836,507
Ensembl chr 9:94,376,174...94,389,174

G

polypeptide N-acetylgalactosaminyltransferase 15

decreases expression

benzo(b)fluoranthene results in decreased expression of GALNT15 mRNA

NCBI chr16:7,227,232...7,267,002
Ensembl chr16:7,227,271...7,267,014

G

growth associated protein 43

increases expression

benzo(b)fluoranthene results in increased expression of GAP43 mRNA

NCBI chr11:71,882,131...71,975,799
Ensembl chr11:58,376,371...58,470,045

G

growth arrest specific 5

increases expression

benzo(b)fluoranthene results in increased expression of GAS5 mRNA

NCBI chr13:75,836,963...75,840,284

G

growth arrest specific 6

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of GAS6 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of GAS6 mRNA

PMID:26377693 PMID:27858113

NCBI chr16:82,747,676...82,778,090
Ensembl chr16:76,045,426...76,075,904

G

golgi associated kinase 1B

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of GASK1B mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of GASK1B mRNA

PMID:26377693 PMID:27858113

NCBI chr 2:165,047,689...165,112,479
Ensembl chr 2:165,047,684...165,112,477

G

GATA binding protein 2

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of GATA2 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of GATA2 mRNA

PMID:26377693 PMID:27858113

NCBI chr 4:122,211,501...122,225,058
Ensembl chr 4:120,658,986...120,667,761

G

GATA binding protein 3

decreases expression

benzo(b)fluoranthene results in decreased expression of GATA3 mRNA

NCBI chr17:73,544,234...73,575,670
Ensembl chr17:68,643,873...68,665,391

G

GATA binding protein 6

decreases expression

benzo(b)fluoranthene results in decreased expression of GATA6 mRNA

NCBI chr18:2,460,909...2,492,322
Ensembl chr18:2,188,121...2,219,532

G

GC, vitamin D binding protein

increases expression

benzo(b)fluoranthene results in increased expression of GC mRNA

NCBI chr14:18,916,255...18,951,670
Ensembl chr14:18,632,135...18,667,567

G

GRIP and coiled-coil domain containing 2

increases expression

benzo(b)fluoranthene results in increased expression of GCC2 mRNA

NCBI chr20:26,788,472...26,836,728
Ensembl chr20:26,247,404...26,293,613

G

glucagon receptor

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of GCGR mRNA

NCBI chr10:106,306,803...106,314,970
Ensembl chr10:105,808,473...105,816,640

G

GTP cyclohydrolase 1

increases expression

benzo(b)fluoranthene results in increased expression of GCH1 mRNA

NCBI chr15:22,884,006...22,917,412
Ensembl chr15:20,402,527...20,437,698

G

glucokinase

multiple interactions

[Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of GCK mRNA

NCBI chr14:84,999,019...85,041,098
Ensembl chr14:80,785,060...80,826,995

G

glial cells missing transcription factor 1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of GCM1 mRNA

NCBI chr 8:87,805,993...87,819,229
Ensembl chr 8:78,925,687...78,938,924

G

guanine deaminase

increases expression

benzo(b)fluoranthene results in increased expression of GDA mRNA

NCBI chr 1:228,333,401...228,408,901
Ensembl chr 1:218,906,815...218,982,416

G

growth differentiation factor 15

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of GDF15 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of GDF15 mRNA

PMID:26377693 PMID:27858113

NCBI chr16:18,838,436...18,842,022
Ensembl chr16:18,805,239...18,808,055

G

glycerophosphodiester phosphodiesterase domain containing 2

decreases expression

benzo(b)fluoranthene results in decreased expression of GDPD2 mRNA

NCBI chr X:65,826,273...65,835,361
Ensembl chr X:65,826,574...65,835,361

G

glycerophosphodiester phosphodiesterase domain containing 5

increases expression

benzo(b)fluoranthene results in increased expression of GDPD5 mRNA

NCBI chr 1:163,091,844...163,173,559
Ensembl chr 1:153,679,718...153,761,446

G

GDNF family receptor alpha 4

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of GFRA4 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of GFRA4 mRNA

PMID:26377693 PMID:27858113

NCBI chr 3:118,254,937...118,262,252
Ensembl chr 3:118,255,402...118,258,329

G

GTPase, IMAP family member 6

increases expression

benzo(b)fluoranthene results in increased expression of GIMAP6 mRNA

NCBI chr 4:77,653,703...77,659,112
Ensembl chr 4:77,652,610...77,659,116

G

gap junction protein, alpha 4

increases expression

benzo(b)fluoranthene results in increased expression of GJA4 mRNA

NCBI chr 5:144,917,791...144,920,324
Ensembl chr 5:139,633,287...139,635,925

G

gap junction protein, beta 1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of GJB1 mRNA

NCBI chr X:70,541,845...70,549,776
Ensembl chr X:66,501,820...66,509,925

G

galactosidase, beta 1-like 2

decreases expression

benzo(b)fluoranthene results in decreased expression of GLB1L2 mRNA

NCBI chr 8:25,115,462...25,166,843
Ensembl chr 8:25,115,462...25,166,783

G

glycine decarboxylase

decreases expression

benzo(b)fluoranthene results in decreased expression of GLDC mRNA

NCBI chr 1:237,296,753...237,375,620
Ensembl chr 1:227,883,249...227,962,097

G

gliomedin

increases expression

benzo(b)fluoranthene results in increased expression of GLDN mRNA

NCBI chr 8:63,575,270...63,619,346
Ensembl chr 8:54,679,119...54,723,196

G

GLIS family zinc finger 2

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of GLIS2 mRNA

NCBI chr10:11,457,594...11,484,948
Ensembl chr10:10,951,371...10,971,578

G

glyoxalase 1

decreases expression

benzo(b)fluoranthene results in decreased expression of GLO1 mRNA

NCBI chr20:8,665,061...8,683,095
Ensembl chr20:8,662,801...8,681,649

G

geminin, DNA replication inhibitor

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of GMNN mRNA

NCBI chr17:40,729,760...40,738,077
Ensembl chr17:40,301,808...40,310,054

G

G protein subunit alpha 14

decreases expression

benzo(b)fluoranthene results in decreased expression of GNA14 mRNA

NCBI chr 1:223,141,802...223,324,210
Ensembl chr 1:213,716,020...213,897,423

G

G protein subunit alpha i1

increases expression

benzo(b)fluoranthene results in increased expression of GNAI1 mRNA

NCBI chr 4:17,706,061...17,790,176
Ensembl chr 4:16,814,001...16,896,417

G

G protein subunit alpha transducin 1

increases expression

benzo(b)fluoranthene results in increased expression of GNAT1 mRNA

NCBI chr 8:117,229,575...117,234,311
Ensembl chr 8:108,350,935...108,355,671

G

golgin A7 family, member B

decreases expression

benzo(b)fluoranthene results in decreased expression of GOLGA7B mRNA

NCBI chr 1:250,999,268...251,030,169
Ensembl chr 1:241,059,171...241,079,081

G

golgi membrane protein 1

increases expression

benzo(b)fluoranthene results in increased expression of GOLM1 mRNA

NCBI chr17:4,996,978...5,049,278
Ensembl chr17:4,996,104...5,034,057

G

glycoprotein IX (platelet)

decreases expression

benzo(b)fluoranthene results in decreased expression of GP9 mRNA

NCBI chr 4:120,235,500...120,237,110
Ensembl chr 4:120,235,421...120,237,110

G

glycerol-3-phosphate dehydrogenase 1

decreases expression

benzo(b)fluoranthene results in decreased expression of GPD1 mRNA

NCBI chr 7:132,722,982...132,730,373
Ensembl chr 7:130,844,138...130,851,529

G

glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of GPIHBP1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of GPIHBP1 mRNA

PMID:26377693 PMID:27858113

NCBI chr 7:109,166,334...109,169,448
Ensembl chr 7:107,285,654...107,288,702

G

G protein-coupled receptor 146

increases expression

benzo(b)fluoranthene results in increased expression of GPR146 mRNA

NCBI chr12:20,365,790...20,381,122
Ensembl chr12:15,251,813...15,267,206

G

G protein-coupled receptor 162

decreases expression

benzo(b)fluoranthene results in decreased expression of GPR162 mRNA

NCBI chr 4:157,662,200...157,668,341
Ensembl chr 4:157,662,200...157,668,121

G

G protein-coupled receptor 182

decreases expression

benzo(b)fluoranthene results in decreased expression of GPR182 mRNA

NCBI chr 7:65,471,254...65,474,110
Ensembl chr 7:63,578,750...63,589,210

G

G protein-coupled receptor 4

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of GPR4 mRNA

NCBI chr 1:87,993,398...88,004,568
Ensembl chr 1:78,865,409...78,876,599

G

GPRIN family member 3

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of GPRIN3 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of GPRIN3 mRNA

PMID:26377693 PMID:27858113

NCBI chr 4:89,902,198...89,987,496
Ensembl chr 4:88,563,607...88,657,429

G

growth factor receptor bound protein 10

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of GRB10 mRNA

NCBI chr14:90,708,653...90,816,399
Ensembl chr14:86,495,054...86,602,806

G

growth regulating estrogen receptor binding 1

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of GREB1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of GREB1 mRNA

PMID:26377693 PMID:27858113

NCBI chr 6:39,440,522...39,562,364
Ensembl chr 6:39,440,504...39,581,633

G

gremlin 2, DAN family BMP antagonist

increases expression

benzo(b)fluoranthene results in increased expression of GREM2 mRNA

NCBI chr13:89,310,897...89,403,856
Ensembl chr13:86,778,500...86,871,615

G

glutamate ionotropic receptor AMPA type subunit 3

increases expression

benzo(b)fluoranthene results in increased expression of GRIA3 mRNA

NCBI chr X:125,103,975...125,369,690
Ensembl chr X:120,238,534...120,504,096

G

galectin-related inter-fiber protein

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of GRIFIN mRNA

NCBI chr12:14,080,170...14,082,892
Ensembl chr12:14,080,910...14,082,877

G

glutamate ionotropic receptor NMDA type subunit 2C

increases expression

benzo(b)fluoranthene results in increased expression of GRIN2C mRNA

NCBI chr10:100,987,410...101,006,064
Ensembl chr10:100,488,431...100,506,427

G

G protein-coupled receptor kinase 3

decreases expression

benzo(b)fluoranthene results in decreased expression of GRK3 mRNA

NCBI chr12:49,285,228...49,395,803
Ensembl chr12:43,624,897...43,731,262

G

gastrin releasing peptide

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of GRP mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of GRP mRNA

PMID:26377693 PMID:27858113

NCBI chr18:61,658,655...61,672,037
Ensembl chr18:59,388,274...59,402,061

G

gasdermin D

increases expression

benzo(b)fluoranthene results in increased expression of GSDMD mRNA

NCBI chr 7:109,423,209...109,427,771
Ensembl chr 7:107,542,083...107,547,055

G

gasdermin E

increases expression

benzo(b)fluoranthene results in increased expression of GSDME mRNA

NCBI chr 4:80,590,344...80,651,943
Ensembl chr 4:79,257,804...79,320,806

G

glutathione S-transferase mu 1

multiple interactions

[Docosahexaenoic Acids co-treated with benzo(b)fluoranthene] results in decreased expression of GSTM1 protein

NCBI chr 2:198,338,005...198,346,007
Ensembl chr 2:195,649,845...195,655,411

G

general transcription factor IIB

increases expression

benzo(b)fluoranthene results in increased expression of GTF2B mRNA

NCBI chr 2:234,427,734...234,446,043
Ensembl chr 2:231,767,238...231,785,651

G

general transcription factor IIE subunit 1

decreases expression

benzo(b)fluoranthene results in decreased expression of GTF2E1 mRNA

NCBI chr11:63,182,073...63,215,349
Ensembl chr11:63,182,349...63,213,942

G

granzyme A

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of GZMA mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of GZMA mRNA

PMID:26377693 PMID:27858113

NCBI chr 2:46,473,763...46,485,696
Ensembl chr 2:44,740,569...44,752,493

G

H1.2 linker histone, cluster member

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of H1F2 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of H1F2 mRNA

PMID:26377693 PMID:27858113

NCBI chr17:41,818,962...41,820,453
Ensembl chr17:41,388,477...41,392,635

G

H1.4 linker histone, cluster member

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of H1F4 mRNA

NCBI chr17:41,914,425...41,915,206
Ensembl chr17:41,486,560...41,487,403

G

H1.5 linker histone, cluster member

increases expression

benzo(b)fluoranthene results in increased expression of H1F5 mRNA

NCBI chr17:47,421,875...47,422,905
Ensembl chr17:42,726,127...42,769,160

G

H2A clustered histone 25

increases expression

benzo(b)fluoranthene results in increased expression of H2AC25 mRNA

NCBI chr10:44,233,283...44,234,835
Ensembl chr10:43,733,668...43,744,874

G

H2A.J histone

increases expression

benzo(b)fluoranthene results in increased expression of H2AJ mRNA

NCBI chr 4:169,675,718...169,676,202
Ensembl chr 4:169,675,752...169,677,006

G

H2A.Z variant histone 1

increases expression

benzo(b)fluoranthene results in increased expression of H2AZ1 mRNA

NCBI chr 2:226,355,668...226,357,984
Ensembl chr 2:226,355,708...226,358,485

G

H2B clustered histone 1

increases expression

benzo(b)fluoranthene results in increased expression of H2BC1 mRNA

NCBI chr17:41,599,912...41,600,381
Ensembl chr17:41,171,903...41,176,782
Ensembl chr17:41,171,903...41,176,782

G

H2B clustered histone 6

increases expression

benzo(b)fluoranthene results in increased expression of H2BC6 mRNA

NCBI chr17:41,948,813...41,949,276

G

hepcidin antimicrobial peptide

increases expression
decreases expression

benzo(b)fluoranthene results in increased expression of HAMP mRNA
benzo(b)fluoranthene results in decreased expression of HAMP mRNA

PMID:16269432 PMID:26377693

NCBI chr 1:95,298,332...95,300,271
Ensembl chr 1:86,170,901...86,172,891

G

huntingtin-associated protein 1

decreases expression

benzo(b)fluoranthene results in decreased expression of HAP1 mRNA

NCBI chr10:85,778,267...85,786,553
Ensembl chr10:85,277,890...85,286,126

G

histone H3 associated protein kinase

increases expression

benzo(b)fluoranthene results in increased expression of HASPIN mRNA

NCBI chr10:58,246,244...58,249,031
Ensembl chr10:57,747,573...57,750,512

G

histone deacetylase 1

decreases expression

benzo(b)fluoranthene results in decreased expression of HDAC1 mRNA

NCBI chr 5:147,138,328...147,165,387
Ensembl chr 5:141,853,989...141,881,111

G

HEAT repeat containing 1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of HEATR1 mRNA

NCBI chr17:62,745,008...62,785,609
Ensembl chr17:58,051,700...58,093,948

G

HEXIM P-TEFb complex subunit 2

decreases expression

benzo(b)fluoranthene results in decreased expression of HEXIM2 mRNA

NCBI chr10:88,077,870...88,084,776
Ensembl chr10:88,079,014...88,084,775

G

hes-related family bHLH transcription factor with YRPW motif 1

decreases expression

benzo(b)fluoranthene results in decreased expression of HEY1 mRNA

NCBI chr 2:95,003,935...95,006,457
Ensembl chr 2:93,095,498...93,100,312

G

HIC ZBTB transcriptional repressor 1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of HIC1 mRNA

NCBI chr10:60,512,855...60,517,812
Ensembl chr10:60,011,528...60,019,475

G

hypoxia inducible factor 1 subunit alpha

increases activity
multiple interactions

benzo(b)fluoranthene results in increased activity of HIF1A protein
[Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of HIF1A mRNA

PMID:17690111 PMID:19502547

NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:92,624,390...92,669,261

G

HIG1 hypoxia inducible domain family, member 2A

increases expression

benzo(b)fluoranthene results in increased expression of HIGD2A mRNA

NCBI chr17:10,026,961...10,027,885
Ensembl chr17:10,021,859...10,022,796

G

hypoxia inducible lipid droplet-associated

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of HILPDA mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of HILPDA mRNA

PMID:26377693 PMID:27858113

NCBI chr 4:58,836,463...58,839,423
Ensembl chr 4:57,871,110...57,874,557

G

histone cluster 1 H2A family member H

increases expression

benzo(b)fluoranthene results in increased expression of H2AC22 mRNA

NCBI chr17:41,812,378...41,812,875

G

histone cluster 1, H2bc

increases expression

benzo(b)fluoranthene results in increased expression of H2BC4 mRNA

NCBI chr17:47,388,085...47,392,349
Ensembl chr17:42,694,723...42,696,642

G

hexokinase domain containing 1

increases expression

benzo(b)fluoranthene results in increased expression of HKDC1 mRNA

NCBI chr20:30,878,037...30,917,044
Ensembl chr20:30,335,628...30,373,867

G

HLF transcription factor, PAR bZIP family member

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of HLF mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of HLF mRNA

PMID:26377693 PMID:27858113

NCBI chr10:75,651,320...75,708,979
Ensembl chr10:75,154,507...75,211,935

G

H2.0-like homeobox

increases expression

benzo(b)fluoranthene results in increased expression of HLX mRNA

NCBI chr13:98,811,852...98,817,264
Ensembl chr13:96,280,339...96,285,750

G

histocompatibility minor 13

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of H13 mRNA

NCBI chr 3:161,606,059...161,641,382
Ensembl chr 3:141,145,782...141,184,703

G

homeobox containing 1

decreases expression

benzo(b)fluoranthene results in decreased expression of HMBOX1 mRNA

NCBI chr15:39,067,805...39,200,633
Ensembl chr15:39,067,804...39,200,323

G

hemicentin 1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of HMCN1 mRNA

NCBI chr13:65,165,532...65,634,681
Ensembl chr13:62,615,461...63,084,524

G

high mobility group 20 B

increases expression

benzo(b)fluoranthene results in increased expression of HMG20B mRNA

NCBI chr 7:9,019,670...9,024,382
Ensembl chr 7:8,368,990...8,373,640

G

high mobility group AT-hook 1

increases expression

benzo(b)fluoranthene results in increased expression of HMGA1 mRNA

NCBI chr20:5,612,902...5,620,596
Ensembl chr20:5,611,694...5,618,752

G

high mobility group box 1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of HMGB1 mRNA

NCBI chr12:11,009,236...11,015,941
Ensembl chr12:5,901,586...5,978,565
Ensembl chr16:5,901,586...5,978,565

G

high mobility group box 2

increases expression

benzo(b)fluoranthene results in increased expression of HMGB2 mRNA

NCBI chr16:37,721,374...37,723,950
Ensembl chr16:32,710,658...32,713,140
Ensembl chr 1:32,710,658...32,713,140

G

3-hydroxy-3-methylglutaryl-CoA reductase

multiple interactions
decreases expression

[Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of HMGCR mRNA
benzo(b)fluoranthene results in decreased expression of HMGCR mRNA

PMID:16269432 PMID:17690111

NCBI chr 2:29,732,163...29,754,276
Ensembl chr 2:27,997,525...28,019,703

G

3-hydroxy-3-methylglutaryl-CoA synthase 1

decreases expression

benzo(b)fluoranthene results in decreased expression of HMGCS1 mRNA

NCBI chr 2:53,379,457...53,399,807
Ensembl chr 2:51,649,497...51,667,100

G

high mobility group nucleosomal binding domain 2

increases expression

benzo(b)fluoranthene results in increased expression of HMGN2 mRNA

NCBI chr 5:151,475,907...151,479,361
Ensembl chr 5:146,192,126...146,195,521
Ensembl chr16:146,192,126...146,195,521

G

high mobility group nucleosome binding domain 5

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of HMGN5 mRNA

NCBI chr X:74,085,871...74,094,488
Ensembl chr X:74,085,875...74,094,441
Ensembl chr 1:74,085,875...74,094,441

G

heme oxygenase 1

increases expression

benzo(b)fluoranthene results in increased expression of HMOX1 mRNA

NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,467,244...13,474,079

G

heterogeneous nuclear ribonucleoprotein D-like

increases expression

benzo(b)fluoranthene results in increased expression of HNRNPDL mRNA

NCBI chr14:9,557,430...9,563,659
Ensembl chr14:9,557,425...9,562,506

G

heterogeneous nuclear ribonucleoprotein F

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of HNRNPF mRNA

NCBI chr 4:152,755,668...152,776,867
Ensembl chr 4:151,083,062...151,109,038

G

homer scaffold protein 3

increases expression

benzo(b)fluoranthene results in increased expression of HOMER3 mRNA

NCBI chr16:19,166,141...19,176,701
Ensembl chr16:19,132,162...19,142,680

G

homeo box B3

decreases expression

benzo(b)fluoranthene results in decreased expression of HOXB3 mRNA

NCBI chr10:81,786,001...81,810,655
Ensembl chr10:81,299,357...81,313,107

G

homeo box B5

decreases expression

benzo(b)fluoranthene results in decreased expression of HOXB5 mRNA

NCBI chr10:81,765,911...81,768,119
Ensembl chr10:81,269,372...81,271,580

G

hippocalcin-like 4

increases expression

benzo(b)fluoranthene results in increased expression of HPCAL4 mRNA

NCBI chr 5:135,454,477...135,466,417
Ensembl chr 5:135,454,540...135,466,416

G

HPS1, biogenesis of lysosomal organelles complex 3 subunit 1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of HPS1 mRNA

NCBI chr 1:241,551,180...241,577,292
Ensembl chr 1:241,551,175...241,577,268

G

HPS4, biogenesis of lysosomal organelles complex 3 subunit 2

increases expression

benzo(b)fluoranthene results in increased expression of HPS4 mRNA

NCBI chr12:49,924,444...49,955,201
Ensembl chr12:44,264,037...44,294,632

G

hydroxysteroid 11-beta dehydrogenase 1

multiple interactions

[Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of HSD11B1 mRNA

NCBI chr13:107,277,526...107,327,462
Ensembl chr13:104,728,539...104,788,687

G

hydroxysteroid (17-beta) dehydrogenase 6

increases expression

benzo(b)fluoranthene results in increased expression of HSD17B6 mRNA

NCBI chr 7:831,407...850,950
Ensembl chr 7:422,480...442,425

G

hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7

increases expression

benzo(b)fluoranthene results in increased expression of HSD3B7 mRNA

NCBI chr 1:191,842,688...191,845,919
Ensembl chr 1:182,412,151...182,415,442

G

heat shock protein 90 alpha family class A member 1

multiple interactions

[Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of HSP90AA1 mRNA

NCBI chr 6:135,523,604...135,529,687
Ensembl chr 6:129,702,383...129,707,268

G

heat shock protein 90 beta family member 1

increases expression

benzo(b)fluoranthene results in increased expression of HSP90B1 mRNA

NCBI chr 7:22,997,962...23,012,293
Ensembl chr 7:21,110,457...21,124,788

G

heat shock protein family A (Hsp70) member 1A

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of HSPA1A mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of HSPA1A mRNA

PMID:26377693 PMID:27858113

NCBI chr20:3,875,411...3,877,866
Ensembl chr20:3,856,006...3,873,227

G

HIV-1 Tat interactive protein 2

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of HTATIP2 mRNA

NCBI chr 1:108,609,424...108,624,810
Ensembl chr 1:99,469,245...99,488,629

G

HIV-1 Tat specific factor 1

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of HTATSF1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of HTATSF1 mRNA

PMID:26377693 PMID:27858113

NCBI chr X:139,972,742...139,986,923
Ensembl chr X:134,935,426...134,949,607

G

5-hydroxytryptamine receptor 2A

increases expression

benzo(b)fluoranthene results in increased expression of HTR2A mRNA

NCBI chr15:56,360,647...56,428,703
Ensembl chr15:49,950,804...50,020,928

G

hormonally upregulated Neu-associated kinase

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of HUNK mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of HUNK mRNA

PMID:26377693 PMID:27858113

NCBI chr11:43,127,244...43,244,502
Ensembl chr11:29,640,775...29,757,526

G

hyccin PI4KA lipid kinase complex subunit 2

decreases expression

benzo(b)fluoranthene results in decreased expression of HYCC2 mRNA

NCBI chr 9:60,056,883...60,129,176
Ensembl chr 9:60,056,890...60,093,007

G

islet cell autoantigen 1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of ICA1 mRNA

NCBI chr 4:37,622,759...37,771,055
Ensembl chr 4:36,656,475...36,804,298

G

inhibitor of DNA binding 1

multiple interactions
increases expression

[Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of ID1 mRNA
benzo(b)fluoranthene results in increased expression of ID1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of ID1 mRNA

PMID:18711122 PMID:26377693 PMID:27858113

NCBI chr 3:161,671,525...161,672,691
Ensembl chr 3:141,211,267...141,212,419

G

inhibitor of DNA binding 2

increases expression

benzo(b)fluoranthene results in increased expression of ID2 mRNA

NCBI chr 6:47,469,162...47,470,995
Ensembl chr 6:41,728,946...41,744,400

G

immediate early response 5

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of IER5 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of IER5 mRNA

PMID:26377693 PMID:27858113

NCBI chr13:69,820,450...69,822,542
Ensembl chr13:67,270,135...67,272,227

G

interferon-induced protein 44

decreases expression

benzo(b)fluoranthene results in decreased expression of IFI44 mRNA

NCBI chr 2:243,286,050...243,303,869
Ensembl chr 2:240,626,066...240,643,844

G

insulin-like growth factor 1

multiple interactions
increases expression

[Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of IGF1 mRNA
benzo(b)fluoranthene results in increased expression of IGF1 mRNA

PMID:16269432 PMID:17690111

NCBI chr 7:24,169,608...24,249,446
Ensembl chr 7:22,282,930...22,359,296

G

insulin-like growth factor 2

multiple interactions

[Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of IGF2 mRNA

NCBI chr 1:207,243,873...207,261,263
Ensembl chr 1:197,814,410...197,823,018

G

insulin-like growth factor 2 receptor

increases expression

benzo(b)fluoranthene results in increased expression of IGF2R mRNA

NCBI chr 1:50,526,878...50,615,265
Ensembl chr 1:47,979,109...48,067,501

G

insulin-like growth factor binding protein 1

multiple interactions
increases expression

[Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of IGFBP1 mRNA
benzo(b)fluoranthene results in increased expression of IGFBP1 mRNA

PMID:16269432 PMID:17690111

NCBI chr14:86,261,277...86,266,344
Ensembl chr14:82,047,415...82,052,482

G

insulin-like growth factor binding protein 2

increases expression

benzo(b)fluoranthene results in increased expression of IGFBP2 mRNA

NCBI chr 9:81,864,811...81,892,179
Ensembl chr 9:74,415,546...74,442,937

G

insulin-like growth factor binding protein 3

decreases expression

benzo(b)fluoranthene results in decreased expression of IGFBP3 mRNA

NCBI chr14:86,270,208...86,277,944
Ensembl chr14:82,056,347...82,064,083

G

insulin-like growth factor binding protein 4

decreases expression

benzo(b)fluoranthene results in decreased expression of IGFBP4 mRNA

NCBI chr10:83,995,253...84,007,272
Ensembl chr10:83,989,591...84,007,225

G

insulin-like growth factor binding protein 6

decreases expression

benzo(b)fluoranthene results in decreased expression of IGFBP6 mRNA

NCBI chr 7:133,276,309...133,280,944
Ensembl chr 7:133,276,234...133,280,966

G

IGF-like family receptor 1

increases expression

benzo(b)fluoranthene results in increased expression of IGFLR1 mRNA

NCBI chr 1:94,945,866...94,948,476
Ensembl chr 1:85,816,326...85,821,030

G

immunoglobulin superfamily, member 3

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of IGSF3 mRNA

NCBI chr 2:191,499,972...191,588,249
Ensembl chr 2:188,811,380...188,899,645

G

Indian hedgehog signaling molecule

increases expression

benzo(b)fluoranthene results in increased expression of IHH mRNA

NCBI chr 9:83,952,986...83,959,203
Ensembl chr 9:76,504,315...76,510,532

G

IKAROS family zinc finger 4

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of IKZF4 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of IKZF4 mRNA

PMID:26377693 PMID:27858113

NCBI chr 7:1,063,283...1,102,940
Ensembl chr 7:1,056,890...1,084,341

G

interleukin 18 receptor 1

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of IL18R1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of IL18R1 mRNA

PMID:26377693 PMID:27858113

NCBI chr 9:50,223,274...50,257,370
Ensembl chr 9:42,727,869...42,760,715

G

interleukin 1 beta

increases expression

benzo(b)fluoranthene results in increased expression of IL1B mRNA

NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415

G

interleukin 1 receptor type 2

increases expression

benzo(b)fluoranthene results in increased expression of IL1R2 mRNA

NCBI chr 9:49,879,928...49,920,374
Ensembl chr 9:42,384,433...42,424,725

G

interleukin 1 receptor-like 1

decreases expression

benzo(b)fluoranthene results in decreased expression of IL1RL1 mRNA

NCBI chr 9:50,157,326...50,222,888
Ensembl chr 9:42,697,192...42,727,256

G

interleukin 2 receptor subunit beta

decreases expression

benzo(b)fluoranthene results in decreased expression of IL2RB mRNA

NCBI chr 7:111,913,828...111,928,537
Ensembl chr 7:110,033,341...110,048,054

G

interleukin 6

increases secretion
increases expression

benzo(b)fluoranthene results in increased secretion of IL6 protein
benzo(b)fluoranthene results in increased expression of IL6 mRNA

NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178

G

interleukin 7 receptor

increases expression

benzo(b)fluoranthene results in increased expression of IL7R mRNA

NCBI chr 2:60,179,561...60,204,937
Ensembl chr 2:58,454,217...58,477,757

G

interleukin enhancer binding factor 2

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ILF2 mRNA

NCBI chr 2:178,256,927...178,268,773
Ensembl chr 2:175,952,186...175,971,337

G

inflammation and lipid regulator with UBA-like and NBR1-like domains

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ILRUN mRNA

NCBI chr20:5,811,721...5,878,082
Ensembl chr20:5,809,936...5,876,012

G

inner mitochondrial membrane peptidase subunit 2

decreases expression

benzo(b)fluoranthene results in decreased expression of IMMP2L mRNA

NCBI chr 6:63,797,189...64,696,906
Ensembl chr 6:58,070,283...58,969,840

G

inner centromere protein

increases expression

benzo(b)fluoranthene results in increased expression of INCENP mRNA

NCBI chr 1:206,520,655...206,550,575
Ensembl chr 1:206,523,380...206,553,265

G

inverted formin 2

increases expression

benzo(b)fluoranthene results in increased expression of INF2 mRNA

NCBI chr 6:137,470,259...137,497,039
Ensembl chr 6:131,649,211...131,675,941

G

inka box actin regulator 2

multiple interactions
increases expression

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of INKA2 mRNA
benzo(b)fluoranthene results in increased expression of INKA2 mRNA

PMID:26377693 PMID:27858113

NCBI chr 2:195,873,617...195,888,983
Ensembl chr 2:193,185,275...193,200,642

G

INO80 complex subunit B

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of INO80B mRNA

NCBI chr 4:115,627,907...115,631,069
Ensembl chr 4:115,627,908...115,631,456

G

inositol polyphosphate-5-phosphatase J

decreases expression

benzo(b)fluoranthene results in decreased expression of INPP5J mRNA

NCBI chr14:82,597,789...82,608,930
Ensembl chr14:78,374,161...78,385,326

G

IQ motif containing GTPase activating protein 3

increases expression

benzo(b)fluoranthene results in increased expression of IQGAP3 mRNA

NCBI chr 2:175,840,001...175,881,799
Ensembl chr 2:173,542,110...173,583,956

G

inositol 1,4,5-triphosphate receptor associated 2

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of IRAG2 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of IRAG2 mRNA

PMID:26377693 PMID:27858113

NCBI chr 4:178,088,902...178,143,569
Ensembl chr 4:178,088,507...178,143,557

G

interferon regulatory factor 2 binding protein 2

decreases expression

benzo(b)fluoranthene results in decreased expression of IRF2BP2 mRNA

NCBI chr19:71,456,689...71,462,368
Ensembl chr19:54,560,128...54,566,642

G

interferon regulatory factor 2 binding protein-like

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of IRF2BPL mRNA

NCBI chr 6:112,258,149...112,262,264
Ensembl chr 6:106,528,053...106,530,401

G

interferon regulatory factor 5

increases expression

benzo(b)fluoranthene results in increased expression of IRF5 mRNA

NCBI chr 4:59,092,914...59,104,596
Ensembl chr 4:58,127,640...58,139,267

G

interferon regulatory factor 7

decreases expression

benzo(b)fluoranthene results in decreased expression of IRF7 mRNA

NCBI chr 1:205,796,956...205,800,543
Ensembl chr 1:196,367,361...196,370,832

G

integrin subunit alpha 1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ITGA1 mRNA

NCBI chr 2:48,379,181...48,545,336
Ensembl chr 2:46,653,193...46,812,238

G

integrin subunit alpha 6

decreases expression

benzo(b)fluoranthene results in decreased expression of ITGA6 mRNA

NCBI chr 3:77,012,168...77,097,076
Ensembl chr 3:56,617,268...56,689,428

G

integrin subunit alpha 7

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ITGA7 mRNA

NCBI chr 7:1,944,447...1,973,347
Ensembl chr 7:1,359,940...1,388,450

G

integrin subunit beta 4

increases expression

benzo(b)fluoranthene results in increased expression of ITGB4 mRNA

NCBI chr10:101,705,592...101,741,933
Ensembl chr10:101,206,665...101,243,012

G

influenza virus NS1A binding protein

decreases expression

benzo(b)fluoranthene results in decreased expression of IVNS1ABP mRNA

NCBI chr13:65,977,069...65,996,685
Ensembl chr13:63,427,041...63,446,701

G

jagged canonical Notch ligand 2

increases expression

benzo(b)fluoranthene results in increased expression of JAG2 mRNA

NCBI chr 6:137,804,133...137,826,738
Ensembl chr 6:131,983,056...132,005,818

G

Janus kinase 3

decreases expression

benzo(b)fluoranthene results in decreased expression of JAK3 mRNA

NCBI chr16:18,418,807...18,432,515
Ensembl chr16:18,386,405...18,398,536

G

KN motif and ankyrin repeat domains 4

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of KANK4 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of KANK4 mRNA

PMID:26377693 PMID:27858113

NCBI chr 5:113,401,491...113,465,526
Ensembl chr 5:113,402,468...113,465,555

G

kazrin, periplakin interacting protein

increases expression

benzo(b)fluoranthene results in increased expression of KAZN mRNA

NCBI chr 5:159,675,803...160,666,084
Ensembl chr 5:154,392,793...154,779,074

G

kelch repeat and BTB domain containing 6

increases expression

benzo(b)fluoranthene results in increased expression of KBTBD6 mRNA

NCBI chr15:61,257,360...61,259,117
Ensembl chr15:54,848,446...54,850,453

G

potassium voltage-gated channel subfamily B member 1

increases expression

benzo(b)fluoranthene results in increased expression of KCNB1 mRNA

NCBI chr 3:176,239,285...176,332,408
Ensembl chr 3:155,822,963...155,916,194

G

potassium voltage-gated channel subfamily E regulatory subunit 3

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of KCNE3 mRNA

NCBI chr 1:163,936,035...163,942,998
Ensembl chr 1:154,523,830...154,532,020

G

potassium voltage-gated channel modifier subfamily G member 1

increases expression

benzo(b)fluoranthene results in increased expression of KCNG1 mRNA

NCBI chr 3:177,379,593...177,412,986
Ensembl chr 3:156,973,156...156,992,635

G

potassium voltage-gated channel subfamily H member 1

increases expression

benzo(b)fluoranthene results in increased expression of KCNH1 mRNA

NCBI chr13:106,253,101...106,555,712
Ensembl chr13:103,722,245...104,024,740

G

potassium voltage-gated channel subfamily Q member 1

increases expression

benzo(b)fluoranthene results in increased expression of KCNQ1 mRNA

NCBI chr 1:207,721,134...208,054,073
Ensembl chr 1:198,291,766...198,624,669

G

kielin cysteine rich BMP regulator

increases expression

benzo(b)fluoranthene results in increased expression of KCP mRNA

NCBI chr 4:58,082,856...58,118,170
Ensembl chr 4:58,082,857...58,109,768

G

potassium channel tetramerization domain containing 14

increases expression

benzo(b)fluoranthene results in increased expression of KCTD14 mRNA

NCBI chr 1:151,761,688...151,766,693
Ensembl chr 1:151,761,663...151,766,691

G

potassium channel tetramerization domain containing 8

decreases expression

benzo(b)fluoranthene results in decreased expression of KCTD8 mRNA

NCBI chr14:38,773,274...39,018,182
Ensembl chr14:38,773,634...39,017,554

G

lysine demethylase 5B

decreases expression

benzo(b)fluoranthene results in decreased expression of KDM5B mRNA

NCBI chr13:48,554,367...48,625,721
Ensembl chr13:46,002,542...46,073,872

G

KH RNA binding domain containing, signal transduction associated 1

decreases expression

benzo(b)fluoranthene results in decreased expression of KHDRBS1 mRNA

NCBI chr 5:147,337,048...147,374,604
Ensembl chr 5:142,063,570...142,089,180

G

kinesin family member 17

decreases expression

benzo(b)fluoranthene results in decreased expression of KIF17 mRNA

NCBI chr 5:150,482,288...150,521,471
Ensembl chr 5:150,481,578...150,519,638

G

kinesin family member 20A

increases expression

benzo(b)fluoranthene results in increased expression of KIF20A mRNA

NCBI chr18:26,504,422...26,512,908
Ensembl chr18:26,230,230...26,238,780

G

kinesin family member 20B

increases expression

benzo(b)fluoranthene results in increased expression of KIF20B mRNA

NCBI chr 1:241,840,898...241,896,451
Ensembl chr 1:232,428,371...232,483,787

G

kinesin family member 22

increases expression

benzo(b)fluoranthene results in increased expression of KIF22 mRNA

NCBI chr 1:191,065,875...191,080,955
Ensembl chr 1:181,635,183...181,650,401

G

kinesin family member 23

increases expression

benzo(b)fluoranthene results in increased expression of KIF23 mRNA

NCBI chr 8:71,293,439...71,321,911
Ensembl chr 8:62,397,948...62,425,072

G

kinesin family member 26B

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of KIF26B mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of KIF26B mRNA

PMID:26377693 PMID:27858113

NCBI chr13:92,815,427...93,221,071
Ensembl chr13:90,283,404...90,682,811

G

kinesin family member C1

increases expression

benzo(b)fluoranthene results in increased expression of KIFC1 mRNA

NCBI chr20:5,000,929...5,018,967
Ensembl chr20:4,999,047...5,017,105

G

KIT proto-oncogene receptor tyrosine kinase

increases expression

benzo(b)fluoranthene results in increased expression of KIT mRNA

NCBI chr14:32,901,615...32,978,895
Ensembl chr14:32,548,877...32,624,652

G

KIT ligand

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of KITL mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of KITL mRNA

PMID:26377693 PMID:27858113

NCBI chr 7:36,782,621...36,863,796
Ensembl chr 7:34,896,053...34,977,214

G

KLF transcription factor 10

increases expression

benzo(b)fluoranthene results in increased expression of KLF10 mRNA

NCBI chr 7:71,352,612...71,358,680
Ensembl chr 7:69,465,619...69,473,994

G

KLF transcription factor 13

decreases expression

benzo(b)fluoranthene results in decreased expression of KLF13 mRNA

NCBI chr 1:126,917,671...126,948,436
Ensembl chr 1:117,503,602...117,551,227

G

KLF transcription factor 4

increases expression

benzo(b)fluoranthene results in increased expression of KLF4 mRNA

NCBI chr 5:75,074,107...75,079,182
Ensembl chr 5:70,278,972...70,283,602

G

kelch-like family member 5

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of KLHL5 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of KLHL5 mRNA

PMID:26377693 PMID:27858113

NCBI chr14:43,497,915...43,565,833
Ensembl chr14:43,144,257...43,184,238

G

kelch-like family member 6

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of KLHL6 mRNA

NCBI chr11:94,475,262...94,514,653
Ensembl chr11:80,970,917...81,009,677

G

kallikrein related-peptidase 13

increases expression

benzo(b)fluoranthene results in increased expression of KLK13 mRNA

NCBI chr 1:103,301,935...103,314,313
Ensembl chr 1:94,165,381...94,177,002

G

killer cell lectin like receptor B1A

decreases expression

benzo(b)fluoranthene results in decreased expression of KLRB1A mRNA

NCBI chr 4:163,576,672...163,590,201
Ensembl chr 4:161,890,577...161,961,675

G

killer cell lectin like receptor B1B

decreases expression

benzo(b)fluoranthene results in decreased expression of KLRB1C mRNA

NCBI chr 4:163,634,357...163,647,629
Ensembl chr 4:161,890,577...161,961,675

G

lysine methyltransferase 2D

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of KMT2D mRNA

NCBI chr 7:131,859,696...131,901,032
Ensembl chr 7:129,962,887...130,020,325

G

lysine methyltransferase 5B

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of KMT5B mRNA

NCBI chr 1:210,429,672...210,479,042
Ensembl chr 1:201,000,444...201,049,819

G

kinetochore-localized astrin/SPAG5 binding protein

increases expression

benzo(b)fluoranthene results in increased expression of KNSTRN mRNA

NCBI chr 3:126,254,633...126,274,412
Ensembl chr 3:105,800,954...105,820,715

G

kinetochore associated 1

increases expression

benzo(b)fluoranthene results in increased expression of KNTC1 mRNA

NCBI chr12:38,429,925...38,500,564
Ensembl chr12:32,769,020...32,839,561

G

karyopherin subunit alpha 2

increases expression

benzo(b)fluoranthene results in increased expression of KPNA2 mRNA

NCBI chr10:92,433,678...92,445,841
Ensembl chr10:91,933,951...91,946,150

G

KRAS proto-oncogene, GTPase

increases mutagenesis

benzo(b)fluoranthene results in increased mutagenesis of KRAS gene

PMID:8571376 PMID:9659573

NCBI chr 4:179,916,255...179,949,613

G

keratin 15

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of KRT15 mRNA

NCBI chr10:85,567,197...85,571,014
Ensembl chr10:85,066,802...85,171,799

G

keratin 23

increases expression

benzo(b)fluoranthene results in increased expression of KRT23 mRNA

NCBI chr10:84,434,445...84,450,773
Ensembl chr10:84,434,380...84,450,983

G

keratin 80

increases expression

benzo(b)fluoranthene results in increased expression of KRT80 mRNA

NCBI chr 7:132,463,216...132,485,134
Ensembl chr 7:132,463,218...132,485,508

G

keratin associated protein 1-1

decreases expression

benzo(b)fluoranthene results in decreased expression of KRTAP1-5 mRNA

NCBI chr10:84,545,765...84,546,331
Ensembl chr10:84,545,580...84,546,354

G

laminin subunit alpha 1

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of LAMA1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of LAMA1 mRNA

PMID:26377693 PMID:27858113

NCBI chr 9:115,139,548...115,263,620
Ensembl chr 9:107,692,770...107,817,478

G

laminin subunit alpha 3

increases expression

benzo(b)fluoranthene results in increased expression of LAMA3 mRNA

NCBI chr18:3,797,898...4,033,021
Ensembl chr18:3,523,133...3,751,353

G

laminin subunit alpha 4

increases expression

benzo(b)fluoranthene results in increased expression of LAMA4 mRNA

NCBI chr20:43,946,898...44,087,972
Ensembl chr20:42,392,268...42,533,347

G

LIM and SH3 protein 1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of LASP1 mRNA

NCBI chr10:82,795,177...82,835,659
Ensembl chr10:82,795,137...82,943,292

G

layilin

increases expression

benzo(b)fluoranthene results in increased expression of LAYN mRNA

NCBI chr 8:60,261,325...60,280,797
Ensembl chr 8:51,367,091...51,384,330

G

late cornified envelope 3E

increases expression

benzo(b)fluoranthene results in increased expression of LCE3B mRNA

NCBI chr 2:181,274,092...181,275,265
Ensembl chr 2:178,579,162...178,579,458

G

ligand dependent nuclear receptor corepressor-like

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of LCORL mRNA

NCBI chr14:69,482,919...69,620,269
Ensembl chr14:65,271,135...65,404,174

G

lactate dehydrogenase B

decreases expression

benzo(b)fluoranthene results in decreased expression of LDHB mRNA

NCBI chr 4:177,159,389...177,177,408
Ensembl chr 4:175,428,385...175,446,403

G

low density lipoprotein receptor class A domain containing 3

decreases expression

benzo(b)fluoranthene results in decreased expression of LDLRAD3 mRNA

NCBI chr 3:108,694,528...108,936,330
Ensembl chr 3:88,239,622...88,481,267

G

liver enriched antimicrobial peptide 2

decreases expression

benzo(b)fluoranthene results in decreased expression of LEAP2 mRNA

NCBI chr10:38,081,001...38,082,073
Ensembl chr10:37,577,855...37,581,244

G

left right determination factor 1

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of LEFTY1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of LEFTY1 mRNA

PMID:26377693 PMID:27858113

NCBI chr13:95,188,091...95,191,488
Ensembl chr13:92,656,323...92,659,720

G

LEO1 homolog, Paf1/RNA polymerase II complex component

decreases expression

benzo(b)fluoranthene results in decreased expression of LEO1 mRNA

NCBI chr 8:85,080,036...85,104,471
Ensembl chr 8:76,199,099...76,223,983

G

leptin receptor

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of LEPR mRNA

NCBI chr 5:121,409,735...121,593,201
Ensembl chr 5:116,289,823...116,475,908

G

galectin 3

increases expression

benzo(b)fluoranthene results in increased expression of LGALS3 mRNA

NCBI chr15:23,099,795...23,111,731
Ensembl chr15:20,607,692...20,632,025

G

galectin 4

increases expression

benzo(b)fluoranthene results in increased expression of LGALS4 mRNA

NCBI chr 1:93,248,463...93,260,002
Ensembl chr 1:84,124,764...84,132,481

G

leucine-rich repeat LGI family, member 2

increases expression

benzo(b)fluoranthene results in increased expression of LGI2 mRNA

NCBI chr14:58,415,965...58,443,450
Ensembl chr14:58,415,965...58,443,407

G

leucine rich repeat containing G protein coupled receptor 5

increases expression

benzo(b)fluoranthene results in increased expression of LGR5 mRNA

NCBI chr 7:51,087,059...51,221,882
Ensembl chr 7:51,088,239...51,222,446

G

LHFPL tetraspan subfamily member 3

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of LHFPL3 mRNA

G

DNA ligase 4

increases expression

benzo(b)fluoranthene results in increased expression of LIG4 mRNA

NCBI chr16:86,220,345...86,228,930
Ensembl chr16:79,518,312...79,527,040

G

Lck interacting transmembrane adaptor 1

increases expression

benzo(b)fluoranthene results in increased expression of LIME1 mRNA

NCBI chr 3:188,868,338...188,870,661
Ensembl chr 3:168,490,074...168,493,127

G

lipase, family member N

decreases expression

benzo(b)fluoranthene results in decreased expression of LIPN mRNA

NCBI chr 1:240,998,154...241,016,658
Ensembl chr 1:231,584,956...231,603,468

G

lamin A/C

increases expression

benzo(b)fluoranthene results in increased expression of LMNA mRNA

NCBI chr 2:176,237,564...176,265,301
Ensembl chr 2:173,939,751...173,960,423

G

lamin B1

increases expression

benzo(b)fluoranthene results in increased expression of LMNB1 mRNA

NCBI chr18:52,373,939...52,413,284
Ensembl chr18:50,175,874...50,214,502

G

lamin tail domain containing 1

decreases expression

benzo(b)fluoranthene results in decreased expression of LMNTD1 mRNA

NCBI chr 4:178,354,302...178,588,483
Ensembl chr 4:178,354,137...178,588,477

G

LON peptidase N-terminal domain and ring finger 3

decreases expression

benzo(b)fluoranthene results in decreased expression of LONRF3 mRNA

NCBI chr X:115,565,214...115,603,886
Ensembl chr X:115,565,267...115,598,809

G

loricrin cornified envelope precursor protein

increases expression

benzo(b)fluoranthene results in increased expression of LORICRIN mRNA

NCBI chr 2:180,253,674...180,256,572
Ensembl chr 2:177,558,252...177,559,807

G

lysyl oxidase-like 2

increases expression

benzo(b)fluoranthene results in increased expression of LOXL2 mRNA

NCBI chr15:51,091,547...51,182,843
Ensembl chr15:44,683,880...44,773,067

G

lysophosphatidic acid receptor 6

increases expression

benzo(b)fluoranthene results in increased expression of LPAR6 mRNA

NCBI chr15:54,826,110...54,827,919
Ensembl chr15:48,416,544...48,422,331

G

lipin 1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of LPIN1 mRNA

NCBI chr 6:45,039,110...45,145,845
Ensembl chr 6:39,312,748...39,417,097

G

leucine-rich repeats and immunoglobulin-like domains 3

decreases expression

benzo(b)fluoranthene results in decreased expression of LRIG3 mRNA

NCBI chr 7:63,701,724...63,751,898
Ensembl chr 7:61,816,342...61,866,481

G

LDL receptor related protein 11

increases expression

benzo(b)fluoranthene results in increased expression of LRP11 mRNA

NCBI chr 1:3,868,665...3,928,513
Ensembl chr 1:2,079,438...2,108,110

G

leucine rich repeat containing 75B

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of LRRC75B mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of LRRC75B mRNA

PMID:26377693 PMID:27858113

NCBI chr20:13,100,302...13,106,503
Ensembl chr20:13,100,302...13,106,503

G

leucine rich repeat containing 8 VRAC subunit E

increases expression

benzo(b)fluoranthene results in increased expression of LRRC8E mRNA

NCBI chr12:2,578,240...2,589,407
Ensembl chr12:2,578,315...2,589,412

G

leucine-rich repeat kinase 1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of LRRK1 mRNA

NCBI chr 1:129,254,815...129,390,217
Ensembl chr 1:119,845,146...119,979,734

G

leucine-rich repeats and transmembrane domains 1

decreases expression

benzo(b)fluoranthene results in decreased expression of LRTM1 mRNA

NCBI chr16:4,210,343...4,217,843

G

leucine-rich repeats and transmembrane domains 2

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of LRTM2 mRNA

NCBI chr 4:152,485,863...152,508,248
Ensembl chr 4:152,485,866...152,500,377

G

LSM4 homolog, U6 small nuclear RNA and mRNA degradation associated

increases expression

benzo(b)fluoranthene results in increased expression of LSM4 mRNA

NCBI chr16:18,755,481...18,761,106
Ensembl chr16:18,755,484...18,760,926

G

lanosterol synthase

decreases expression

benzo(b)fluoranthene results in decreased expression of LSS mRNA

NCBI chr20:12,090,641...12,118,230
Ensembl chr20:12,092,774...12,118,762

G

leukocyte specific transcript 1

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of LST1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of LST1 mRNA

PMID:26377693 PMID:27858113

NCBI chr20:3,639,353...3,644,399
Ensembl chr20:3,634,749...3,637,997

G

latent transforming growth factor beta binding protein 2

increases expression

benzo(b)fluoranthene results in increased expression of LTBP2 mRNA

NCBI chr 6:110,161,029...110,261,586
Ensembl chr 6:104,429,947...104,526,208

G

leukotriene C4 synthase

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of LTC4S mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of LTC4S mRNA

PMID:26377693 PMID:27858113

NCBI chr10:35,060,002...35,066,466
Ensembl chr10:34,560,360...34,562,651

G

LTV1 ribosome biogenesis factor

increases expression

benzo(b)fluoranthene results in increased expression of LTV1 mRNA

NCBI chr 1:7,565,673...7,578,398
Ensembl chr 1:7,565,669...7,578,563

G

lumican

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of LUM mRNA

NCBI chr 7:34,245,323...34,252,510
Ensembl chr 7:32,358,614...32,365,793

G

latexin

increases expression

benzo(b)fluoranthene results in increased expression of LXN mRNA

NCBI chr 2:151,727,556...151,733,426
Ensembl chr 2:151,727,102...151,733,460

G

lymphocyte antigen 6 family member A

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of LY6A mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of LY6A mRNA

PMID:26377693 PMID:27858113

NCBI chr 7:107,177,191...107,189,436
Ensembl chr 7:107,183,469...107,189,981

G

lymphocyte antigen 6 family member K

increases expression

benzo(b)fluoranthene results in increased expression of LY6K mRNA

NCBI chr 7:108,572,732...108,575,450
Ensembl chr 7:106,683,753...106,686,372

G

lymphatic vessel endothelial hyaluronan receptor 1

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of LYVE1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of LYVE1 mRNA

PMID:26377693 PMID:27858113

NCBI chr 1:174,393,387...174,410,977
Ensembl chr 1:164,962,872...164,976,309

G

leucine zipper like post translational regulator 1

increases expression

benzo(b)fluoranthene results in increased expression of LZTR1 mRNA

NCBI chr11:96,991,956...97,008,127
Ensembl chr11:83,487,717...83,503,633

G

leucine zipper tumor suppressor family member 3

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of LZTS3 mRNA

NCBI chr 3:117,850,286...117,861,132
Ensembl chr 3:117,851,702...117,860,081

G

mitotic arrest deficient 2 like 1

increases expression

benzo(b)fluoranthene results in increased expression of MAD2L1 mRNA

NCBI chr 4:97,236,419...97,247,603
Ensembl chr 4:95,906,817...95,913,470

G

MAF bZIP transcription factor F

increases expression

benzo(b)fluoranthene results in increased expression of MAFF mRNA

NCBI chr 7:112,792,787...112,804,139
Ensembl chr 7:110,912,499...110,923,851

G

membrane associated guanylate kinase, WW and PDZ domain containing 3

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of MAGI3 mRNA

NCBI chr 2:194,206,587...194,405,468
Ensembl chr 2:191,518,506...191,716,735

G

magnesium transporter 1

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of MAGT1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of MAGT1 mRNA

PMID:26377693 PMID:27858113

NCBI chr X:75,104,040...75,145,247
Ensembl chr X:71,038,489...71,079,699

G

MAM domain containing 2

increases expression

benzo(b)fluoranthene results in increased expression of MAMDC2 mRNA

NCBI chr 1:220,863,959...221,016,493
Ensembl chr 1:220,863,976...221,016,354

G

monoamine oxidase A

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MAOA mRNA

NCBI chr X:8,615,239...8,681,372
Ensembl chr X:6,030,795...6,099,593

G

microtubule-associated protein 1A

increases expression

benzo(b)fluoranthene results in increased expression of MAP1A mRNA

NCBI chr 3:128,716,907...128,736,638
Ensembl chr 3:108,263,151...108,282,899

G

mitogen-activated protein kinase kinase kinase 6

increases expression

benzo(b)fluoranthene results in increased expression of MAP3K6 mRNA

NCBI chr 5:150,724,029...150,736,113
Ensembl chr 5:145,440,346...145,452,212

G

mitogen-activated protein kinase kinase kinase kinase 4

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of MAP4K4 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MAP4K4 mRNA

PMID:26377693 PMID:27858113

NCBI chr 9:49,696,573...49,822,353
Ensembl chr 9:42,200,278...42,326,698

G

mitogen activated protein kinase 10

decreases expression

benzo(b)fluoranthene results in decreased expression of MAPK10 mRNA

NCBI chr14:6,802,247...7,094,103
Ensembl chr14:6,497,707...6,786,201

G

mitogen-activated protein kinase 11

increases expression

benzo(b)fluoranthene results in increased expression of MAPK11 mRNA

NCBI chr 7:122,098,120...122,105,023
Ensembl chr 7:120,218,478...120,225,395

G

macrophage receptor with collagenous structure

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of MARCO mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MARCO mRNA

PMID:26377693 PMID:27858113

NCBI chr13:34,169,011...34,210,340
Ensembl chr13:31,616,278...31,648,521

G

microtubule affinity regulating kinase 4

increases expression

benzo(b)fluoranthene results in increased expression of MARK4 mRNA

NCBI chr 1:88,203,352...88,239,858
Ensembl chr 1:79,068,904...79,108,556

G

MARVEL domain containing 2

increases expression

benzo(b)fluoranthene results in increased expression of MARVELD2 mRNA

NCBI chr 2:33,474,750...33,498,225
Ensembl chr 2:31,657,220...31,764,150

G

MARVEL domain containing 3

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of MARVELD3 mRNA

NCBI chr19:54,818,180...54,832,871
Ensembl chr19:37,905,638...37,923,420

G

microtubule associated serine/threonine kinase 1

increases expression

benzo(b)fluoranthene results in increased expression of MAST1 mRNA

NCBI chr19:40,121,271...40,149,073
Ensembl chr19:23,207,991...23,244,235

G

methionine adenosyltransferase 1A

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MAT1A mRNA

NCBI chr16:17,017,168...17,035,368
Ensembl chr16:16,983,022...17,001,274

G

methionine adenosyltransferase 2A

increases expression

benzo(b)fluoranthene results in increased expression of MAT2A mRNA

NCBI chr 4:106,048,043...106,053,612
Ensembl chr 4:104,488,466...104,495,493

G

matrilin 4

decreases expression

benzo(b)fluoranthene results in decreased expression of MATN4 mRNA

NCBI chr 3:153,120,605...153,135,628
Ensembl chr 3:153,120,632...153,135,865

G

membrane bound O-acyltransferase domain containing 2

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of MBOAT2 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MBOAT2 mRNA

PMID:26377693 PMID:27858113

NCBI chr 6:47,199,751...47,326,215
Ensembl chr 6:41,471,161...41,593,485

G

melanoma cell adhesion molecule

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MCAM mRNA

NCBI chr 8:53,376,225...53,384,407
Ensembl chr 8:44,479,376...44,487,571

G

MCL1 apoptosis regulator, BCL2 family member

multiple interactions

[Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of MCL1 mRNA

NCBI chr 2:185,884,840...185,912,532
Ensembl chr 2:183,219,220...183,222,303

G

minichromosome maintenance complex component 2

increases expression

benzo(b)fluoranthene results in increased expression of MCM2 mRNA

NCBI chr 4:122,903,679...122,918,205
Ensembl chr 4:121,346,434...121,360,847

G

minichromosome maintenance complex component 3

increases expression

benzo(b)fluoranthene results in increased expression of MCM3 mRNA

NCBI chr 9:30,715,602...30,733,746
Ensembl chr 9:23,219,169...23,237,314

G

minichromosome maintenance complex component 4

increases expression

benzo(b)fluoranthene results in increased expression of MCM4 mRNA

NCBI chr11:98,762,599...98,776,300
Ensembl chr11:85,258,443...85,272,144

G

minichromosome maintenance complex component 5

increases expression

benzo(b)fluoranthene results in increased expression of MCM5 mRNA

NCBI chr19:13,488,813...13,510,131
Ensembl chr19:13,483,066...13,504,389

G

minichromosome maintenance complex component 6

increases expression

benzo(b)fluoranthene results in increased expression of MCM6 mRNA

NCBI chr13:39,826,745...39,851,937
Ensembl chr13:39,826,763...39,851,960

G

minichromosome maintenance complex component 7

increases expression

benzo(b)fluoranthene results in increased expression of MCM7 mRNA

NCBI chr12:22,155,921...22,163,320
Ensembl chr12:17,042,212...17,050,063

G

mucolipin TRP cation channel 2

increases expression

benzo(b)fluoranthene results in increased expression of MCOLN2 mRNA

NCBI chr 2:237,714,100...237,762,979
Ensembl chr 2:235,053,816...235,102,702

G

midkine

increases expression

benzo(b)fluoranthene results in increased expression of MDK mRNA

NCBI chr 3:98,356,789...98,358,960
Ensembl chr 3:77,901,158...77,903,130

G

MDM2 proto-oncogene

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of MDM2 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MDM2 mRNA

PMID:26377693 PMID:27858113

NCBI chr 7:55,176,558...55,201,757
Ensembl chr 7:53,290,664...53,314,915

G

MDM4 regulator of p53

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of MDM4 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of MDM4 mRNA

PMID:26377693 PMID:27858113

NCBI chr13:46,922,236...47,068,241
Ensembl chr13:44,406,213...44,474,226

G

midasin AAA ATPase 1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of MDN1 mRNA

NCBI chr 5:47,055,435...47,190,426
Ensembl chr 5:47,055,447...47,186,332

G

malic enzyme 1

multiple interactions

[Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of ME1 mRNA

NCBI chr 8:96,429,057...96,540,244
Ensembl chr 8:87,549,043...87,660,304

G

MEFV innate immunity regulator, pyrin

increases expression

benzo(b)fluoranthene results in increased expression of MEFV mRNA

NCBI chr10:12,288,514...12,303,337
Ensembl chr10:11,787,422...11,796,973

G

maternally expressed 3

increases expression

benzo(b)fluoranthene results in increased expression of MEG3 mRNA

NCBI chr 6:134,274,056...134,306,249

G

multiple EGF-like-domains 6

increases expression

benzo(b)fluoranthene results in increased expression of MEGF6 mRNA

NCBI chr 5:164,738,272...164,839,142
Ensembl chr 5:164,738,352...164,839,139

G

maternal embryonic leucine zipper kinase

increases expression

benzo(b)fluoranthene results in increased expression of MELK mRNA

NCBI chr 5:63,336,151...63,396,254
Ensembl chr 5:58,540,449...58,600,937

G

mesenchyme homeobox 1

decreases expression

benzo(b)fluoranthene results in decreased expression of MEOX1 mRNA

NCBI chr10:87,318,668...87,338,169
Ensembl chr10:86,818,478...86,837,660

G

mesoderm specific transcript

increases expression

benzo(b)fluoranthene results in increased expression of MEST mRNA

NCBI chr 4:59,354,445...59,364,919
Ensembl chr 4:59,354,447...59,366,145

G

methyltransferase 18, RPL3 N3(tau)-histidine

decreases expression

benzo(b)fluoranthene results in decreased expression of METTL18 mRNA

NCBI chr13:78,879,053...78,881,226
Ensembl chr13:76,345,957...76,348,836

G

microfibril associated protein 2

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of MFAP2 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of MFAP2 mRNA

PMID:26377693 PMID:27858113

NCBI chr 5:158,595,121...158,603,283
Ensembl chr 5:153,314,711...153,320,259

G

microfibril associated protein 4

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MFAP4 mRNA

NCBI chr10:46,666,552...46,669,613
Ensembl chr10:46,167,217...46,170,155

G

milk fat globule EGF and factor V/VIII domain containing

increases expression

benzo(b)fluoranthene results in increased expression of MFGE8 mRNA

NCBI chr 1:142,474,027...142,489,431
Ensembl chr 1:133,064,665...133,080,073

G

MFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase

increases expression

benzo(b)fluoranthene results in increased expression of MFNG mRNA

NCBI chr 7:112,191,288...112,209,129
Ensembl chr 7:110,310,812...110,328,653

G

MFSD2 lysolipid transporter A, lysophospholipid

decreases expression

benzo(b)fluoranthene results in decreased expression of MFSD2A mRNA

NCBI chr 5:140,510,933...140,525,828
Ensembl chr 5:135,225,816...135,240,690

G

maltase-glucoamylase

increases expression

benzo(b)fluoranthene results in increased expression of MGAM mRNA

NCBI chr 4:70,408,263...70,568,752
Ensembl chr 4:69,446,150...69,692,715

G

alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of MGAT2 mRNA

NCBI chr 6:93,392,416...93,394,905
Ensembl chr 6:87,656,349...87,658,177

G

monoglyceride lipase

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of MGLL mRNA

NCBI chr 4:122,749,436...122,851,440
Ensembl chr 4:121,192,195...121,294,179

G

O-6-methylguanine-DNA methyltransferase

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of MGMT mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MGMT mRNA

PMID:26377693 PMID:27858113

NCBI chr 1:201,140,832...201,367,481
Ensembl chr 1:191,710,930...191,937,756

G

matrix Gla protein

increases expression

benzo(b)fluoranthene results in increased expression of MGP mRNA

NCBI chr 4:171,497,472...171,500,888
Ensembl chr 4:169,766,279...169,769,667

G

microtubule associated monooxygenase, calponin and LIM domain containing 2

decreases expression

benzo(b)fluoranthene results in decreased expression of MICAL2 mRNA

NCBI chr 1:175,780,441...175,965,157
Ensembl chr 1:166,345,859...166,471,719
Ensembl chr 1:166,345,859...166,471,719

G

mitotic deacetylase associated SANT domain protein

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of MIDEAS mRNA

NCBI chr 6:109,519,011...109,585,631
Ensembl chr 6:103,787,873...103,829,178

G

marker of proliferation Ki-67

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of MKI67 protein
benzo(b)fluoranthene results in increased expression of MKI67 mRNA
[benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with Benzo(a)pyrene co-treated with chrysene] results in increased expression of MKI67 protein; [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MKI67 mRNA

PMID:21776270 PMID:26377693 PMID:27858113 PMID:38237855

NCBI chr 1:199,926,150...199,952,847
Ensembl chr 1:190,496,319...190,522,762

G

mixed lineage kinase domain like pseudokinase

increases expression

benzo(b)fluoranthene results in increased expression of MLKL mRNA

NCBI chr19:56,186,860...56,213,886
Ensembl chr19:39,276,785...39,304,502

G

monocyte to macrophage differentiation-associated 2

decreases expression

benzo(b)fluoranthene results in decreased expression of MMD2 mRNA

NCBI chr12:17,075,870...17,123,255
Ensembl chr12:11,962,757...12,009,773

G

matrix metallopeptidase 14

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of MMP14 mRNA

NCBI chr15:31,857,824...31,867,049
Ensembl chr15:27,887,727...27,899,864

G

matrix metallopeptidase 23

decreases expression

benzo(b)fluoranthene results in decreased expression of MMP23 mRNA

NCBI chr 5:171,521,905...171,525,007
Ensembl chr 5:166,239,644...166,242,433

G

matrix metallopeptidase 8

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of MMP8 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MMP8 mRNA

PMID:26377693 PMID:27858113

NCBI chr 8:13,008,873...13,018,729
Ensembl chr 8:4,724,029...4,733,520

G

multimerin 2

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of MMRN2 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MMRN2 mRNA

PMID:26377693 PMID:27858113

NCBI chr16:9,712,181...9,733,653
Ensembl chr16:9,705,892...9,727,405

G

myeloid cell nuclear differentiation antigen

increases expression

benzo(b)fluoranthene results in increased expression of PYHIN1 mRNA

NCBI chr13:88,550,224...88,567,892
Ensembl chr13:86,017,892...86,034,201

G

motile sperm domain containing 2

decreases expression

benzo(b)fluoranthene results in decreased expression of MOSPD2 mRNA

NCBI chr X:33,052,063...33,105,550
Ensembl chr X:29,420,586...29,462,398

G

monooxygenase, DBH-like 1

decreases expression

benzo(b)fluoranthene results in decreased expression of MOXD1 mRNA

NCBI chr 1:22,894,543...22,984,599
Ensembl chr 1:21,075,122...21,161,779

G

macrophage expressed 1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of MPEG1 mRNA

NCBI chr 1:218,876,848...218,881,364
Ensembl chr 1:209,452,133...209,458,855

G

MPL proto-oncogene, thrombopoietin receptor

decreases expression

benzo(b)fluoranthene results in decreased expression of MPL mRNA

NCBI chr 5:137,259,288...137,281,540
Ensembl chr 5:131,973,895...131,986,797

G

myelin protein zero-like 2

increases expression

benzo(b)fluoranthene results in increased expression of MPZL2 mRNA

NCBI chr 8:54,244,920...54,256,064
Ensembl chr 8:45,348,285...45,359,298

G

membrane spanning 4-domains A1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MS4A1 mRNA

NCBI chr 1:217,331,274...217,351,934
Ensembl chr 1:207,906,374...207,918,512

G

membrane spanning 4-domains A7

increases expression

benzo(b)fluoranthene results in increased expression of MS4A7 mRNA

NCBI chr 1:207,969,117...207,984,743
Ensembl chr 1:207,968,761...207,983,260

G

mesothelin

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of MSLN mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of MSLN mRNA

PMID:26377693 PMID:27858113

NCBI chr10:15,276,489...15,285,921
Ensembl chr10:14,771,961...14,777,643

G

macrophage scavenger receptor 1

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of MSR1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MSR1 mRNA

PMID:26377693 PMID:27858113

NCBI chr16:59,421,250...59,507,070
Ensembl chr16:52,717,732...52,799,676

G

mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4L

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of ND4L mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ND4L mRNA

PMID:26377693 PMID:27858113

NCBI chr MT:9,870...10,166
Ensembl chr MT:9,870...10,166

G

mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 5

decreases expression

benzo(b)fluoranthene results in decreased expression of ND5 mRNA

NCBI chr MT:11,736...13,565
Ensembl chr MT:11,736...13,565

G

mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of ND6 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ND6 mRNA

PMID:26377693 PMID:27858113

NCBI chr MT:13,543...14,061
Ensembl chr MT:13,543...14,061

G

metallothionein 1

increases expression

benzo(b)fluoranthene results in increased expression of MT1 mRNA

NCBI chr19:10,831,959...10,832,975
Ensembl chr19:10,826,032...10,827,049
Ensembl chr17:10,826,032...10,827,049
Ensembl chr X:10,826,032...10,827,049

G

metallothionein 1, pseudogene 3

multiple interactions

[Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of MT1E mRNA

NCBI chr17:79,695,812...79,696,200
Ensembl chr17:74,786,654...74,787,135

G

methylenetetrahydrofolate dehydrogenase, cyclohydrolase and formyltetrahydrofolate synthetase 1

decreases expression

benzo(b)fluoranthene results in decreased expression of MTHFD1 mRNA

NCBI chr 6:100,713,510...100,781,013
Ensembl chr 6:94,977,862...95,045,372

G

methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of MTHFD1L mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MTHFD1L mRNA

PMID:26377693 PMID:27858113

NCBI chr 1:40,443,926...40,632,911
Ensembl chr 1:40,444,008...40,632,905

G

methylenetetrahydrofolate reductase

decreases expression

benzo(b)fluoranthene results in decreased expression of MTHFR mRNA

NCBI chr 5:163,748,346...163,768,141
Ensembl chr 5:158,465,296...158,483,797

G

myotubularin related protein 10

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MTMR10 mRNA

NCBI chr 1:127,271,139...127,322,621
Ensembl chr 1:117,859,267...117,910,849

G

mucin 16, cell surface associated

increases expression

benzo(b)fluoranthene results in increased expression of MUC16 mRNA

NCBI chr 8:24,440,840...24,644,494

G

mucin 5AC, oligomeric mucus/gel-forming

increases expression

benzo(b)fluoranthene results in increased expression of MUC5AC mRNA; benzo(b)fluoranthene results in increased expression of MUC5AC protein

NCBI chr 1:206,293,717...206,326,006
Ensembl chr 1:196,864,336...196,896,475

G

Max dimerization protein 3

increases expression

benzo(b)fluoranthene results in increased expression of MXD3 mRNA

NCBI chr17:9,301,430...9,305,156
Ensembl chr17:9,301,399...9,305,157

G

myeloid-associated differentiation marker

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of MYADM mRNA

NCBI chr 1:74,779,616...74,796,752
Ensembl chr 1:65,864,173...65,874,035

G

myosin binding protein H-like

decreases expression

benzo(b)fluoranthene results in decreased expression of MYBPHL mRNA

NCBI chr 2:198,692,857...198,706,953
Ensembl chr 2:196,005,325...196,018,824

G

myosin, heavy chain 9

increases expression

benzo(b)fluoranthene results in increased expression of MYH9 mRNA

NCBI chr 7:111,224,291...111,304,963
Ensembl chr 7:109,343,706...109,424,457

G

myosin, light chain 1

decreases expression

benzo(b)fluoranthene results in decreased expression of MYL1 mRNA

Ensembl chr 9:68,437,517...68,458,261

G

myosin light chain 2

increases expression

benzo(b)fluoranthene results in increased expression of MYL2 mRNA

NCBI chr12:40,114,964...40,126,236
Ensembl chr12:34,454,218...34,468,983

G

myosin light chain 7

decreases expression

benzo(b)fluoranthene results in decreased expression of MYL7 mRNA

NCBI chr14:80,780,684...80,783,259
Ensembl chr14:80,779,776...80,783,244

G

myosin IG

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of MYO1G mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MYO1G mRNA

PMID:26377693 PMID:27858113

NCBI chr14:85,600,619...85,615,760
Ensembl chr14:81,386,701...81,401,843

G

myozenin 2

decreases expression

benzo(b)fluoranthene results in decreased expression of MYOZ2 mRNA

NCBI chr 2:213,826,052...213,852,778
Ensembl chr 2:211,141,463...211,168,221

G

Ngfi-A binding protein 2

increases expression

benzo(b)fluoranthene results in increased expression of NAB2 mRNA

NCBI chr 7:65,382,863...65,389,527
Ensembl chr 7:63,497,589...63,503,989

G

N-acetyltransferase 8

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of NAT8 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of NAT8 mRNA

PMID:26377693 PMID:27858113

NCBI chr 4:119,836,986...119,837,764
Ensembl chr 4:118,270,954...118,281,763

G

N-acetyltransferase 8B

decreases expression

benzo(b)fluoranthene results in decreased expression of NAT8B mRNA

NCBI chr 4:119,916,909...119,923,544
Ensembl chr 4:118,359,443...118,363,563

G

neurobeachin-like 1

decreases expression

benzo(b)fluoranthene results in decreased expression of NBEAL1 mRNA

NCBI chr 9:69,069,326...69,237,932
Ensembl chr 9:61,575,356...61,736,750

G

non-SMC condensin I complex, subunit D2

increases expression

benzo(b)fluoranthene results in increased expression of NCAPD2 mRNA

NCBI chr 4:159,655,051...159,677,938
Ensembl chr 4:157,968,815...157,992,020

G

non-SMC condensin II complex, subunit D3

increases expression

benzo(b)fluoranthene results in increased expression of NCAPD3 mRNA

NCBI chr 8:33,696,214...33,765,520
Ensembl chr 8:25,437,123...25,506,373

G

non-SMC condensin II complex, subunit G2

increases expression

benzo(b)fluoranthene results in increased expression of NCAPG2 mRNA

NCBI chr 6:143,484,651...143,561,850
Ensembl chr 6:137,342,943...137,415,159

G

non-SMC condensin I complex, subunit H

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of NCAPH mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of NCAPH mRNA

PMID:26377693 PMID:27858113

NCBI chr 3:134,825,271...134,852,502
Ensembl chr 3:114,371,941...114,399,180

G

nuclear cap binding protein subunit 2

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of NCBP2 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of NCBP2 mRNA

PMID:26377693 PMID:27858113

NCBI chr11:82,326,002...82,334,839
Ensembl chr11:68,817,740...68,851,885

G

nuclear cap binding subunit 3

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of NCBP3 mRNA

NCBI chr10:57,665,716...57,695,432
Ensembl chr10:57,665,716...57,695,432

G

NCK-associated protein 5

increases expression

benzo(b)fluoranthene results in increased expression of NCKAP5 mRNA

NCBI chr13:39,922,576...40,835,849
Ensembl chr13:37,370,792...38,283,268

G

noncompact myelin associated protein

increases expression

benzo(b)fluoranthene results in increased expression of NCMAP mRNA

NCBI chr 5:152,893,173...152,921,175
Ensembl chr 5:147,610,677...147,618,775

G

natural cytotoxicity triggering receptor 1

decreases expression

benzo(b)fluoranthene results in decreased expression of NCR1 mRNA

NCBI chr 1:78,657,409...78,665,255
Ensembl chr 1:69,616,601...69,660,558

G

nudE neurodevelopment protein 1

increases expression

benzo(b)fluoranthene results in increased expression of NDE1 mRNA

NCBI chr10:1,347,010...1,391,167
Ensembl chr10:839,788...883,869

G

N-myc downstream regulated 1

increases expression

benzo(b)fluoranthene results in increased expression of NDRG1 mRNA

NCBI chr 7:100,573,526...100,614,902
Ensembl chr 7:98,684,487...98,725,880

G

nuclear paraspeckle assembly transcript 1

increases expression

benzo(b)fluoranthene results in increased expression of NEAT1 mRNA

NCBI chr 1:203,129,229...203,140,014

G

nectin cell adhesion molecule 1

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of NECTIN1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of PVRL1 mRNA

PMID:26377693 PMID:27858113

NCBI chr 8:52,998,662...53,061,745
Ensembl chr 8:44,101,776...44,189,787

G

nectin cell adhesion molecule 3

increases expression

benzo(b)fluoranthene results in increased expression of NECTIN3 mRNA

NCBI chr11:67,825,296...67,931,999
Ensembl chr11:54,364,487...54,462,519

G

NEDD4 E3 ubiquitin protein ligase

increases expression

benzo(b)fluoranthene results in increased expression of NEDD4 mRNA

NCBI chr 8:82,264,751...82,349,642
Ensembl chr 8:73,383,695...73,468,951

G

nestin

increases expression

benzo(b)fluoranthene results in increased expression of NES mRNA

NCBI chr 2:175,735,715...175,745,631
Ensembl chr 2:173,438,734...173,447,777

G

neuraminidase 2

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of NEU2 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of NEU2 mRNA

PMID:26377693 PMID:27858113

NCBI chr 9:95,666,338...95,715,209
Ensembl chr 9:88,249,135...88,267,355

G

neuralized E3 ubiquitin protein ligase 3

increases expression

benzo(b)fluoranthene results in increased expression of NEURL3 mRNA

NCBI chr 9:45,990,373...45,998,470
Ensembl chr 9:38,494,489...38,502,649

G

neurite extension and migration factor

increases expression

benzo(b)fluoranthene results in increased expression of NEXMIF mRNA

NCBI chr X:69,088,076...69,219,253
Ensembl chr X:69,088,076...69,112,930

G

nuclear factor of activated T-cells 1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of NFATC1 mRNA

NCBI chr18:76,321,386...76,430,997
Ensembl chr18:74,046,904...74,156,028

G

nuclear factor, erythroid 2

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of NFE2 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of NFE2 mRNA

PMID:26377693 PMID:27858113

NCBI chr 7:136,261,234...136,273,850
Ensembl chr 7:134,382,761...134,390,108

G

nuclear factor, interleukin 3 regulated

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of NFIL3 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of NFIL3 mRNA

PMID:26377693 PMID:27858113

NCBI chr17:12,280,499...12,295,728
Ensembl chr17:12,280,484...12,295,858

G

NFKB inhibitor alpha

increases expression

benzo(b)fluoranthene results in increased expression of NFKBIA mRNA

NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:72,858,712...72,861,941

G

neuroglobin

increases expression

benzo(b)fluoranthene results in increased expression of NGB mRNA

NCBI chr 6:112,475,332...112,480,786
Ensembl chr 6:106,744,378...106,749,830

G

NHL repeat containing 2

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of NHLRC2 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of NHLRC2 mRNA

PMID:26377693 PMID:27858113

NCBI chr 1:255,589,743...255,648,904
Ensembl chr 1:255,589,742...255,651,408

G

NIPA-like domain containing 1

increases expression

benzo(b)fluoranthene results in increased expression of NIPAL1 mRNA

NCBI chr14:35,537,641...35,561,656
Ensembl chr14:35,540,324...35,561,659

G

NKD inhibitor of WNT signaling pathway 1

increases expression

benzo(b)fluoranthene results in increased expression of NKD1 mRNA

NCBI chr19:18,476,344...18,549,380
Ensembl chr19:18,476,344...18,549,380

G

NFKB inhibitor interacting Ras-like 1

increases expression

benzo(b)fluoranthene results in increased expression of NKIRAS1 mRNA

NCBI chr15:7,493,531...7,503,758
Ensembl chr15:7,493,531...7,503,854

G

natural killer cell triggering receptor

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of NKTR mRNA

NCBI chr 8:121,380,010...121,420,495
Ensembl chr 8:121,382,436...121,418,314

G

NME/NM23 family member 5

decreases expression

benzo(b)fluoranthene results in decreased expression of NME5 mRNA

NCBI chr18:26,437,705...26,454,828
Ensembl chr18:26,163,555...26,180,794

G

neuronatin

decreases expression

benzo(b)fluoranthene results in decreased expression of NNAT mRNA

NCBI chr 3:166,646,373...166,648,845
Ensembl chr 3:146,226,407...146,228,834

G

NOC3-like DNA replication regulator

decreases expression

benzo(b)fluoranthene results in decreased expression of NOC3L mRNA

NCBI chr 1:236,556,037...236,585,372
Ensembl chr 1:236,556,789...236,585,318

G

nitric oxide synthase 1 adaptor protein

decreases expression

benzo(b)fluoranthene results in decreased expression of NOS1AP mRNA

NCBI chr13:85,080,558...85,353,741
Ensembl chr13:82,530,577...82,820,949

G

nitric oxide synthase 3

increases expression

benzo(b)fluoranthene results in increased expression of NOS3 mRNA

NCBI chr 4:11,686,088...11,706,604
Ensembl chr 4:10,793,834...10,814,166

G

notch receptor 1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of NOTCH1 mRNA

NCBI chr 3:29,676,040...29,721,613
Ensembl chr 3:9,278,086...9,323,531

G

NADPH oxidase 1

increases expression

benzo(b)fluoranthene results in increased expression of NOX1 mRNA

NCBI chr X:101,572,338...101,625,571
Ensembl chr X:97,279,056...97,302,236

G

nephrocystin 1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of NPHP1 mRNA

NCBI chr 3:114,960,650...115,016,234
Ensembl chr 3:114,960,650...115,016,234

G

natriuretic peptide receptor 3

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of NPR3 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of NPR3 mRNA

PMID:26377693 PMID:27858113

NCBI chr 2:62,592,557...62,660,497
Ensembl chr 2:60,870,594...60,932,955

G

neuropeptide Y receptor Y1

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of NPY1R mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of NPY1R mRNA

PMID:26377693 PMID:27858113

NCBI chr16:27,804,416...27,814,070
Ensembl chr16:23,037,789...23,046,759

G

NAD(P)H quinone dehydrogenase 1

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of NQO1 mRNA
[Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of NQO1 mRNA

PMID:17253728 PMID:18711122 PMID:26377693

NCBI chr19:52,205,374...52,220,267
Ensembl chr19:35,295,573...35,310,557

G

nuclear receptor subfamily 1, group D, member 1

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of NR1D1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of NR1D1 mRNA

PMID:26377693 PMID:27858113

NCBI chr10:84,224,599...84,231,812
Ensembl chr10:83,728,318...83,735,705

G

nuclear receptor subfamily 1, group D, member 2

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of NR1D2 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of NR1D2 mRNA

PMID:26377693 PMID:27858113

NCBI chr15:9,955,034...9,981,329
Ensembl chr15:7,524,257...7,550,553

G

neurotrophin receptor associated death domain

increases expression

benzo(b)fluoranthene results in increased expression of NRADD mRNA

NCBI chr 8:110,599,667...110,603,068
Ensembl chr 8:110,599,667...110,603,149

G

Notch-regulated ankyrin repeat protein

increases expression

benzo(b)fluoranthene results in increased expression of NRARP mRNA

NCBI chr 3:28,390,745...28,393,299
Ensembl chr 3:7,992,552...7,995,133

G

neuronal cell adhesion molecule

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of NRCAM mRNA

NCBI chr 6:67,129,723...67,425,510
Ensembl chr 6:61,329,863...61,702,992

G

nardilysin convertase

decreases expression

benzo(b)fluoranthene results in decreased expression of NRDC mRNA

NCBI chr 5:128,983,395...129,047,578
Ensembl chr 5:123,755,806...123,818,595

G

neuregulin 4

increases expression

benzo(b)fluoranthene results in increased expression of NRG4 mRNA

NCBI chr 8:55,586,253...55,677,829
Ensembl chr 8:55,592,893...55,677,483

G

neurogranin

decreases expression

benzo(b)fluoranthene results in decreased expression of NRGN mRNA

NCBI chr 8:45,444,223...45,452,417
Ensembl chr 8:37,256,930...37,257,516

G

neurturin

increases expression

benzo(b)fluoranthene results in increased expression of NRTN mRNA

NCBI chr 9:1,669,099...1,674,957
Ensembl chr 9:1,581,975...1,583,102

G

nuclear receptor binding SET domain protein 1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of NSD1 mRNA

NCBI chr17:9,317,085...9,431,528
Ensembl chr17:9,315,237...9,425,358

G

neuronal vesicle trafficking associated 1

increases expression

benzo(b)fluoranthene results in increased expression of NSG1 mRNA

NCBI chr14:76,861,079...76,882,822
Ensembl chr14:72,648,741...72,670,514

G

neuronal vesicle trafficking associated 2

increases expression

benzo(b)fluoranthene results in increased expression of NSG2 mRNA

NCBI chr10:16,106,073...16,165,915
Ensembl chr10:15,601,596...15,661,441

G

NSL1 component of MIS12 kinetochore complex

increases expression

benzo(b)fluoranthene results in increased expression of NSL1 mRNA

NCBI chr13:105,176,163...105,205,179
Ensembl chr13:102,649,058...102,674,054

G

5'-nucleotidase domain containing 2

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of NT5DC2 mRNA

NCBI chr16:6,328,925...6,336,978
Ensembl chr16:6,322,236...6,330,537

G

5' nucleotidase, ecto

increases expression

benzo(b)fluoranthene results in increased expression of NT5E mRNA

NCBI chr 8:98,150,925...98,195,646
Ensembl chr 8:89,270,696...89,314,881

G

netrin 1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of NTN1 mRNA

NCBI chr10:53,398,852...53,597,595
Ensembl chr10:52,899,934...53,085,326

G

nucleoside-triphosphatase, cancer-related

increases expression

benzo(b)fluoranthene results in increased expression of NTPCR mRNA

NCBI chr19:53,701,496...53,715,260
Ensembl chr19:53,695,976...53,715,202

G

NUF2 component of NDC80 kinetochore complex

increases expression

benzo(b)fluoranthene results in increased expression of NUF2 mRNA

NCBI chr13:84,226,448...84,290,957
Ensembl chr13:81,693,598...81,722,766

G

nuclear FMR1 interacting protein 2

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of NUFIP2 mRNA

NCBI chr10:62,574,922...62,607,729
Ensembl chr10:62,574,882...62,600,346

G

NUMB, endocytic adaptor protein

decreases expression

benzo(b)fluoranthene results in decreased expression of NUMB mRNA

NCBI chr 6:109,162,499...109,284,527
Ensembl chr 6:103,431,400...103,553,354

G

nuclear protein 1, transcriptional regulator

multiple interactions

[Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of NUPR1 mRNA

NCBI chr 1:190,643,866...190,645,901
Ensembl chr 1:181,213,368...181,215,281

G

nucleolar and spindle associated protein 1

increases expression

benzo(b)fluoranthene results in increased expression of NUSAP1 mRNA

NCBI chr 3:127,057,220...127,092,779
Ensembl chr 3:106,603,289...106,633,624

G

neurexophilin 3

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of NXPH3 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of NXPH3 mRNA

PMID:26377693 PMID:27858113

NCBI chr10:80,456,283...80,459,949
Ensembl chr10:80,455,429...80,462,415

G

2'-5'-oligoadenylate synthetase-like

decreases expression

benzo(b)fluoranthene results in decreased expression of OASL1 mRNA

NCBI chr12:47,343,551...47,356,509
Ensembl chr12:41,682,900...41,695,641

G

O-GlcNAcase

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of OGA mRNA

NCBI chr 1:254,547,311...254,589,596
Ensembl chr 1:244,598,292...244,634,359

G

olfactomedin-like 3

increases expression

benzo(b)fluoranthene results in increased expression of OLFML3 mRNA

NCBI chr 2:193,932,665...193,935,494
Ensembl chr 2:191,244,221...191,247,050

G

oligodendrocyte transcription factor 1

increases expression

benzo(b)fluoranthene results in increased expression of OLIG1 mRNA

NCBI chr11:44,000,450...44,002,592
Ensembl chr11:30,514,379...30,516,521

G

oxysterol binding protein-like 3

increases expression

benzo(b)fluoranthene results in increased expression of OSBPL3 mRNA

NCBI chr 4:80,677,383...80,854,169
Ensembl chr 4:79,350,349...79,523,393

G

oxidative stress induced growth inhibitor 1

increases expression

benzo(b)fluoranthene results in increased expression of OSGIN1 mRNA

NCBI chr19:64,380,336...64,409,165
Ensembl chr19:47,492,171...47,500,516

G

ornithine transcarbamylase

decreases expression

benzo(b)fluoranthene results in decreased expression of OTC mRNA

NCBI chr X:15,126,358...15,202,473
Ensembl chr X:12,453,834...12,566,918

G

purinergic receptor P2X 5

increases expression

benzo(b)fluoranthene results in increased expression of P2RX5 mRNA

NCBI chr10:58,276,329...58,291,108
Ensembl chr10:57,777,819...57,789,423

G

purinergic receptor P2X 7

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of P2RX7 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of P2RX7 mRNA

PMID:26377693 PMID:27858113

NCBI chr12:39,550,531...39,594,984
Ensembl chr12:33,879,745...33,934,619

G

P2Y receptor family member 10

increases expression

benzo(b)fluoranthene results in increased expression of P2RY10 mRNA

NCBI chr X:72,121,558...72,207,174
Ensembl chr X:72,111,264...72,212,265

G

purinergic receptor P2Y13

increases expression

benzo(b)fluoranthene results in increased expression of P2RY13 mRNA

NCBI chr 2:143,470,437...143,476,360
Ensembl chr 2:143,470,425...143,473,434

G

purinergic receptor P2Y2

increases expression

benzo(b)fluoranthene results in increased expression of P2RY2 mRNA

NCBI chr 1:164,764,119...164,779,578
Ensembl chr 1:155,351,165...155,367,632

G

proliferation-associated 2G4

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of PA2G4 mRNA

NCBI chr 7:1,569,326...1,576,794
Ensembl chr 7:983,971...992,331

G

PABPN1 like

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of PABPN1L mRNA

NCBI chr19:67,578,494...67,581,938
Ensembl chr19:50,669,967...50,673,366

G

proton activated chloride channel 1

increases expression

benzo(b)fluoranthene results in increased expression of PACC1 mRNA

NCBI chr13:102,904,668...102,929,770
Ensembl chr13:102,894,612...102,929,770

G

palladin, cytoskeletal associated protein

decreases expression

benzo(b)fluoranthene results in decreased expression of PALLD mRNA

NCBI chr16:33,238,943...33,632,236
Ensembl chr16:27,981,354...28,621,337

G

palmdelphin

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of PALMD mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PALMD mRNA

PMID:26377693 PMID:27858113

NCBI chr 2:207,574,413...207,626,239
Ensembl chr 2:204,889,533...204,941,519

G

peptidase domain containing associated with muscle regeneration 1

increases expression

benzo(b)fluoranthene results in increased expression of PAMR1 mRNA

NCBI chr 3:109,340,411...109,443,595
Ensembl chr 3:88,889,046...88,988,606

G

pantothenate kinase 3

decreases expression

benzo(b)fluoranthene results in decreased expression of PANK3 mRNA

NCBI chr10:20,733,191...20,757,017
Ensembl chr10:20,229,129...20,252,955

G

poly (A) polymerase alpha

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of PAPOLA mRNA

NCBI chr 6:124,682,015...124,734,706
Ensembl chr 6:124,682,105...124,734,468

G

prostate androgen-regulated mucin-like protein 1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of PARM1 mRNA

NCBI chr14:16,752,541...16,861,570
Ensembl chr14:16,468,459...16,577,314

G

poly (ADP-ribose) polymerase 1

increases cleavage

benzo(b)fluoranthene results in increased cleavage of PARP1 protein

NCBI chr13:94,839,484...94,871,295
Ensembl chr13:92,307,586...92,339,404

G

poly (ADP-ribose) polymerase family, member 6

increases expression

benzo(b)fluoranthene results in increased expression of PARP6 mRNA

NCBI chr 8:68,912,393...68,944,904
Ensembl chr 8:60,016,877...60,049,108

G

PAS domain containing serine/threonine kinase

increases expression

benzo(b)fluoranthene results in increased expression of PASK mRNA

NCBI chr 9:101,291,673...101,333,288
Ensembl chr 9:93,844,278...93,885,111

G

paired box 2

decreases expression

benzo(b)fluoranthene results in decreased expression of PAX2 mRNA

NCBI chr 1:253,555,447...253,646,623
Ensembl chr 1:243,616,606...243,695,321

G

PDZ binding kinase

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of PBK mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PBK mRNA

PMID:26377693 PMID:27858113

NCBI chr15:44,198,506...44,209,572
Ensembl chr15:40,023,002...40,034,014

G

PBX homeobox 1

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of PBX1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of PBX1 mRNA

PMID:26377693 PMID:27858113

NCBI chr13:82,811,664...83,121,447
Ensembl chr13:80,278,770...80,588,594

G

poly(rC) binding protein 3

increases expression

benzo(b)fluoranthene results in increased expression of PCBP3 mRNA

NCBI chr20:11,635,579...11,877,721
Ensembl chr20:11,678,269...11,878,210

G

protocadherin 1

increases expression

benzo(b)fluoranthene results in increased expression of PCDH1 mRNA

NCBI chr18:30,258,154...30,290,828
Ensembl chr18:30,013,185...30,039,318

G

protocadherin 17

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of PCDH17 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PCDH17 mRNA

PMID:26377693 PMID:27858113

NCBI chr15:66,631,549...66,725,007
Ensembl chr15:60,222,004...60,313,999

G

protocadherin alpha subfamily C, 2

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of PCDHAC2 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of PCDHAC2 mRNA

PMID:26377693 PMID:27858113

Ensembl chr18:28,581,225...28,846,211

G

protocadherin gamma subfamily A, 9

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of PCDHGA9 mRNA

NCBI chr18:29,564,614...29,667,865

G

phosphoenolpyruvate carboxykinase 2 (mitochondrial)

multiple interactions

[Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of PCK2 mRNA

NCBI chr15:32,997,853...33,006,691
Ensembl chr15:29,027,894...29,037,283

G

proliferating cell nuclear antigen

increases expression

benzo(b)fluoranthene results in increased expression of PCNA mRNA

NCBI chr 3:139,951,948...139,955,820
Ensembl chr 3:119,498,810...119,502,995

G

Purkinje cell protein 4-like 1

decreases expression

benzo(b)fluoranthene results in decreased expression of PCP4L1 mRNA

NCBI chr13:83,588,992...83,612,631
Ensembl chr13:83,588,992...83,609,966

G

phosphatidylcholine transfer protein

increases expression

benzo(b)fluoranthene results in increased expression of PCTP mRNA

NCBI chr10:75,305,999...75,351,919
Ensembl chr10:74,808,887...74,849,867

G

phosphate cytidylyltransferase 2, ethanolamine

increases expression

benzo(b)fluoranthene results in increased expression of PCYT2 mRNA

NCBI chr10:106,387,150...106,394,500
Ensembl chr10:105,888,775...105,896,172

G

phosphodiesterase 2A

decreases expression

benzo(b)fluoranthene results in decreased expression of PDE2A mRNA

NCBI chr 1:165,235,623...165,327,466
Ensembl chr 1:155,813,180...155,915,434

G

phosphodiesterase 4A

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PDE4A mRNA

NCBI chr 8:27,966,978...28,029,721
Ensembl chr 8:19,703,290...19,751,961

G

phosphodiesterase 6C

increases expression

benzo(b)fluoranthene results in increased expression of PDE6C mRNA

NCBI chr 1:245,322,015...245,377,874
Ensembl chr 1:235,909,775...235,965,315

G

phosphodiesterase 9A

increases expression

benzo(b)fluoranthene results in increased expression of PDE9A mRNA

NCBI chr20:9,471,136...9,564,286
Ensembl chr20:9,469,848...9,562,948

G

platelet-derived growth factor receptor-like

decreases expression

benzo(b)fluoranthene results in decreased expression of PDGFRL mRNA

NCBI chr16:58,051,421...58,111,327
Ensembl chr16:51,347,948...51,407,850

G

pyruvate dehydrogenase kinase 4

decreases expression

benzo(b)fluoranthene results in decreased expression of PDK4 mRNA

NCBI chr 4:34,558,327...34,568,329
Ensembl chr 4:33,589,799...33,601,850

G

PDZK1 interacting protein 1

increases expression

benzo(b)fluoranthene results in increased expression of PDZK1IP1 mRNA

NCBI chr 5:128,618,050...128,623,131
Ensembl chr 5:128,618,237...128,623,131

G

platelet endothelial aggregation receptor 1

increases expression

benzo(b)fluoranthene results in increased expression of PEAR1 mRNA

NCBI chr 2:173,206,298...173,234,106
Ensembl chr 2:173,207,664...173,227,440

G

phosphatidylethanolamine binding protein 1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of PEBP1 mRNA

NCBI chr12:44,946,307...44,967,890
Ensembl chr12:39,302,840...39,307,862

G

platelet and endothelial cell adhesion molecule 1

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of PECAM1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PECAM1 mRNA

PMID:26377693 PMID:27858113

NCBI chr10:92,090,263...92,152,002
Ensembl chr10:91,590,521...91,652,116

G

peptidase D

multiple interactions

[Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of PEPD mRNA

NCBI chr 1:96,673,624...96,818,197
Ensembl chr 1:87,536,609...87,681,231

G

period circadian regulator 1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PER1 mRNA

NCBI chr10:54,299,002...54,313,804
Ensembl chr10:53,805,535...53,814,431

G

period circadian regulator 2

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of PER2 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PER2 mRNA

PMID:26377693 PMID:27858113

NCBI chr 9:99,454,828...99,497,069
Ensembl chr 9:92,007,296...92,049,459

G

period circadian regulator 3

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of PER3 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PER3 mRNA

PMID:26377693 PMID:27858113

NCBI chr 5:166,740,914...166,778,243
Ensembl chr 5:161,459,533...161,495,607

G

6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1

multiple interactions

[Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of PFKFB1 mRNA

NCBI chr X:22,936,038...22,989,691
Ensembl chr X:19,508,546...19,562,182

G

6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PFKFB3 mRNA

NCBI chr17:71,893,320...71,974,526
Ensembl chr17:66,983,686...67,063,125

G

phosphoglycerate mutase 2

decreases expression

benzo(b)fluoranthene results in decreased expression of PGAM2 mRNA

NCBI chr14:84,895,763...84,897,874
Ensembl chr14:80,681,776...80,683,940

G

post-GPI attachment to proteins 2

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of PGAP2 mRNA

NCBI chr 1:166,003,593...166,030,088
Ensembl chr 1:156,591,615...156,618,114

G

peptidoglycan recognition protein 1

increases expression

benzo(b)fluoranthene results in increased expression of PGLYRP1 mRNA

NCBI chr 1:87,659,863...87,665,048
Ensembl chr 1:78,531,815...78,537,001

G

pyroglutamyl-peptidase I

increases expression

benzo(b)fluoranthene results in increased expression of PGPEP1 mRNA

NCBI chr16:18,804,408...18,817,466
Ensembl chr16:18,771,021...18,783,478

G

PH domain containing endocytic trafficking adaptor 1

increases expression

benzo(b)fluoranthene results in increased expression of PHETA1 mRNA

NCBI chr12:34,711,831...34,717,601
Ensembl chr12:34,711,810...34,717,081

G

PH domain containing endocytic trafficking adaptor 2

increases expression

benzo(b)fluoranthene results in increased expression of PHETA2 mRNA

NCBI chr 7:113,855,437...113,861,910
Ensembl chr 7:113,857,249...113,861,871

G

PHD finger protein 19

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of PHF19 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PHF19 mRNA

PMID:26377693 PMID:27858113

NCBI chr 3:38,572,766...38,604,950
Ensembl chr 3:18,175,282...18,196,405

G

PHD finger protein 21A

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of PHF21A mRNA

NCBI chr 3:98,600,933...98,791,132
Ensembl chr 3:78,194,549...78,331,865

G

phosphorylase kinase regulatory subunit beta

increases expression

benzo(b)fluoranthene results in increased expression of PHKB mRNA

NCBI chr19:37,179,937...37,383,979
Ensembl chr19:21,025,733...21,210,633

G

pleckstrin homology-like domain, family A, member 1

increases expression

benzo(b)fluoranthene results in increased expression of PHLDA1 mRNA

NCBI chr 7:48,853,690...48,855,894
Ensembl chr 7:46,967,409...46,969,861

G

pleckstrin homology-like domain, family A, member 3

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of PHLDA3 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PHLDA3 mRNA

PMID:26377693 PMID:27858113

NCBI chr13:49,745,003...49,748,088
Ensembl chr13:47,193,086...47,196,335

G

PH domain and leucine rich repeat protein phosphatase 1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PHLPP1 mRNA

NCBI chr13:22,823,132...23,045,619
Ensembl chr13:22,308,548...22,530,977

G

PILR alpha associated neural protein

decreases expression

benzo(b)fluoranthene results in decreased expression of PIANP mRNA

NCBI chr 4:159,482,678...159,491,085
Ensembl chr 4:157,798,808...157,804,842

G

piezo-type mechanosensitive ion channel component 1

increases expression

benzo(b)fluoranthene results in increased expression of PIEZO1 mRNA

NCBI chr19:67,453,120...67,515,347
Ensembl chr19:50,544,582...50,606,501

G

piezo-type mechanosensitive ion channel component 2

increases expression

benzo(b)fluoranthene results in increased expression of PIEZO2 mRNA

NCBI chr18:58,738,734...59,115,252
Ensembl chr18:56,469,680...56,844,216

G

PIF1 5'-to-3' DNA helicase

decreases expression

benzo(b)fluoranthene results in decreased expression of PIF1 mRNA

NCBI chr 8:75,005,820...75,015,331
Ensembl chr 8:66,111,072...66,120,200

G

polymeric immunoglobulin receptor

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of PIGR mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of PIGR mRNA

PMID:26377693 PMID:27858113

NCBI chr13:44,851,001...44,879,143
Ensembl chr13:42,298,914...42,326,875

G

phosphoinositide-3-kinase regulatory subunit 3

increases expression

benzo(b)fluoranthene results in increased expression of PIK3R3 mRNA

NCBI chr 5:134,936,790...135,009,303
Ensembl chr 5:129,701,229...129,772,583

G

Pim-1 proto-oncogene, serine/threonine kinase

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of PIM1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of PIM1 mRNA

PMID:26377693 PMID:27858113

NCBI chr20:7,556,496...7,560,747
Ensembl chr20:7,554,921...7,559,174

G

PICALM interacting mitotic regulator

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of PIMREG mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PIMREG mRNA

PMID:26377693 PMID:27858113

NCBI chr10:56,669,603...56,674,540
Ensembl chr10:56,669,675...56,674,791

G

PIN2/TERF1 interacting, telomerase inhibitor 1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of PINX1 mRNA

NCBI chr15:42,273,805...42,333,047
Ensembl chr15:38,097,886...38,157,140

G

phosphatidylinositol-4,5-bisphosphate 4-phosphatase 1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PIP4P1 mRNA

NCBI chr15:24,146,854...24,150,739
Ensembl chr15:24,146,856...24,150,702

G

paired-Ig-like receptor A2

increases expression

benzo(b)fluoranthene results in increased expression of PIRA2 mRNA

NCBI chr 1:65,352,125...65,422,842
Ensembl chr 1:65,415,946...65,422,853

G

phosphatidylinositol transfer protein, alpha

increases expression

benzo(b)fluoranthene results in increased expression of PITPNA mRNA

NCBI chr10:60,929,050...60,969,614
Ensembl chr10:60,430,748...60,471,342

G

cAMP-dependent protein kinase inhibitor gamma

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of PKIG mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PKIG mRNA

PMID:26377693 PMID:27858113

NCBI chr 3:172,749,871...172,817,514
Ensembl chr 3:152,366,041...152,398,082

G

protein kinase N3

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of PKN3 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PKN3 mRNA

PMID:26377693 PMID:27858113

NCBI chr 3:33,747,610...33,761,405
Ensembl chr 3:13,335,041...13,363,567

G

phospholipase A2, group IID

increases expression

benzo(b)fluoranthene results in increased expression of PLA2G2D mRNA

NCBI chr 5:156,299,374...156,305,816
Ensembl chr 5:151,018,870...151,022,525

G

phospholipase A2 group 4A

decreases expression

benzo(b)fluoranthene results in decreased expression of PLA2G4A mRNA

NCBI chr13:64,427,921...64,572,352
Ensembl chr13:61,877,813...62,022,266

G

phospholipase A2 group VII

increases expression

benzo(b)fluoranthene results in increased expression of PLA2G7 mRNA

NCBI chr 9:24,859,491...24,901,747
Ensembl chr 9:17,362,225...17,404,476

G

placenta associated 8

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PLAC8 mRNA

NCBI chr14:9,356,950...9,378,586
Ensembl chr14:9,063,048...9,074,264

G

plasminogen activator, tissue type

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of PLAT mRNA

NCBI chr16:75,943,061...76,022,037
Ensembl chr16:69,240,585...69,268,223

G

plasminogen activator, urokinase

increases expression

benzo(b)fluoranthene results in increased expression of PLAU mRNA

NCBI chr15:3,505,485...3,511,987
Ensembl chr15:3,456,232...3,462,775

G

plasminogen activator, urokinase receptor

increases expression

benzo(b)fluoranthene results in increased expression of PLAUR mRNA

NCBI chr 1:89,181,363...89,196,308
Ensembl chr 1:80,050,324...80,068,595

G

phospholipase C beta 1

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of PLCB1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PLCB1 mRNA

PMID:26377693 PMID:27858113

NCBI chr 3:142,512,765...143,224,042
Ensembl chr 3:122,060,031...122,772,869

G

phospholipase C, beta 4

decreases expression

benzo(b)fluoranthene results in decreased expression of PLCB4 mRNA

NCBI chr 3:143,405,721...143,775,129
Ensembl chr 3:122,953,196...123,322,392

G

phospholipase C, delta 1

increases expression

benzo(b)fluoranthene results in increased expression of PLCD1 mRNA

NCBI chr 8:127,672,955...127,695,939
Ensembl chr 8:118,795,201...118,818,186

G

phospholipase C, delta 4

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of PLCD4 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PLCD4 mRNA

PMID:26377693 PMID:27858113

NCBI chr 9:83,564,616...83,613,742
Ensembl chr 9:76,117,168...76,142,453

G

phospholipase C, gamma 1

increases expression

benzo(b)fluoranthene results in increased expression of PLCG1 mRNA

NCBI chr 3:169,805,299...169,836,040
Ensembl chr 3:149,385,587...149,416,330

G

plectin

increases expression

benzo(b)fluoranthene results in increased expression of PLEC mRNA

NCBI chr 7:109,768,447...109,829,798
Ensembl chr 7:107,887,764...107,945,467

G

pleckstrin homology and RhoGEF domain containing G5

increases expression

benzo(b)fluoranthene results in increased expression of PLEKHG5 mRNA

NCBI chr 5:167,860,730...167,904,229
Ensembl chr 5:162,578,071...162,621,513

G

perilipin 1

decreases expression

benzo(b)fluoranthene results in decreased expression of PLIN1 mRNA

NCBI chr 1:143,073,612...143,086,199
Ensembl chr 1:133,664,892...133,676,828

G

perilipin 4

decreases expression

benzo(b)fluoranthene results in decreased expression of PLIN4 mRNA

NCBI chr 9:1,016,334...1,025,249
Ensembl chr 9:929,176...938,056

G

perilipin 5

decreases expression

benzo(b)fluoranthene results in decreased expression of PLIN5 mRNA

NCBI chr 9:1,026,910...1,033,352
Ensembl chr 9:939,747...946,120

G

polo-like kinase 1

increases expression

benzo(b)fluoranthene results in increased expression of PLK1 mRNA

NCBI chr 1:186,147,658...186,157,637
Ensembl chr 1:176,716,420...176,726,400

G

polo-like kinase 2

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of PLK2 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PLK2 mRNA

PMID:26377693 PMID:27858113

NCBI chr 2:43,702,536...43,708,305
Ensembl chr 2:41,969,176...41,974,947

G

polo-like kinase 3

increases expression

benzo(b)fluoranthene results in increased expression of PLK3 mRNA

NCBI chr 5:135,843,725...135,848,900
Ensembl chr 5:130,607,142...130,612,317

G

polo-like kinase 5

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PLK5 mRNA

NCBI chr 7:9,346,777...9,367,923
Ensembl chr 7:9,346,777...9,355,196

G

phospholipid phosphatase 1

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of PPAP2A mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PPAP2A mRNA

PMID:26377693 PMID:27858113

NCBI chr 2:46,172,202...46,233,632
Ensembl chr 2:44,438,994...44,501,268

G

phospholipid scramblase 3

increases expression

benzo(b)fluoranthene results in increased expression of PLSCR3 mRNA

NCBI chr10:55,064,349...55,070,120
Ensembl chr10:54,566,873...54,578,709

G

plasmalemma vesicle associated protein

decreases expression

benzo(b)fluoranthene results in decreased expression of PLVAP mRNA

NCBI chr16:18,218,966...18,231,279
Ensembl chr16:18,184,975...18,197,301

G

plexin A2

increases expression

benzo(b)fluoranthene results in increased expression of PLXNA2 mRNA

NCBI chr13:108,683,155...108,888,336
Ensembl chr13:106,163,103...106,358,979

G

plexin B1

increases expression

benzo(b)fluoranthene results in increased expression of PLXNB1 mRNA

NCBI chr 8:118,621,961...118,647,491
Ensembl chr 8:109,744,697...109,769,027

G

phorbol-12-myristate-13-acetate-induced protein 1

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of PMAIP1 protein
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PMAIP1 mRNA

PMID:21392559 PMID:27858113

NCBI chr18:62,255,970...62,262,384
Ensembl chr18:59,986,017...59,992,429

G

peripheral myelin protein 22

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of PMP22 mRNA

NCBI chr10:48,294,932...48,324,941
Ensembl chr10:47,795,709...47,825,714

G

PNMA family member 2

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of PNMA2 mRNA

NCBI chr15:45,287,445...45,296,340
Ensembl chr15:41,112,009...41,121,427

G

patatin-like phospholipase domain containing 6

increases expression

benzo(b)fluoranthene results in increased expression of PNPLA6 mRNA

NCBI chr12:6,372,284...6,401,632
Ensembl chr12:1,560,363...1,603,734

G

podocalyxin-like

increases expression

benzo(b)fluoranthene results in increased expression of PODXL mRNA

NCBI chr 4:61,102,434...61,149,131
Ensembl chr 4:60,135,109...60,181,899

G

DNA polymerase epsilon, catalytic subunit

increases expression

benzo(b)fluoranthene results in increased expression of POLE mRNA

NCBI chr12:52,005,155...52,053,761
Ensembl chr12:46,345,420...46,393,939

G

DNA polymerase kappa

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of POLK mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of POLK mRNA

PMID:26377693 PMID:27858113

NCBI chr 2:29,556,831...29,616,960
Ensembl chr 2:27,822,679...27,882,313

G

paraoxonase 2

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of PON2 mRNA

NCBI chr 4:34,356,270...34,391,684
Ensembl chr 4:33,389,714...33,425,248

G

popeye domain cAMP effector 1

decreases expression

benzo(b)fluoranthene results in decreased expression of POPDC1 mRNA

NCBI chr20:50,401,611...50,442,653
Ensembl chr20:48,822,308...48,857,472

G

popeye domain cAMP effector 2

decreases expression

benzo(b)fluoranthene results in decreased expression of POPDC2 mRNA

NCBI chr11:75,850,068...75,897,094
Ensembl chr11:62,374,759...62,390,756

G

periostin

increases expression

benzo(b)fluoranthene results in increased expression of POSTN mRNA

NCBI chr 2:140,677,774...140,709,304
Ensembl chr 2:138,527,696...138,559,099

G

POU class 2 homeobox associating factor 1

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of POU2AF1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of POU2AF1 mRNA

PMID:26377693 PMID:27858113

NCBI chr 8:60,418,173...60,445,176
Ensembl chr 8:51,474,015...51,548,819

G

POU class 2 homeobox 1

decreases expression

benzo(b)fluoranthene results in decreased expression of POU2F1 mRNA

NCBI chr13:80,653,602...80,796,279
Ensembl chr13:78,130,685...78,263,363

G

peroxisome proliferator-activated receptor delta

decreases expression

benzo(b)fluoranthene results in decreased expression of PPARD mRNA

NCBI chr20:6,300,527...6,365,707
Ensembl chr20:6,298,785...6,363,968

G

peptidylprolyl isomerase G

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of PPIG mRNA

NCBI chr 3:74,891,846...74,923,010
Ensembl chr 3:54,484,023...54,512,926

G

protein phosphatase, Mg2+/Mn2+ dependent, 1L

decreases expression

benzo(b)fluoranthene results in decreased expression of PPM1L mRNA

NCBI chr 2:153,566,653...153,839,434
Ensembl chr 2:153,566,653...153,839,434

G

protein phosphatase 1, regulatory (inhibitor) subunit 14B

increases expression

benzo(b)fluoranthene results in increased expression of PPP1R14B mRNA

NCBI chr 1:213,594,416...213,596,527
Ensembl chr 1:204,163,299...204,167,319
Ensembl chr12:204,163,299...204,167,319

G

protein phosphatase 1, regulatory (inhibitor) subunit 2

increases expression

benzo(b)fluoranthene results in increased expression of PPP1R2 mRNA

NCBI chr11:69,472,676...69,494,468
Ensembl chr11:69,472,555...69,494,463

G

protein phosphatase 1, regulatory subunit 3B

decreases expression

benzo(b)fluoranthene results in decreased expression of PPP1R3B mRNA

NCBI chr16:63,533,318...63,545,683
Ensembl chr16:56,829,660...56,842,406

G

protein phosphatase 1, regulatory subunit 3C

decreases expression

benzo(b)fluoranthene results in decreased expression of PPP1R3C mRNA

NCBI chr 1:243,873,524...243,878,527
Ensembl chr 1:234,460,652...234,465,961

G

protein phosphatase 1, regulatory subunit 3D

increases expression

benzo(b)fluoranthene results in increased expression of PPP1R3D mRNA

NCBI chr 3:185,880,087...185,883,158
Ensembl chr 3:165,502,384...165,505,455

G

protein phosphatase 2, regulatory subunit B, gamma

increases expression

benzo(b)fluoranthene results in increased expression of PPP2R2C mRNA

NCBI chr14:73,846,547...73,931,489
Ensembl chr14:73,846,547...73,931,864

G

protein phosphatase 4, regulatory subunit 4

increases expression

benzo(b)fluoranthene results in increased expression of PPP4R4 mRNA

NCBI chr 6:128,427,884...128,518,776
Ensembl chr 6:122,663,344...122,753,384

G

protein regulator of cytokinesis 1

increases expression

benzo(b)fluoranthene results in increased expression of PRC1 mRNA

NCBI chr 1:143,659,312...143,681,019
Ensembl chr 1:134,250,081...134,271,765

G

perforin 1

decreases expression

benzo(b)fluoranthene results in decreased expression of PRF1 mRNA

NCBI chr20:29,789,040...29,794,550
Ensembl chr20:29,246,202...29,251,701

G

proteoglycan 4

increases expression

benzo(b)fluoranthene results in increased expression of PRG4 mRNA

NCBI chr13:65,037,363...65,054,764
Ensembl chr13:62,487,257...62,504,119

G

DNA primase subunit 1

increases expression

benzo(b)fluoranthene results in increased expression of PRIM1 mRNA

NCBI chr 7:1,031,436...1,047,134
Ensembl chr 7:431,805...462,526

G

protein kinase AMP-activated non-catalytic subunit gamma 3

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PRKAG3 mRNA

NCBI chr 9:83,744,385...83,753,629
Ensembl chr 9:76,295,715...76,304,959

G

protein kinase C, epsilon

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of PRKCE mRNA

NCBI chr 6:13,718,050...14,204,931
Ensembl chr 6:7,965,048...8,451,719

G

protein kinase C, theta

increases expression

benzo(b)fluoranthene results in increased expression of PRKCQ mRNA

NCBI chr17:72,156,215...72,288,508
Ensembl chr17:67,246,394...67,378,704

G

protein interacting with cyclin A1

increases expression

benzo(b)fluoranthene results in increased expression of PROCA1 mRNA

NCBI chr10:63,588,061...63,601,011
Ensembl chr10:63,090,018...63,102,940

G

protein C receptor

increases expression

benzo(b)fluoranthene results in increased expression of PROCR mRNA

NCBI chr 3:164,714,727...164,718,994
Ensembl chr 3:144,254,380...144,258,903

G

proline and serine rich 2

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of PROSER2 mRNA

NCBI chr17:77,061,371...77,096,788
Ensembl chr17:72,151,872...72,185,825

G

protein Z, vitamin K-dependent plasma glycoprotein

increases expression

benzo(b)fluoranthene results in increased expression of PROZ mRNA

NCBI chr16:83,150,104...83,165,688
Ensembl chr16:76,450,013...76,463,480

G

pre-mRNA processing factor 38B

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of PRPF38B mRNA

NCBI chr 2:199,241,312...199,250,342
Ensembl chr 2:196,553,225...196,562,250

G

pre-mRNA processing factor 40 homolog B

increases expression

benzo(b)fluoranthene results in increased expression of PRPF40B mRNA

NCBI chr 7:130,392,611...130,454,053
Ensembl chr 7:130,432,112...130,454,052

G

pre-mRNA processing factor 4B

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of PRPF4B mRNA

NCBI chr17:30,190,721...30,230,153
Ensembl chr17:29,985,343...30,019,625

G

proline rich 7 (synaptic)

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PRR7 mRNA

NCBI chr17:9,170,405...9,178,814
Ensembl chr17:9,165,269...9,172,536

G

proline rich and Gla domain 3

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PRRG3 mRNA

NCBI chr X:149,666,498...149,689,353
Ensembl chr X:149,670,257...149,677,373

G

serine protease 12

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of PRSS12 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PRSS12 mRNA

PMID:26377693 PMID:27858113

NCBI chr 2:214,308,695...214,368,679
Ensembl chr 2:211,624,134...211,684,126

G

serine protease 23

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of PRSS23 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PRSS23 mRNA

PMID:26377693 PMID:27858113

NCBI chr 1:152,815,301...152,835,005
Ensembl chr 1:143,401,396...143,422,091

G

serine protease 8

increases expression

benzo(b)fluoranthene results in increased expression of PRSS8 mRNA

NCBI chr 1:191,966,701...191,971,271
Ensembl chr 1:182,536,229...182,540,815

G

proteasome 20S subunit alpha 7

increases expression

benzo(b)fluoranthene results in increased expression of PSMA7 mRNA

NCBI chr 3:187,514,901...187,521,289
Ensembl chr 3:167,137,263...167,143,672

G

proteasome 26S subunit, non-ATPase 12

increases expression

benzo(b)fluoranthene results in increased expression of PSMD12 mRNA

NCBI chr10:92,937,957...92,956,601
Ensembl chr10:92,438,298...92,457,287

G

proline and serine rich coiled-coil 1

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of PSRC1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PSRC1 mRNA

PMID:26377693 PMID:27858113

NCBI chr 2:198,710,427...198,715,001
Ensembl chr 2:196,022,361...196,026,874

G

polypyrimidine tract binding protein 1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of PTBP1 mRNA

NCBI chr 7:10,493,199...10,502,957
Ensembl chr 7:9,842,574...9,852,397

G

prostaglandin reductase 1

multiple interactions
increases expression

[Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of PTGR1 mRNA
benzo(b)fluoranthene results in increased expression of PTGR1 mRNA

PMID:18711122 PMID:26377693

NCBI chr 5:78,579,060...78,597,671
Ensembl chr 5:73,784,009...73,802,666

G

prostaglandin-endoperoxide synthase 1

increases expression

benzo(b)fluoranthene results in increased expression of PTGS1 mRNA

NCBI chr 3:39,981,419...40,002,993
Ensembl chr 3:19,584,015...19,605,586

G

prostaglandin-endoperoxide synthase 2

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of PTGS2 protein
[Docosahexaenoic Acids co-treated with benzo(b)fluoranthene] results in increased expression of PTGS2 mRNA

NCBI chr13:64,714,063...64,722,320
Ensembl chr13:62,163,932...62,172,188

G

protein tyrosine kinase 2 beta

increases expression

benzo(b)fluoranthene results in increased expression of PTK2B mRNA

NCBI chr15:44,536,275...44,656,754
Ensembl chr15:40,360,723...40,481,282

G

prothymosin alpha

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of PTMA mRNA

NCBI chr 9:94,624,194...94,628,276
Ensembl chr 9:87,176,230...87,180,333

G

protein tyrosine phosphatase domain containing 1

increases expression

benzo(b)fluoranthene results in increased expression of PTPDC1 mRNA

NCBI chr17:16,028,964...16,076,512
Ensembl chr17:16,049,382...16,076,512

G

protein tyrosine phosphatase, non-receptor type 5

decreases expression

benzo(b)fluoranthene results in decreased expression of PTPN5 mRNA

NCBI chr 1:106,756,896...106,817,369
Ensembl chr 1:97,620,642...97,679,882

G

protein tyrosine phosphatase, non-receptor type 9

decreases expression

benzo(b)fluoranthene results in decreased expression of PTPN9 mRNA

NCBI chr 8:57,391,290...57,472,352
Ensembl chr 8:57,391,259...57,470,952

G

protein tyrosine phosphatase, receptor type, B

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of PTPRB mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of PTPRB mRNA

PMID:26377693 PMID:27858113

NCBI chr 7:53,816,197...53,920,760
Ensembl chr 7:51,930,015...52,034,748

G

protein tyrosine phosphatase, receptor type, G

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of PTPRG mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PTPRG mRNA

PMID:26377693 PMID:27858113

NCBI chr15:15,298,669...15,982,581
Ensembl chr15:12,871,721...13,554,094

G

PTTG1 regulator of sister chromatid separation, securin

increases expression

benzo(b)fluoranthene results in increased expression of PTTG1 mRNA

NCBI chr10:28,394,940...28,406,410
Ensembl chr10:27,893,689...27,904,837

G

peroxisomal testis enriched protein 1

decreases expression

benzo(b)fluoranthene results in decreased expression of PXT1 mRNA

NCBI chr20:7,002,270...7,005,296
Ensembl chr20:7,002,271...7,006,780

G

glycogen phosphorylase B

decreases expression

benzo(b)fluoranthene results in decreased expression of PYGB mRNA

NCBI chr 3:160,072,141...160,118,930
Ensembl chr 3:139,611,749...139,663,553

G

R3H domain containing 2

decreases expression

benzo(b)fluoranthene results in decreased expression of R3HDM2 mRNA

NCBI chr 7:65,097,685...65,225,863
Ensembl chr 7:63,232,346...63,340,540

G

RAB11 family interacting protein 1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of RAB11FIP1 mRNA

NCBI chr16:71,589,753...71,620,341
Ensembl chr16:64,884,676...64,917,491

G

RAB3C, member RAS oncogene family

increases expression

benzo(b)fluoranthene results in increased expression of RAB3C mRNA

NCBI chr 2:43,353,822...43,577,226
Ensembl chr 2:41,627,720...41,843,749

G

RAB42, member RAS oncogene family

increases expression

benzo(b)fluoranthene results in increased expression of RAB42 mRNA

NCBI chr 5:144,497,159...144,498,829
Ensembl chr 5:144,496,215...144,498,848

G

rabaptin, RAB GTPase binding effector protein 2

increases expression

benzo(b)fluoranthene results in increased expression of RABEP2 mRNA

NCBI chr 1:190,433,501...190,457,241
Ensembl chr 1:181,010,305...181,026,648

G

Rac GTPase-activating protein 1

increases expression

benzo(b)fluoranthene results in increased expression of RACGAP1 mRNA

NCBI chr 7:132,629,789...132,659,738
Ensembl chr 7:130,750,936...130,780,831

G

RAD51 recombinase

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of RAD51 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of RAD51 mRNA

PMID:26377693 PMID:27858113

NCBI chr 3:126,554,210...126,578,888
Ensembl chr 3:106,100,381...106,125,035

G

RAD51 associated protein 1

increases expression

benzo(b)fluoranthene results in increased expression of RAD51AP1 mRNA

NCBI chr 4:159,759,454...159,772,473
Ensembl chr 4:159,759,459...159,772,524

G

retinoic acid induced 2

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of RAI2 mRNA

NCBI chr X:36,580,406...36,642,943
Ensembl chr X:32,948,656...33,011,264

G

Ral GTPase activating protein catalytic subunit alpha 2

increases expression

benzo(b)fluoranthene results in increased expression of RALGAPA2 mRNA

NCBI chr 3:154,112,005...154,392,070
Ensembl chr 3:133,659,761...133,938,916

G

receptor activity modifying protein 3

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of RAMP3 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of RAMP3 mRNA

PMID:26377693 PMID:27858113

NCBI chr14:81,527,404...81,544,905
Ensembl chr14:81,527,385...81,544,902

G

Rap1 GTPase-activating protein

increases expression

benzo(b)fluoranthene results in increased expression of RAP1GAP mRNA

NCBI chr 5:155,157,511...155,222,622
Ensembl chr 5:149,892,019...149,939,253

G

RAS p21 protein activator 4

decreases expression

benzo(b)fluoranthene results in decreased expression of RASA4 mRNA

NCBI chr12:20,552,805...20,580,177
Ensembl chr12:20,552,806...20,580,147

G

RASD family, member 2

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of RASD2 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of RASD2 mRNA

PMID:26377693 PMID:27858113

NCBI chr19:13,600,028...13,610,753
Ensembl chr19:13,594,291...13,605,016

G

RasGEF domain family, member 1C

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of RASGEF1C mRNA

NCBI chr10:34,728,573...34,794,763
Ensembl chr10:34,227,483...34,293,675

G

RAS guanyl releasing protein 3

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of RASGRP3 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of RASGRP3 mRNA

PMID:26377693 PMID:27858113

NCBI chr 6:25,647,386...25,745,952
Ensembl chr 6:19,895,390...19,958,578

G

RAS-like family 11 member A

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of RASL11A mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of RASL11A mRNA

PMID:26377693 PMID:27858113

NCBI chr12:8,258,148...8,260,909
Ensembl chr12:8,258,159...8,262,576

G

RNA binding fox-1 homolog 3

decreases expression

benzo(b)fluoranthene results in decreased expression of RBFOX3 mRNA

NCBI chr10:104,218,940...104,655,863
Ensembl chr10:103,720,636...104,156,935

G

retinol binding protein 1

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of RBP1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of RBP1 mRNA

PMID:26377693 PMID:27858113

NCBI chr 8:107,904,589...107,926,109
Ensembl chr 8:99,025,206...99,046,743

G

RCSD domain containing 1

increases expression

benzo(b)fluoranthene results in increased expression of RCSD1 mRNA

NCBI chr13:80,434,878...80,497,312
Ensembl chr13:77,901,898...77,966,228

G

retinol dehydrogenase 5

increases expression

benzo(b)fluoranthene results in increased expression of RDH5 mRNA

NCBI chr 7:1,912,120...1,931,836
Ensembl chr 7:1,340,934...1,351,558

G

retinol dehydrogenase 9

increases expression

benzo(b)fluoranthene results in increased expression of RDH9 mRNA

NCBI chr 7:63,642,305...63,645,149

G

receptor accessory protein 1

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of REEP1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of REEP1 mRNA

PMID:26377693 PMID:27858113

NCBI chr 4:105,303,974...105,420,611
Ensembl chr 4:103,745,633...103,862,338

G

receptor accessory protein 2

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of REEP2 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of REEP2 mRNA

PMID:26377693 PMID:27858113

NCBI chr18:26,712,236...26,721,275
Ensembl chr18:26,438,346...26,447,161

G

RELT-like 1

increases expression

benzo(b)fluoranthene results in increased expression of RELL1 mRNA

NCBI chr14:44,318,640...44,378,541
Ensembl chr14:44,303,009...44,378,500

G

resistin

decreases expression

benzo(b)fluoranthene results in decreased expression of RETN mRNA

NCBI chr12:6,508,653...6,511,115
Ensembl chr12:1,710,881...1,712,620

G

REV1, DNA directed polymerase

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of REV1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of REV1 mRNA

PMID:26377693 PMID:27858113

NCBI chr 9:47,773,907...47,847,554
Ensembl chr 9:40,278,101...40,351,576

G

refilin B

increases expression

benzo(b)fluoranthene results in increased expression of RFLNB mRNA

NCBI chr10:61,391,947...61,398,224
Ensembl chr10:60,893,713...60,899,976

G

regulator of G-protein signaling 12

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of RGS12 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of RGS12 mRNA

PMID:26377693 PMID:27858113

NCBI chr14:79,940,561...80,048,637
Ensembl chr14:75,715,934...75,794,596

G

regulator of G-protein signaling 18

decreases expression

benzo(b)fluoranthene results in decreased expression of RGS18 mRNA

NCBI chr13:56,493,134...56,516,045
Ensembl chr13:56,494,010...56,516,098

G

regulator of G-protein signaling 7 binding protein

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of RGS7BP mRNA

NCBI chr 2:37,867,698...37,965,587
Ensembl chr 2:36,139,201...36,231,505

G

regulator of G-protein signaling 9

increases expression

benzo(b)fluoranthene results in increased expression of RGS9 mRNA

NCBI chr10:94,696,556...94,770,387
Ensembl chr10:94,197,054...94,270,892

G

Rh family B glycoprotein

increases expression

benzo(b)fluoranthene results in increased expression of RHBG mRNA

NCBI chr 2:176,002,886...176,015,201
Ensembl chr 2:173,704,562...173,717,321

G

ras homolog family member B

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of RHOB mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of RHOB mRNA

PMID:26377693 PMID:27858113

NCBI chr 6:37,083,030...37,085,204
Ensembl chr 6:31,363,548...31,366,108

G

ras homolog family member C

increases expression

benzo(b)fluoranthene results in increased expression of RHOC mRNA

NCBI chr 2:194,975,586...194,981,637
Ensembl chr 2:192,287,130...192,295,306

G

reproductive homeobox 8

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of RHOX8 mRNA

NCBI chr X:121,450,408...121,454,031
Ensembl chr X:116,584,582...116,588,365

G

regulatory subunit of type II PKA R-subunit domain containing 1

increases expression

benzo(b)fluoranthene results in increased expression of RIIAD1 mRNA

NCBI chr 2:182,099,924...182,110,544
Ensembl chr 2:182,101,795...182,110,319

G

ribosomal modification protein rimK-like family member A

increases expression

benzo(b)fluoranthene results in increased expression of RIMKLA mRNA

NCBI chr 5:133,072,179...133,098,840
Ensembl chr 5:133,073,960...133,098,792

G

Ras and Rab interactor 2

decreases expression

benzo(b)fluoranthene results in decreased expression of RIN2 mRNA

NCBI chr 3:153,540,147...153,756,897
Ensembl chr 3:133,086,749...133,303,604

G

receptor-interacting serine-threonine kinase 3

increases expression

benzo(b)fluoranthene results in increased expression of RIPK3 mRNA

NCBI chr15:33,253,071...33,262,025
Ensembl chr15:29,283,145...29,292,121

G

ripply transcriptional repressor 3

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of RIPPLY3 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of RIPPLY3 mRNA

PMID:26377693 PMID:27858113

NCBI chr11:33,648,471...33,656,587
Ensembl chr11:33,648,486...33,656,584

G

required for meiotic nuclear division 5 homolog B

increases expression

benzo(b)fluoranthene results in increased expression of RMND5B mRNA

NCBI chr10:36,382,212...36,394,801
Ensembl chr10:35,881,268...35,892,265

G

ribonuclease A family member 10

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of RNASE10 mRNA

NCBI chr15:26,700,219...26,702,681
Ensembl chr15:24,226,691...24,228,561

G

ribonuclease H2, subunit B

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of RNASEH2B mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of RNASEH2B mRNA

PMID:26377693 PMID:27858113

NCBI chr15:36,541,200...36,592,016
Ensembl chr15:36,541,218...36,584,118

G

Rho family GTPase 1

decreases expression

benzo(b)fluoranthene results in decreased expression of RND1 mRNA

NCBI chr 7:131,700,321...131,707,392
Ensembl chr 7:129,821,311...129,828,399

G

ring finger protein 144A

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of RNF144A mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of RNF144A mRNA

PMID:26377693 PMID:27858113

NCBI chr 6:48,628,241...48,748,241
Ensembl chr 6:42,903,174...43,020,012

G

ring finger protein 169

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of RNF169 mRNA

NCBI chr 1:163,662,582...163,724,154
Ensembl chr 1:154,254,473...154,311,653

G

ring finger protein 215

increases expression

benzo(b)fluoranthene results in increased expression of RNF215 mRNA

NCBI chr14:83,230,234...83,236,668
Ensembl chr14:79,006,688...79,013,091

G

ring finger protein 39

increases expression

benzo(b)fluoranthene results in increased expression of RNF39 mRNA

NCBI chr20:1,610,027...1,615,516
Ensembl chr20:1,604,794...1,610,283

G

roundabout guidance receptor 2

increases expression

benzo(b)fluoranthene results in increased expression of ROBO2 mRNA

NCBI chr11:26,015,919...27,583,750
Ensembl chr11:12,528,951...13,041,536

G

Rho-associated coiled-coil containing protein kinase 2

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ROCK2 mRNA

NCBI chr 6:45,407,823...45,502,773
Ensembl chr 6:39,679,082...39,774,031

G

RAR-related orphan receptor C

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of RORC mRNA

NCBI chr 2:184,698,779...184,723,942
Ensembl chr 2:182,009,286...182,034,907

G

ROS proto-oncogene 1 , receptor tyrosine kinase

increases expression

benzo(b)fluoranthene results in increased expression of ROS1 mRNA

NCBI chr20:31,975,328...32,126,675
Ensembl chr20:31,432,637...31,583,865

G

RNA polymerase II associated protein 2

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of RPAP2 mRNA

NCBI chr14:2,253,966...2,332,251
Ensembl chr14:2,109,053...2,187,350

G

ribosomal protein S27-like

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of RPS27L mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of RPS27L mRNA

PMID:26377693 PMID:27858113

NCBI chr 8:76,443,658...76,448,593
Ensembl chr 8:67,562,483...67,567,418
Ensembl chr12:67,562,483...67,567,418
Ensembl chr 2:67,562,483...67,567,418

G

ribosome binding protein 1

increases expression

benzo(b)fluoranthene results in increased expression of RRBP1 mRNA

NCBI chr 3:151,768,386...151,830,255
Ensembl chr 3:131,314,998...131,376,981

G

ribonucleotide reductase catalytic subunit M1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of RRM1 mRNA

NCBI chr 1:166,235,904...166,260,206
Ensembl chr 1:156,823,960...156,848,261

G

ribonucleotide reductase regulatory subunit M2

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of RRM2 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of RRM2 mRNA

PMID:26377693 PMID:27858113

NCBI chr 6:47,044,755...47,075,370
Ensembl chr 6:41,340,557...41,346,773

G

ribosomal RNA processing 1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of RRP1 mRNA

NCBI chr20:10,260,580...10,271,829
Ensembl chr20:10,260,870...10,272,144

G

retinoschisin 1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of RS1 mRNA

NCBI chr X:37,771,135...37,800,894
Ensembl chr X:33,963,657...33,992,115

G

arginine and serine rich protein 1

increases expression

benzo(b)fluoranthene results in increased expression of RSRP1 mRNA

NCBI chr 5:152,431,448...152,435,202
Ensembl chr 5:147,147,784...147,151,523

G

RT1 class II, locus Db1

increases expression

benzo(b)fluoranthene results in increased expression of H2-EB1 mRNA

NCBI chr20:4,550,594...4,560,182
Ensembl chr20:4,548,666...4,558,258

G

RT1 class II, locus DMb

increases expression

benzo(b)fluoranthene results in increased expression of H2-DMB1 mRNA

NCBI chr20:4,695,009...4,702,560
Ensembl chr20:4,693,103...4,700,340

G

RT1 class II, locus DOa

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of H2-OA mRNA

NCBI chr20:4,755,287...4,758,491
Ensembl chr20:4,753,598...4,756,577

G

RT1 class II, locus DOb

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of H2-OB mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of H2-OB mRNA

PMID:26377693 PMID:27858113

NCBI chr20:4,621,336...4,627,537
Ensembl chr20:4,619,816...4,625,667

G

regulator of telomere elongation helicase 1

increases expression

benzo(b)fluoranthene results in increased expression of RTEL1 mRNA

NCBI chr 3:188,778,329...188,842,877
Ensembl chr 3:168,419,579...168,465,348

G

rhotekin

increases expression

benzo(b)fluoranthene results in increased expression of RTKN mRNA

NCBI chr 4:117,198,496...117,215,660
Ensembl chr 4:115,640,774...115,657,952

G

retrotransposon Gag like 8A

increases expression

benzo(b)fluoranthene results in increased expression of RTL8A mRNA

NCBI chr X:133,414,027...133,415,240
Ensembl chr X:133,414,030...133,415,240

G

receptor (chemosensory) transporter protein 3

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of RTP3 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of RTP3 mRNA

PMID:26377693 PMID:27858113

NCBI chr 8:119,847,947...119,853,549
Ensembl chr 8:110,970,160...110,974,699

G

RUN and FYVE domain containing 2

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of RUFY2 mRNA

NCBI chr20:25,626,958...25,658,157
Ensembl chr20:25,621,999...25,658,186

G

RUN and FYVE domain containing 4

increases expression

benzo(b)fluoranthene results in increased expression of RUFY4 mRNA

NCBI chr 9:83,152,139...83,172,683
Ensembl chr 9:75,703,750...75,723,525

G

S100 calcium binding protein A14

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of S100A14 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of S100A14 mRNA

PMID:26377693 PMID:27858113

NCBI chr 2:178,305,976...178,308,004
Ensembl chr 2:176,008,395...176,010,423

G

S100 calcium-binding protein A4

increases expression

benzo(b)fluoranthene results in increased expression of S100A4 mRNA

NCBI chr 2:178,388,529...178,390,838
Ensembl chr 2:176,091,804...176,093,254

G

S100 calcium binding protein A6

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of S100A6 mRNA

NCBI chr 2:178,398,189...178,399,763
Ensembl chr 2:176,100,899...176,102,180

G

S100 calcium binding protein A8

increases expression

benzo(b)fluoranthene results in increased expression of S100A8 mRNA

NCBI chr 2:178,464,095...178,465,223
Ensembl chr 2:176,167,124...176,167,643

G

S100 calcium binding protein A9

increases expression

benzo(b)fluoranthene results in increased expression of S100A9 mRNA

NCBI chr 2:178,487,941...178,490,622
Ensembl chr 2:176,190,361...176,193,230

G

sphingosine-1-phosphate receptor 1

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of S1PR1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of S1PR1 mRNA

PMID:26377693 PMID:27858113

NCBI chr 2:206,309,715...206,314,070
Ensembl chr 2:203,621,587...203,629,681

G

sphingosine-1-phosphate receptor 5

decreases expression

benzo(b)fluoranthene results in decreased expression of S1PR5 mRNA

NCBI chr 8:28,062,841...28,068,013
Ensembl chr 8:19,786,663...19,791,795

G

SAC3 domain containing 1

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of SAC3D1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SAC3D1 mRNA

PMID:26377693 PMID:27858113

NCBI chr 1:203,414,184...203,416,563
Ensembl chr 1:203,414,187...203,416,604

G

Sin3A-associated protein 25

increases expression

benzo(b)fluoranthene results in increased expression of SAP25 mRNA

NCBI chr12:19,055,762...19,057,425
Ensembl chr12:19,055,763...19,076,089

G

suppressor APC domain containing 2

increases expression

benzo(b)fluoranthene results in increased expression of SAPCD2 mRNA

NCBI chr 3:28,583,615...28,590,694
Ensembl chr 3:8,187,266...8,192,546

G

spermidine/spermine N1-acetyl transferase 1

multiple interactions

[Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of SAT1 mRNA

NCBI chr X:44,008,089...44,011,376
Ensembl chr X:40,157,046...40,196,813

G

stearoyl-CoA desaturase

multiple interactions

[Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of SCD mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SCD1 mRNA

PMID:17690111 PMID:27858113

NCBI chr 1:253,218,968...253,232,101
Ensembl chr 1:243,269,747...243,282,562

G

sodium voltage-gated channel beta subunit 3

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of SCN3B mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SCN3B mRNA

PMID:26377693 PMID:27858113

NCBI chr 8:49,527,529...49,550,019
Ensembl chr 8:40,630,455...40,652,868

G

sodium voltage-gated channel alpha subunit 7

increases expression

benzo(b)fluoranthene results in increased expression of SCN7A mRNA

NCBI chr 3:71,743,873...71,846,454
Ensembl chr 3:51,335,841...51,438,256

G

scleraxis bHLH transcription factor

decreases expression

benzo(b)fluoranthene results in decreased expression of SCX mRNA

NCBI chr 7:110,056,897...110,059,283
Ensembl chr 7:108,176,608...108,178,626

G

syndecan binding protein 2

increases expression

benzo(b)fluoranthene results in increased expression of SDCBP2 mRNA

NCBI chr 3:140,060,746...140,098,063
Ensembl chr 3:140,070,540...140,098,057

G

stromal cell derived factor 4

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SDF4 mRNA

NCBI chr 5:171,868,591...171,885,827
Ensembl chr 5:166,586,390...166,604,521

G

selectin L

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of SELL mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SELL mRNA

PMID:26377693 PMID:27858113

NCBI chr13:78,950,100...78,969,604
Ensembl chr13:76,416,915...76,436,456

G

semaphorin 3C

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of SEMA3C mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SEMA3C mRNA

PMID:26377693 PMID:27858113

NCBI chr 4:18,538,452...18,702,453
Ensembl chr 4:17,583,212...17,746,534

G

semaphorin 3G

decreases expression

benzo(b)fluoranthene results in decreased expression of SEMA3G mRNA

NCBI chr16:6,420,025...6,431,655
Ensembl chr16:6,413,589...6,425,221

G

semaphorin 6A

decreases expression

benzo(b)fluoranthene results in decreased expression of SEMA6A mRNA

NCBI chr18:42,237,227...42,358,540
Ensembl chr18:40,050,624...40,171,954

G

semaphorin 7A (John Milton Hagen blood group)

increases expression

benzo(b)fluoranthene results in increased expression of SEMA7A mRNA

NCBI chr 8:67,244,318...67,267,060
Ensembl chr 8:58,348,448...58,370,536

G

septin 11

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SEPTIN11 mRNA

NCBI chr14:15,119,760...15,275,222
Ensembl chr14:14,844,580...14,990,853

G

septin 3

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of SEPTIN3 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SEPTIN3 mRNA

PMID:26377693 PMID:27858113

NCBI chr 7:113,783,217...113,811,089
Ensembl chr 7:113,783,095...113,811,087

G

septin 8

increases expression

benzo(b)fluoranthene results in increased expression of SEPTIN8 mRNA

NCBI chr10:38,185,454...38,214,502
Ensembl chr10:37,684,639...37,713,174

G

stress-associated endoplasmic reticulum protein family member 2

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of SERP2 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SERP2 mRNA

PMID:26377693 PMID:27858113

NCBI chr15:51,879,882...51,903,958
Ensembl chr15:51,879,877...51,904,785

G

serpin family A member 10

increases expression

benzo(b)fluoranthene results in increased expression of SERPINA10 mRNA

NCBI chr 6:128,520,894...128,529,332
Ensembl chr 6:122,756,108...122,764,544

G

serpin family A member 3N

multiple interactions

[Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of SERPINA3 mRNA

NCBI chr 6:129,088,392...129,095,950
Ensembl chr 6:123,323,629...123,332,433

G

serpin family B member 10

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of SERPINB10 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SERPINB10 mRNA

PMID:26377693 PMID:27858113

NCBI chr13:24,067,971...24,085,814
Ensembl chr13:23,553,430...23,571,182

G

serpin family B member 1A

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of SERPINB1A mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SERPINB1A mRNA

PMID:26377693 PMID:27858113

NCBI chr17:31,799,446...31,807,853
Ensembl chr17:31,590,677...31,599,102

G

serpin family B member 3A

increases expression

benzo(b)fluoranthene results in increased expression of SERPINB3A mRNA

NCBI chr13:23,755,690...23,766,188
Ensembl chr13:23,236,972...23,246,985

G

serpin family E member 1

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of SERPINE1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SERPINE1 mRNA

PMID:26377693 PMID:27858113

NCBI chr12:25,237,977...25,248,356
Ensembl chr12:19,601,272...19,611,657

G

serpin family F member 1

decreases expression

benzo(b)fluoranthene results in decreased expression of SERPINF1 mRNA

NCBI chr10:60,748,504...60,760,898
Ensembl chr10:60,249,708...60,262,646

G

SERTA domain containing 1

increases expression

benzo(b)fluoranthene results in increased expression of SERTAD1 mRNA

NCBI chr 1:91,903,297...91,906,565
Ensembl chr 1:82,775,252...82,779,091

G

SERTA domain containing 2

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SERTAD2 mRNA

NCBI chr14:98,935,428...99,039,536
Ensembl chr14:94,733,579...94,838,313

G

sestrin 2

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of SESN2 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SESN2 mRNA

PMID:26377693 PMID:27858113

NCBI chr 5:149,986,304...150,005,255
Ensembl chr 5:144,701,530...144,721,260

G

SET domain containing 1B, histone lysine methyltransferase

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SETD1B mRNA

NCBI chr12:39,056,809...39,082,399
Ensembl chr12:33,396,120...33,426,934

G

SET domain containing 7, histone lysine methyltransferase

increases expression

benzo(b)fluoranthene results in increased expression of SETD7 mRNA

NCBI chr 2:137,713,545...137,756,319
Ensembl chr 2:135,562,683...135,605,468

G

SFI1 centrin binding protein

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of SFI1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SFI1 mRNA

PMID:26377693 PMID:27858113

NCBI chr14:82,215,423...82,272,811
Ensembl chr14:77,990,965...78,048,255

G

SFT2 domain containing 2

decreases expression

benzo(b)fluoranthene results in decreased expression of SFT2D2 mRNA

NCBI chr13:77,484,778...77,504,123
Ensembl chr13:77,484,636...77,504,112

G

surfactant protein D

increases expression

benzo(b)fluoranthene results in increased expression of SFTPD mRNA

NCBI chr16:17,080,575...17,093,047
Ensembl chr16:17,046,483...17,059,927

G

sideroflexin 2

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SFXN2 mRNA

NCBI chr 1:255,388,428...255,400,724
Ensembl chr 1:245,447,015...245,468,411
Ensembl chr 1:245,447,015...245,468,411

G

sphingomyelin synthase 1

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of SGMS1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SGMS1 mRNA

PMID:26377693 PMID:27858113

NCBI chr 1:229,996,673...230,259,591
Ensembl chr 1:229,998,119...230,259,603

G

shugoshin 1

increases expression

benzo(b)fluoranthene results in increased expression of SGO1 mRNA

NCBI chr 9:6,908,661...6,943,483
Ensembl chr 9:6,672,123...6,687,805

G

SH3 domain containing 19

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of SH3D19 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SH3D19 mRNA

PMID:26377693 PMID:27858113

NCBI chr 2:173,654,234...173,814,030
Ensembl chr 2:171,356,251...171,515,561

G

SH3 and PX domains 2A

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SH3PXD2A mRNA

NCBI chr 1:256,094,991...256,301,120
Ensembl chr 1:246,160,502...246,360,166

G

SHC adaptor protein 4

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SHC4 mRNA

NCBI chr 3:133,334,026...133,428,404
Ensembl chr 3:112,880,600...112,974,366

G

SHC binding and spindle associated 1

increases expression

benzo(b)fluoranthene results in increased expression of SHCBP1 mRNA

NCBI chr16:91,373,843...91,405,409
Ensembl chr16:84,672,321...84,703,844

G

signal-induced proliferation-associated 1 like 2

increases expression

benzo(b)fluoranthene results in increased expression of SIPA1L2 mRNA

NCBI chr19:53,389,792...53,540,466
Ensembl chr19:53,389,805...53,540,428

G

SIX homeobox 1

decreases expression

benzo(b)fluoranthene results in decreased expression of SIX1 mRNA

NCBI chr 6:97,482,617...97,487,853
Ensembl chr 6:91,746,739...91,751,975

G

spindle and kinetochore associated complex subunit 1

increases expression

benzo(b)fluoranthene results in increased expression of SKA1 mRNA

NCBI chr18:70,069,957...70,080,303
Ensembl chr18:67,794,725...67,805,037

G

solute carrier family 10 member 2

increases expression

benzo(b)fluoranthene results in increased expression of SLC10A2 mRNA

NCBI chr16:91,088,089...91,111,025
Ensembl chr16:84,374,862...84,409,475

G

solute carrier family 10 member 6

decreases expression

benzo(b)fluoranthene results in decreased expression of SLC10A6 mRNA

NCBI chr14:6,080,716...6,102,902
Ensembl chr14:6,080,717...6,103,037

G

solute carrier family 12 member 4

increases expression

benzo(b)fluoranthene results in increased expression of SLC12A4 mRNA

NCBI chr19:50,748,268...50,770,217
Ensembl chr19:33,838,419...33,860,331

G

solute carrier family 13 member 5

increases expression

benzo(b)fluoranthene results in increased expression of SLC13A5 mRNA

NCBI chr10:56,866,249...56,891,189
Ensembl chr10:56,866,249...56,890,945

G

solute carrier family 16 member 1

multiple interactions

[Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of SLC16A1 mRNA

NCBI chr 2:194,805,556...194,832,966
Ensembl chr 2:192,124,289...192,144,611

G

solute carrier family 16 member 10

decreases expression

benzo(b)fluoranthene results in decreased expression of SLC16A10 mRNA

NCBI chr20:45,014,229...45,122,392
Ensembl chr20:43,459,709...43,567,839

G

solute carrier family 16, member 11

increases expression

benzo(b)fluoranthene results in increased expression of SLC16A11 mRNA

NCBI chr10:54,929,129...54,933,021
Ensembl chr10:54,927,725...54,942,915

G

solute carrier family 16 member 5

increases expression

benzo(b)fluoranthene results in increased expression of SLC16A5 mRNA

NCBI chr10:100,707,434...100,721,338
Ensembl chr10:100,707,434...100,721,338

G

solute carrier family 16, member 9

decreases expression

benzo(b)fluoranthene results in decreased expression of SLC16A9 mRNA

NCBI chr20:18,334,946...18,376,195
Ensembl chr20:18,335,862...18,377,022

G

solute carrier family 17, member 4

increases expression

benzo(b)fluoranthene results in increased expression of SLC17A4 mRNA

NCBI chr17:41,201,546...41,218,752
Ensembl chr17:41,207,552...41,218,752

G

solute carrier family 19 member 2

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of SLC19A2 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SLC19A2 mRNA

PMID:26377693 PMID:27858113

NCBI chr13:76,601,975...76,616,175
Ensembl chr13:76,601,900...76,616,172

G

solute carrier family 20 member 1

increases expression

benzo(b)fluoranthene results in increased expression of SLC20A1 mRNA

NCBI chr 3:136,880,360...136,894,255
Ensembl chr 3:116,427,098...116,441,051

G

solute carrier family 22 member 3

multiple interactions

[Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of SLC22A3 mRNA

NCBI chr 1:50,783,218...50,872,358
Ensembl chr 1:48,235,476...48,324,612

G

solute carrier family 24 member 3

decreases expression

benzo(b)fluoranthene results in decreased expression of SLC24A3 mRNA

NCBI chr 3:153,005,418...153,504,497
Ensembl chr 3:132,551,595...133,051,192

G

solute carrier family 25 member 33

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SLC25A33 mRNA

NCBI chr 5:165,478,070...165,518,186
Ensembl chr 5:160,195,042...160,219,961

G

solute carrier family 25, member 45

decreases expression

benzo(b)fluoranthene results in decreased expression of SLC25A45 mRNA

NCBI chr 1:203,166,362...203,174,473
Ensembl chr 1:203,166,683...203,174,473

G

solute carrier family 26, member 10

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of SLC26A10 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SLC26A10 mRNA

PMID:26377693 PMID:27858113

NCBI chr 7:62,995,165...63,005,099
Ensembl chr 7:62,995,381...63,004,087

G

solute carrier family 26 member 11

increases expression

benzo(b)fluoranthene results in increased expression of SLC26A11 mRNA

NCBI chr10:104,613,498...104,635,873
Ensembl chr10:104,613,564...104,635,970

G

solute carrier family 26 member 4

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SLC26A4 mRNA

NCBI chr 6:53,835,102...53,873,968
Ensembl chr 6:48,107,588...48,145,703

G

solute carrier family 26 member 6

increases expression

benzo(b)fluoranthene results in increased expression of SLC26A6 mRNA

NCBI chr 8:118,438,110...118,448,271
Ensembl chr 8:109,559,642...109,569,778

G

solute carrier family 29 member 4

increases expression

benzo(b)fluoranthene results in increased expression of SLC29A4 mRNA

NCBI chr12:11,853,540...11,884,660
Ensembl chr12:11,853,540...11,874,834

G

solute carrier family 2 member 6

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of SLC2A6 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SLC2A6 mRNA

PMID:26377693 PMID:27858113

NCBI chr 3:30,746,472...30,753,287
Ensembl chr 3:10,348,395...10,355,208

G

solute carrier family 2 member 9

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of SLC2A9 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SLC2A9 mRNA

PMID:26377693 PMID:27858113

NCBI chr14:76,540,649...76,674,277
Ensembl chr14:72,328,320...72,461,981

G

solute carrier family 30 member 1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SLC30A1 mRNA

NCBI chr13:106,022,019...106,025,892
Ensembl chr13:103,491,037...103,494,910

G

solute carrier family 35, member G2

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SLC35G2 mRNA

NCBI chr 8:101,085,579...101,113,339
Ensembl chr 8:101,085,545...101,113,349

G

solute carrier family 36 member 2

increases expression

benzo(b)fluoranthene results in increased expression of SLC36A2 mRNA

NCBI chr10:39,778,667...39,806,781
Ensembl chr10:39,278,046...39,306,082

G

solute carrier family 38, member 9

increases expression

benzo(b)fluoranthene results in increased expression of SLC38A9 mRNA

NCBI chr 2:46,024,731...46,102,419
Ensembl chr 2:44,291,989...44,368,955

G

solute carrier family 43 member 1

increases expression

benzo(b)fluoranthene results in increased expression of SLC43A1 mRNA

NCBI chr 3:90,327,250...90,353,438
Ensembl chr 3:69,920,649...69,946,768

G

solute carrier family 45, member 3

decreases expression

benzo(b)fluoranthene results in decreased expression of SLC45A3 mRNA

NCBI chr13:43,407,293...43,427,588
Ensembl chr13:43,407,293...43,427,588

G

solute carrier family 45, member 4

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of SLC45A4 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SLC45A4 mRNA

PMID:26377693 PMID:27858113

NCBI chr 7:105,478,886...105,550,160
Ensembl chr 7:105,481,792...105,550,170

G

solute carrier family 46, member 3

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SLC46A3 mRNA

NCBI chr12:7,140,610...7,157,093
Ensembl chr12:7,140,668...7,157,092

G

solute carrier family 4 member 1 (Diego blood group)

increases expression

benzo(b)fluoranthene results in increased expression of SLC4A1 mRNA

NCBI chr10:87,807,010...87,823,274
Ensembl chr10:87,306,872...87,323,117

G

solute carrier family 5 member 12

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of SLC5A12 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SLC5A12 mRNA

PMID:26377693 PMID:27858113

NCBI chr 3:117,633,885...117,683,966
Ensembl chr 3:97,179,326...97,228,405

G

solute carrier family 5 member 3

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SLC5A3 mRNA

NCBI chr11:44,799,787...44,802,233
Ensembl chr11:31,295,476...31,318,883

G

solute carrier family 66 member 3

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of SLC66A3 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SLC66A3 mRNA

PMID:26377693 PMID:27858113

NCBI chr 6:45,503,541...45,515,293
Ensembl chr 6:39,774,808...39,786,303

G

solute carrier family 6 member 2

decreases expression

benzo(b)fluoranthene results in decreased expression of SLC6A2 mRNA

NCBI chr19:30,183,289...30,228,292
Ensembl chr19:14,010,386...14,050,357

G

solute carrier family 7 member 3

decreases expression

benzo(b)fluoranthene results in decreased expression of SLC7A3 mRNA

NCBI chr X:70,250,089...70,256,610
Ensembl chr X:66,210,081...66,215,708

G

solute carrier family 8 member A1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SLC8A1 mRNA

NCBI chr 6:18,975,498...19,299,704
Ensembl chr 6:13,194,662...13,535,628

G

sarcolipin

decreases expression

benzo(b)fluoranthene results in decreased expression of SLN mRNA

NCBI chr 8:63,117,577...63,144,290
Ensembl chr 8:54,243,542...54,247,791

G

SMAD family member 3

multiple interactions

[Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of SMAD3 mRNA

NCBI chr 8:73,022,204...73,132,324
Ensembl chr 8:64,110,039...64,236,960

G

structural maintenance of chromosomes 2

increases expression

benzo(b)fluoranthene results in increased expression of SMC2 mRNA

NCBI chr 5:71,592,428...71,648,636
Ensembl chr 5:66,807,011...66,853,242

G

structural maintenance of chromosomes 4

increases expression

benzo(b)fluoranthene results in increased expression of SMC4 mRNA

NCBI chr 2:155,550,262...155,578,695
Ensembl chr 2:153,240,283...153,271,571

G

sphingomyelin phosphodiesterase 2

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SMPD2 mRNA

NCBI chr20:46,568,627...46,571,741
Ensembl chr20:44,986,231...44,989,441

G

synaptosome associated protein 23

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SNAP23 mRNA

NCBI chr 3:127,966,184...127,999,929
Ensembl chr 3:107,514,131...107,544,320

G

synaptosome associated protein 47

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SNAP47 mRNA

NCBI chr10:44,692,430...44,733,986
Ensembl chr10:44,191,218...44,234,424

G

synuclein, gamma

increases expression

benzo(b)fluoranthene results in increased expression of SNCG mRNA

NCBI chr16:9,706,765...9,712,072
Ensembl chr16:9,700,514...9,705,368

G

small nucleolar RNA host gene 11

increases expression

benzo(b)fluoranthene results in increased expression of SNHG11 mRNA

NCBI chr 3:167,451,272...167,456,945

G

small nucleolar RNA, C/D box 123

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SNORD123 mRNA

NCBI chr 2:83,306,918...83,306,987
Ensembl chr 2:83,306,918...83,306,987

G

syntrophin, beta 1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SNTB1 mRNA

NCBI chr 7:88,950,642...89,219,017
Ensembl chr 7:87,060,926...87,329,315

G

sine oculis binding protein homolog

decreases expression

benzo(b)fluoranthene results in decreased expression of SOBP mRNA

NCBI chr20:48,064,445...48,243,607
Ensembl chr20:46,482,765...46,663,541

G

suppressor of cytokine signaling 3

increases expression

benzo(b)fluoranthene results in increased expression of SOCS3 mRNA

NCBI chr10:103,692,579...103,695,975
Ensembl chr10:103,193,537...103,197,787

G

sortilin-related VPS10 domain containing receptor 2

increases expression

benzo(b)fluoranthene results in increased expression of SORCS2 mRNA

NCBI chr14:74,371,089...74,735,943
Ensembl chr14:74,371,415...74,735,943

G

sorbitol dehydrogenase

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of SORD mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SORD mRNA

PMID:26377693 PMID:27858113

NCBI chr 3:129,638,282...129,669,727
Ensembl chr 3:109,184,676...109,216,133

G

SRY-box transcription factor 11

decreases expression

benzo(b)fluoranthene results in decreased expression of SOX11 mRNA

NCBI chr 6:49,736,773...49,738,794
Ensembl chr 6:44,008,340...44,010,354

G

SRY-box transcription factor 17

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of SOX17 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SOX17 mRNA

PMID:26377693 PMID:27858113

NCBI chr 5:19,814,345...19,819,859
Ensembl chr 5:15,016,731...15,022,228

G

SRY-box transcription factor 18

increases expression

benzo(b)fluoranthene results in increased expression of SOX18 mRNA

NCBI chr 3:189,163,000...189,164,802
Ensembl chr 3:168,785,490...168,787,290

G

SRY-box transcription factor 4

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of SOX4 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SOX4 mRNA

PMID:26377693 PMID:27858113

NCBI chr17:35,876,298...35,881,004
Ensembl chr17:35,667,537...35,673,665

G

Sp5 transcription factor

increases expression

benzo(b)fluoranthene results in increased expression of SP5 mRNA

NCBI chr 3:55,274,931...55,277,733
Ensembl chr 3:55,274,931...55,277,733

G

sperm associated antigen 5

increases expression

benzo(b)fluoranthene results in increased expression of SPAG5 mRNA

NCBI chr10:63,693,300...63,714,813
Ensembl chr10:63,198,768...63,216,745

G

secreted protein acidic and cysteine rich

increases expression

benzo(b)fluoranthene results in increased expression of SPARC mRNA

NCBI chr10:40,017,065...40,038,816
Ensembl chr10:39,516,406...39,538,396

G

spermatogenesis associated 2-like

increases expression

benzo(b)fluoranthene results in increased expression of SPATA2L mRNA

NCBI chr19:51,269,078...51,273,605
Ensembl chr19:51,269,078...51,273,510

G

SPC25 component of NDC80 kinetochore complex

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of SPC25 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SPC25 mRNA

PMID:26377693 PMID:27858113

NCBI chr 3:74,337,872...74,396,825
Ensembl chr 3:53,975,704...53,988,959

G

signal peptidase complex subunit 2

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SPCS2 mRNA

NCBI chr 1:163,575,842...163,595,269
Ensembl chr 1:154,163,724...154,183,186

G

spindlin 1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SPIN1 mRNA

NCBI chr17:14,207,384...14,257,330
Ensembl chr17:14,055,689...14,105,411

G

serine peptidase inhibitor, Kazal type 1

increases expression

benzo(b)fluoranthene results in increased expression of SPINK1 mRNA

NCBI chr18:36,121,626...36,133,596
Ensembl chr18:35,824,550...35,882,642

G

spondin 1

increases expression

benzo(b)fluoranthene results in increased expression of SPON1 mRNA

NCBI chr 1:177,363,526...177,662,689
Ensembl chr 1:167,928,972...168,228,226

G

spondin 2

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of SPON2 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SPON2 mRNA

PMID:26377693 PMID:27858113

NCBI chr14:81,713,070...81,742,510
Ensembl chr14:77,511,901...77,517,996

G

secreted phosphoprotein 1

multiple interactions
decreases expression

[Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of SPP1 mRNA
benzo(b)fluoranthene results in decreased expression of SPP1 mRNA

PMID:17690111 PMID:18711122 PMID:26377693

NCBI chr14:5,613,569...5,620,695
Ensembl chr14:5,308,885...5,315,162

G

signal peptide peptidase like 3

decreases expression

benzo(b)fluoranthene results in decreased expression of SPPL3 mRNA

NCBI chr12:47,176,317...47,260,756
Ensembl chr12:41,515,640...41,600,126

G

spectrin, beta, non-erythrocytic 1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SPTBN1 mRNA

NCBI chr14:108,042,629...108,217,884
Ensembl chr14:103,842,684...104,008,507

G

spectrin, beta, non-erythrocytic 2

multiple interactions

[Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of SPTBN2 mRNA

NCBI chr 1:211,432,373...211,473,016
Ensembl chr 1:202,002,970...202,044,283

G

squalene epoxidase

decreases expression

benzo(b)fluoranthene results in decreased expression of SQLE mRNA

NCBI chr 7:92,758,175...92,773,049
Ensembl chr 7:90,868,011...90,883,618

G

serglycin

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of SRGN mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SRGN mRNA

PMID:26377693 PMID:27858113

NCBI chr20:30,985,508...31,022,296
Ensembl chr20:30,442,813...30,457,406

G

SRSF protein kinase 3

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SRPK3 mRNA

NCBI chr X:156,661,888...156,666,537
Ensembl chr X:151,510,539...151,515,198

G

serine/arginine repetitive matrix 2

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SRRM2 mRNA

NCBI chr10:12,815,471...12,848,750
Ensembl chr10:12,815,471...12,848,751

G

serine/arginine repetitive matrix 4

increases expression

benzo(b)fluoranthene results in increased expression of SRRM4 mRNA

NCBI chr12:45,659,729...45,819,643
Ensembl chr12:39,999,488...40,155,725

G

serine and arginine rich splicing factor 5

increases expression

benzo(b)fluoranthene results in increased expression of SRSF5 mRNA

NCBI chr 6:106,333,998...106,341,467
Ensembl chr 6:100,605,456...100,610,177

G

small RNA binding exonuclease protection factor La

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SSB mRNA

NCBI chr 3:75,024,385...75,034,016
Ensembl chr 3:54,616,619...54,626,203

G

sarcospan

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SSPN mRNA

NCBI chr 4:178,890,030...178,946,267
Ensembl chr 4:178,897,147...178,931,554

G

signal sequence receptor subunit 3

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SSR3 mRNA

NCBI chr 2:149,605,005...149,625,069
Ensembl chr 2:149,605,005...149,625,132

G

ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ST6GALNAC1 mRNA

NCBI chr10:101,972,656...101,983,053
Ensembl chr10:101,972,668...101,983,053

G

ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 2

increases expression

benzo(b)fluoranthene results in increased expression of ST6GALNAC2 mRNA

NCBI chr10:101,910,220...101,928,412
Ensembl chr10:101,909,971...101,915,008
Ensembl chr10:101,909,971...101,915,008

G

ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of ST8SIA4 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of ST8SIA4 mRNA

PMID:26377693 PMID:27858113

NCBI chr 9:103,437,479...103,532,008
Ensembl chr 9:95,993,503...96,084,653

G

stabilin 1

decreases expression

benzo(b)fluoranthene results in decreased expression of STAB1 mRNA

NCBI chr16:6,336,871...6,367,374
Ensembl chr16:6,330,444...6,360,923

G

stabilin 2

increases expression

benzo(b)fluoranthene results in increased expression of STAB2 mRNA

NCBI chr 7:23,136,938...23,342,633
Ensembl chr 7:21,249,391...21,434,042

G

staufen double-stranded RNA binding protein 2

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of STAU2 mRNA

NCBI chr 5:7,623,528...7,868,206
Ensembl chr 5:2,840,765...3,084,929

G

STEAP family member 1

decreases expression

benzo(b)fluoranthene results in decreased expression of STEAP1 mRNA

NCBI chr 4:29,231,809...29,242,317
Ensembl chr 4:28,276,909...28,287,479

G

STEAP4 metalloreductase

increases expression

benzo(b)fluoranthene results in increased expression of STEAP4 mRNA

NCBI chr 4:27,032,096...27,054,769
Ensembl chr 4:26,054,671...26,099,859

G

serine/threonine kinase 4

decreases expression

benzo(b)fluoranthene results in decreased expression of STK4 mRNA

NCBI chr 3:173,165,238...173,247,135
Ensembl chr 3:152,745,681...152,827,744

G

stathmin 1

increases expression

benzo(b)fluoranthene results in increased expression of STMN1 mRNA

NCBI chr 5:151,964,308...151,970,843
Ensembl chr 5:146,681,436...146,687,154

G

stathmin 2

increases expression

benzo(b)fluoranthene results in increased expression of STMN2 mRNA

NCBI chr 2:95,112,017...95,159,642
Ensembl chr 2:93,204,692...93,252,011

G

stonin 1

decreases expression

benzo(b)fluoranthene results in decreased expression of STON1 mRNA

NCBI chr 6:11,596,726...11,646,098
Ensembl chr 6:5,843,185...5,892,449

G

syntaxin 17

increases expression

benzo(b)fluoranthene results in increased expression of STX17 mRNA

NCBI chr 5:67,241,673...67,302,228
Ensembl chr 5:62,446,187...62,504,451

G

syntaxin binding protein 1

increases expression

benzo(b)fluoranthene results in increased expression of STXBP1 mRNA

NCBI chr 3:36,474,428...36,536,120
Ensembl chr 3:16,076,391...16,138,369

G

succinate receptor 1

decreases expression

benzo(b)fluoranthene results in decreased expression of SUCNR1 mRNA

NCBI chr 2:146,368,858...146,380,360
Ensembl chr 2:144,219,122...144,230,034

G

sulfatase 2

increases expression

benzo(b)fluoranthene results in increased expression of SULF2 mRNA

NCBI chr 3:175,241,322...175,323,808
Ensembl chr 3:154,822,085...154,904,415

G

Sad1 and UNC84 domain containing 2

increases expression

benzo(b)fluoranthene results in increased expression of SUN2 mRNA

NCBI chr 7:113,155,766...113,172,950
Ensembl chr 7:111,275,380...111,292,553

G

sushi domain containing 4

increases expression

benzo(b)fluoranthene results in increased expression of SUSD4 mRNA

NCBI chr13:96,982,867...97,109,419
Ensembl chr13:94,455,165...94,577,750

G

synaptonemal complex central element protein 1

decreases expression

benzo(b)fluoranthene results in decreased expression of SYCE1 mRNA

NCBI chr 1:195,852,171...195,863,174
Ensembl chr 1:195,852,172...195,863,174

G

synapsin II

increases expression

benzo(b)fluoranthene results in increased expression of SYN2 mRNA

NCBI chr 4:149,858,919...150,016,845
Ensembl chr 4:148,186,270...148,344,192

G

spectrin repeat containing nuclear envelope protein 2

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of SYNE2 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SYNE2 mRNA

PMID:26377693 PMID:27858113

NCBI chr 6:100,272,729...100,586,364
Ensembl chr 6:94,537,088...94,848,064

G

synaptotagmin 1

increases expression

benzo(b)fluoranthene results in increased expression of SYT1 mRNA

NCBI chr 7:45,699,649...46,244,460
Ensembl chr 7:43,815,785...44,357,803

G

synaptotagmin 10

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SYT10 mRNA

NCBI chr 7:122,737,301...122,800,462
Ensembl chr 7:120,862,972...120,920,863

G

synaptotagmin 15

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of SYT15 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SYT15 mRNA

PMID:26377693 PMID:27858113

NCBI chr16:9,538,740...9,549,548
Ensembl chr16:9,532,478...9,543,281

G

SZT2 subunit of KICSTOR complex

increases expression

benzo(b)fluoranthene results in increased expression of SZT2 mRNA

NCBI chr 5:137,182,648...137,229,349
Ensembl chr 5:131,897,275...131,943,904

G

TGF-beta activated kinase 1/MAP3K7 binding protein 2

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of TAB2 mRNA

NCBI chr 1:4,195,400...4,245,485
Ensembl chr 1:2,375,490...2,424,756

G

transforming, acidic coiled-coil containing protein 3

increases expression

benzo(b)fluoranthene results in increased expression of TACC3 mRNA

NCBI chr14:81,275,755...81,289,894
Ensembl chr14:77,051,215...77,065,219

G

TATA-box binding protein associated factor 1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of TAF1 mRNA

NCBI chr X:70,680,901...70,756,535
Ensembl chr X:66,640,982...66,716,543

G

TATA-box binding protein associated factor 6

increases expression

benzo(b)fluoranthene results in increased expression of TAF6 mRNA

NCBI chr12:22,169,570...22,178,031
Ensembl chr12:17,055,873...17,064,247

G

T-cell activation RhoGTPase activating protein

increases expression

benzo(b)fluoranthene results in increased expression of TAGAP mRNA

NCBI chr 1:49,575,750...49,584,747
Ensembl chr 1:47,170,725...47,179,792

G

tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1

decreases expression

benzo(b)fluoranthene results in decreased expression of TANC1 mRNA

NCBI chr 3:64,508,037...64,741,826
Ensembl chr 3:44,134,016...44,331,627

G

transporter 1, ATP binding cassette subfamily B member

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of TAP1 mRNA

NCBI chr20:4,658,171...4,668,543
Ensembl chr20:4,656,263...4,666,901

G

tyrosine aminotransferase

decreases expression

benzo(b)fluoranthene results in decreased expression of TAT mRNA

NCBI chr19:54,856,604...54,867,168
Ensembl chr19:37,947,112...37,958,031

G

TatD DNase domain containing 2

decreases expression

benzo(b)fluoranthene results in decreased expression of TATDN2 mRNA

NCBI chr 4:146,845,156...146,865,708
Ensembl chr 4:146,845,156...146,860,897

G

TBC1 domain family, member 30

increases expression

benzo(b)fluoranthene results in increased expression of TBC1D30 mRNA

NCBI chr 7:58,665,054...58,754,427
Ensembl chr 7:56,782,165...56,870,515

G

T-box transcription factor 21

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of TBX21 mRNA

NCBI chr10:82,578,751...82,595,253
Ensembl chr10:82,082,322...82,098,831

G

thromboxane A synthase 1

increases expression

benzo(b)fluoranthene results in increased expression of TBXAS1 mRNA

NCBI chr 4:68,631,841...68,803,959
Ensembl chr 4:67,665,007...67,837,096

G

transcription elongation factor A3

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of TCEA3 mRNA

NCBI chr 5:153,760,401...153,792,934
Ensembl chr 5:148,476,941...148,509,448

G

transcription factor 12

decreases expression

benzo(b)fluoranthene results in decreased expression of TCF12 mRNA

NCBI chr 8:81,371,201...81,682,337
Ensembl chr 8:72,492,567...72,799,201

G

transcription factor 19

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of TCF19 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of TCF19 mRNA

PMID:26377693 PMID:27858113

NCBI chr20:3,223,464...3,227,569
Ensembl chr20:3,218,693...3,223,271

G

transcription factor 7 like 2

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of TCF7L2 mRNA

NCBI chr 1:264,791,335...264,984,225
Ensembl chr 1:254,786,091...254,978,967

G

treacle ribosome biogenesis factor 1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of TCOF1 mRNA

NCBI chr18:56,537,437...56,570,727
Ensembl chr18:54,267,026...54,300,324

G

testis development related protein

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of TDRP mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of TDRP mRNA

PMID:26377693 PMID:27858113

NCBI chr16:75,624,047...75,652,635
Ensembl chr16:75,624,907...75,652,420

G

tec protein tyrosine kinase

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of TEC mRNA

NCBI chr14:35,352,551...35,461,585
Ensembl chr14:35,352,829...35,461,557

G

tectonin beta-propeller repeat containing 1

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of TECPR1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of TECPR1 mRNA

PMID:26377693 PMID:27858113

NCBI chr12:15,504,456...15,534,541
Ensembl chr12:10,391,696...10,419,611

G

TEF transcription factor, PAR bZIP family member

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of TEF mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of TEF mRNA

PMID:26377693 PMID:27858113

NCBI chr 7:115,197,180...115,221,930
Ensembl chr 7:113,317,283...113,341,783

G

terminal nucleotidyltransferase 5C

decreases expression

benzo(b)fluoranthene results in decreased expression of TENT5C mRNA

NCBI chr 2:190,541,668...190,563,902
Ensembl chr 2:187,853,024...187,894,744

G

testis expressed 11

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of TEX11 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of TEX11 mRNA

PMID:26377693 PMID:27858113

NCBI chr X:69,973,012...70,236,544
Ensembl chr X:65,932,988...66,196,187

G

transferrin

multiple interactions

[Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of TF mRNA

NCBI chr 8:112,668,667...112,695,376
Ensembl chr 8:103,767,995...103,816,511

G

transcription factor CP2-like 1

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of TFCP2L1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of TFCP2L1 mRNA

PMID:26377693 PMID:27858113

NCBI chr13:32,286,643...32,346,671
Ensembl chr13:29,733,840...29,793,870

G

trefoil factor 1

decreases expression

benzo(b)fluoranthene results in decreased expression of TFF1 mRNA

NCBI chr20:9,237,095...9,240,956
Ensembl chr20:9,235,736...9,239,597

G

tissue factor pathway inhibitor

increases expression

benzo(b)fluoranthene results in increased expression of TFPI mRNA

NCBI chr 3:89,939,862...89,989,253
Ensembl chr 3:69,533,156...69,576,880

G

transforming growth factor, beta receptor 2

increases expression

benzo(b)fluoranthene results in increased expression of TGFBR2 mRNA

NCBI chr 8:124,672,677...124,761,741
Ensembl chr 8:115,794,537...115,883,228

G

thrombomodulin

increases expression

benzo(b)fluoranthene results in increased expression of THBD mRNA

NCBI chr 3:156,316,526...156,320,178
Ensembl chr 3:135,862,835...135,867,193

G

thrombospondin 1

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of THBS1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of THBS1 mRNA

PMID:26377693 PMID:27858113

NCBI chr 3:125,510,250...125,525,402
Ensembl chr 3:105,056,292...105,071,440

G

thrombospondin 3

decreases expression

benzo(b)fluoranthene results in decreased expression of THBS3 mRNA

NCBI chr 2:176,919,549...176,931,357
Ensembl chr 2:174,621,812...174,633,594

G

thrombopoietin

decreases expression

benzo(b)fluoranthene results in decreased expression of THPO mRNA

Ensembl chr11:80,182,820...80,188,167

G

thyroid hormone receptor alpha

decreases expression

benzo(b)fluoranthene results in decreased expression of THRA mRNA

NCBI chr10:84,198,141...84,225,659
Ensembl chr10:83,700,755...83,729,936

G

thyroid hormone receptor associated protein 3

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of THRAP3 mRNA

NCBI chr 5:143,729,821...143,772,105
Ensembl chr 5:138,445,295...138,487,477

G

thyroid hormone responsive

decreases expression

benzo(b)fluoranthene results in decreased expression of THRSP mRNA

NCBI chr 1:161,134,640...161,138,964
Ensembl chr 1:151,723,086...151,728,075

G

thrombospondin type 1 domain containing 1

increases expression

benzo(b)fluoranthene results in increased expression of THSD1 mRNA

NCBI chr16:76,473,026...76,507,404
Ensembl chr16:69,771,408...69,801,504

G

thrombospondin type 1 domain containing 4

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of THSD4 mRNA

NCBI chr 8:69,280,397...69,880,144
Ensembl chr 8:60,386,875...61,024,995

G

thrombospondin type 1 domain containing 7A

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of THSD7A mRNA

NCBI chr 4:41,427,276...41,865,524
Ensembl chr 4:40,460,814...40,899,583

G

thymocyte nuclear protein 1

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of THYN1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of THYN1 mRNA

PMID:26377693 PMID:27858113

NCBI chr 8:25,406,563...25,415,445
Ensembl chr 8:25,406,500...25,415,445

G

TIAM Rac1 associated GEF 1

increases expression

benzo(b)fluoranthene results in increased expression of TIAM1 mRNA

NCBI chr11:42,517,527...42,866,280
Ensembl chr11:29,031,348...29,159,901

G

tyrosine kinase with immunoglobulin-like and EGF-like domains 1

increases expression

benzo(b)fluoranthene results in increased expression of TIE1 mRNA

NCBI chr 5:137,285,408...137,305,047
Ensembl chr 5:132,000,015...132,019,592

G

TRAF-interacting protein with forkhead-associated domain

increases expression

benzo(b)fluoranthene results in increased expression of TIFA mRNA

NCBI chr 2:218,927,724...218,942,111
Ensembl chr 2:216,234,774...216,267,841

G

timeless circadian regulator

increases expression

benzo(b)fluoranthene results in increased expression of TIMELESS mRNA

NCBI chr 7:1,239,388...1,263,344
Ensembl chr 7:654,822...678,738

G

TCDD-inducible poly(ADP-ribose) polymerase

increases expression

benzo(b)fluoranthene results in increased expression of TIPARP mRNA

NCBI chr 2:152,063,769...152,090,414
Ensembl chr 2:149,753,682...149,780,327

G

tight junction protein 3

decreases expression

benzo(b)fluoranthene results in decreased expression of TJP3 mRNA

NCBI chr 7:8,427,650...8,446,279
Ensembl chr 7:8,432,811...8,446,279

G

thymidine kinase 1

increases expression

benzo(b)fluoranthene results in increased expression of TK1 mRNA

NCBI chr10:103,533,449...103,544,818
Ensembl chr10:103,031,521...103,046,920

G

TLC domain containing 3B

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of TLCD3B mRNA

NCBI chr 1:190,851,582...190,870,278
Ensembl chr 1:181,422,830...181,439,743

G

TLE family member 1, transcriptional corepressor

decreases expression

benzo(b)fluoranthene results in decreased expression of TLE1 mRNA

NCBI chr 5:90,898,182...90,982,118
Ensembl chr 5:85,851,827...85,934,774

G

TLE family member 3, transcriptional corepressor

decreases expression

benzo(b)fluoranthene results in decreased expression of TLE3 mRNA

NCBI chr 8:70,753,182...70,799,080
Ensembl chr 8:61,858,200...61,903,493

G

tolloid-like 1

decreases expression

benzo(b)fluoranthene results in decreased expression of TLL1 mRNA

NCBI chr16:30,275,492...30,476,673
Ensembl chr16:25,509,146...25,709,543

G

talin 1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of TLN1 mRNA

NCBI chr 5:62,583,730...62,613,687
Ensembl chr 5:57,787,943...57,817,900

G

transmembrane 6 superfamily member 1

increases expression

benzo(b)fluoranthene results in increased expression of TM6SF1 mRNA

NCBI chr 1:135,799,844...135,828,515
Ensembl chr 1:135,786,381...135,828,443

G

transmembrane 7 superfamily member 3

decreases expression

benzo(b)fluoranthene results in decreased expression of TM7SF3 mRNA

NCBI chr 4:179,518,127...179,550,154
Ensembl chr 4:179,518,130...179,550,154

G

transmembrane and coiled-coil domains 4

increases expression

benzo(b)fluoranthene results in increased expression of TMCO4 mRNA

NCBI chr 5:151,216,499...151,294,726
Ensembl chr 5:151,216,812...151,294,723

G

transmembrane protein with EGF-like and two follistatin-like domains 2

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of TMEFF2 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of TMEFF2 mRNA

PMID:26377693 PMID:27858113

NCBI chr 9:57,937,873...58,225,372
Ensembl chr 9:50,436,079...50,733,475

G

transmembrane protein 144

increases expression

benzo(b)fluoranthene results in increased expression of TMEM144 mRNA

NCBI chr 2:164,960,649...164,993,562
Ensembl chr 2:164,961,247...164,992,368

G

transmembrane protein 171

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of TMEM171 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of TMEM171 mRNA

PMID:26377693 PMID:27858113

NCBI chr 2:30,035,278...30,045,996
Ensembl chr 2:30,035,278...30,045,049

G

transmembrane protein 178A

increases expression

benzo(b)fluoranthene results in increased expression of TMEM178 mRNA

NCBI chr 6:19,756,919...19,815,961
Ensembl chr 6:14,004,630...14,063,549

G

transmembrane protein 184C

increases expression

benzo(b)fluoranthene results in increased expression of TMEM184C mRNA

NCBI chr19:30,345,183...30,361,275
Ensembl chr19:30,345,290...30,361,269

G

transmembrane protein 221

decreases expression

benzo(b)fluoranthene results in decreased expression of TMEM221 mRNA

NCBI chr16:18,253,622...18,271,094
Ensembl chr16:18,262,052...18,266,967

G

transmembrane protein 245

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of TMEM245 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of TMEM245 mRNA

PMID:26377693 PMID:27858113

NCBI chr 5:71,570,952...71,647,915
Ensembl chr 5:71,514,858...71,647,763

G

transmembrane protein 25

increases expression

benzo(b)fluoranthene results in increased expression of TMEM25 mRNA

NCBI chr 8:54,003,907...54,009,469
Ensembl chr 8:45,107,121...45,116,389

G

transmembrane protein 252

increases expression

benzo(b)fluoranthene results in increased expression of TMEM252 mRNA

NCBI chr 1:222,316,982...222,321,946
Ensembl chr 1:222,316,795...222,321,943

G

transmembrane protein 253

increases expression

benzo(b)fluoranthene results in increased expression of TMEM253 mRNA

NCBI chr15:24,706,517...24,709,107
Ensembl chr15:24,706,529...24,708,625

G

transmembrane protein 255A

increases expression

benzo(b)fluoranthene results in increased expression of TMEM255A mRNA

NCBI chr X:116,970,793...117,035,008
Ensembl chr X:116,970,695...117,035,008

G

transmembrane protein 30B

increases expression

benzo(b)fluoranthene results in increased expression of TMEM30B mRNA

NCBI chr 6:97,987,471...97,990,546
Ensembl chr 6:92,249,790...92,254,842

G

transmembrane protein 40

decreases expression

benzo(b)fluoranthene results in decreased expression of TMEM40 mRNA

NCBI chr 4:148,791,509...148,819,287
Ensembl chr 4:148,791,505...148,823,665

G

transmembrane protein 42

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of TMEM42 mRNA

NCBI chr 8:131,551,616...131,554,749
Ensembl chr 8:122,674,070...122,677,276

G

transmembrane protein 44

increases expression

benzo(b)fluoranthene results in increased expression of TMEM44 mRNA

NCBI chr11:83,685,191...83,725,254
Ensembl chr11:70,181,345...70,216,958

G

transmembrane protein 82

increases expression

benzo(b)fluoranthene results in increased expression of TMEM82 mRNA

NCBI chr 5:159,210,531...159,214,462
Ensembl chr 5:153,927,471...153,936,979

G

transmembrane protein 98

increases expression

benzo(b)fluoranthene results in increased expression of TMEM98 mRNA

NCBI chr10:66,293,895...66,304,806
Ensembl chr10:65,796,145...65,807,079

G

tropomodulin 2

increases expression

benzo(b)fluoranthene results in increased expression of TMOD2 mRNA

NCBI chr 8:85,197,222...85,250,627
Ensembl chr 8:76,325,667...76,365,720

G

tropomodulin 4

increases expression

benzo(b)fluoranthene results in increased expression of TMOD4 mRNA

NCBI chr 2:185,384,547...185,389,549
Ensembl chr 2:182,695,709...182,700,540

G

transmembrane serine protease 4

increases expression

benzo(b)fluoranthene results in increased expression of TMPRSS4 mRNA

NCBI chr 8:54,372,805...54,405,157
Ensembl chr 8:45,476,053...45,508,409

G

thymosin beta 4, X-linked

increases expression

benzo(b)fluoranthene results in increased expression of TMSB4X mRNA

NCBI chr X:30,761,611...30,763,612
Ensembl chr X:27,128,610...27,146,667
Ensembl chr10:27,128,610...27,146,667

G

transmembrane O-mannosyltransferase targeting cadherins 1

increases expression

benzo(b)fluoranthene results in increased expression of TMTC1 mRNA

NCBI chr 4:181,142,937...181,357,979
Ensembl chr 4:181,146,251...181,359,289

G

transmembrane O-mannosyltransferase targeting cadherins 2

increases expression

benzo(b)fluoranthene results in increased expression of TMTC2 mRNA

NCBI chr 7:40,392,377...40,806,685
Ensembl chr 7:40,394,220...40,807,298

G

tenascin C

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of TNC mRNA

NCBI chr 5:82,391,340...82,476,197
Ensembl chr 5:77,375,851...77,460,624

G

TNF alpha induced protein 8 like 1

increases expression

benzo(b)fluoranthene results in increased expression of TNFAIP8L1 mRNA

NCBI chr 9:988,587...999,342
Ensembl chr 9:988,594...1,002,254

G

TNF receptor superfamily member 10b

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of TNFRSF10B mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of TNFRSF10B mRNA

PMID:26377693 PMID:27858113

NCBI chr15:51,249,883...51,278,091
Ensembl chr15:44,840,386...44,867,467

G

TNF receptor superfamily member 9

decreases expression

benzo(b)fluoranthene results in decreased expression of TNFRSF9 mRNA

NCBI chr 5:166,664,494...166,690,834
Ensembl chr 5:161,381,662...161,408,000

G

TNF superfamily member 10

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of TNFSF10 mRNA

NCBI chr 2:112,136,550...112,155,903
Ensembl chr 2:110,207,916...110,225,135

G

TNF superfamily member 4

multiple interactions

[Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of TNFSF4 mRNA

NCBI chr13:76,256,654...76,280,133
Ensembl chr13:73,723,329...73,746,788

G

troponin I3, cardiac type

decreases expression

benzo(b)fluoranthene results in decreased expression of TNNI3 mRNA

NCBI chr 1:78,342,571...78,346,255
Ensembl chr 1:69,299,900...69,303,580

G

tensin 1

decreases expression

benzo(b)fluoranthene results in decreased expression of TNS1 mRNA

NCBI chr 9:82,941,068...83,152,007
Ensembl chr 9:75,495,814...75,703,225

G

tenascin XB

increases expression

benzo(b)fluoranthene results in increased expression of TNXB mRNA

G

DNA topoisomerase II alpha

increases expression

benzo(b)fluoranthene results in increased expression of TOP2A mRNA

NCBI chr10:84,441,954...84,473,093
Ensembl chr10:83,945,735...83,976,874

G

DNA topoisomerase II binding protein 1

increases expression

benzo(b)fluoranthene results in increased expression of TOPBP1 mRNA

NCBI chr 8:112,766,791...112,815,203
Ensembl chr 8:103,887,865...103,931,674

G

TOX high mobility group box family member 3

decreases expression

benzo(b)fluoranthene results in decreased expression of TOX3 mRNA

NCBI chr19:32,820,957...32,929,776
Ensembl chr19:16,648,342...16,757,148

G

TOX high mobility group box family member 4

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of TOX4 mRNA

NCBI chr15:24,989,246...25,002,833
Ensembl chr15:24,988,853...25,002,833

G

tumor protein p53

increases expression
multiple interactions
affects activity

benzo(b)fluoranthene results in increased expression of TP53 protein
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of TRP53 mRNA
benzo(b)fluoranthene affects the activity of TP53 protein; benzo(b)fluoranthene metabolite affects the activity of TP53 protein

PMID:21776270 PMID:27858113 PMID:35435491

NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,300,048...54,311,524

G

tumor protein p53 inducible nuclear protein 1

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of TRP53INP1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of TRP53INP1 mRNA

PMID:26377693 PMID:27858113

NCBI chr 5:29,051,267...29,069,486
Ensembl chr 5:24,260,568...24,267,968

G

tumor protein p53 inducible nuclear protein 2

decreases expression

benzo(b)fluoranthene results in decreased expression of TRP53INP2 mRNA

NCBI chr 3:164,341,618...164,350,270
Ensembl chr 3:143,882,021...143,890,097

G

thiamin pyrophosphokinase 1

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of TPK1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of TPK1 mRNA

PMID:26377693 PMID:27858113

NCBI chr 4:73,170,125...73,557,683
Ensembl chr 4:72,170,134...72,557,694

G

tryptase beta 2

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of TPSB2 mRNA

NCBI chr10:14,886,310...14,888,102
Ensembl chr10:14,382,013...14,383,569

G

TPX2, microtubule nucleation factor

increases expression

benzo(b)fluoranthene results in increased expression of TPX2 mRNA

NCBI chr 3:161,778,709...161,820,941
Ensembl chr 3:141,318,455...141,360,468

G

TRAF3 interacting protein 3

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of TRAF3IP3 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of TRAF3IP3 mRNA

PMID:26377693 PMID:27858113

NCBI chr13:107,223,499...107,248,358
Ensembl chr13:104,694,805...104,719,673

G

triggering receptor expressed on myeloid cells 2

increases expression

benzo(b)fluoranthene results in increased expression of TREM2 mRNA

NCBI chr 9:20,145,215...20,151,797
Ensembl chr 9:12,647,259...12,654,170

G

triggering receptor expressed on myeloid cells-like 1

decreases expression

benzo(b)fluoranthene results in decreased expression of TREML1 mRNA

NCBI chr 9:12,635,584...12,642,324
Ensembl chr 9:12,635,590...12,642,347

G

transcriptional regulating factor 1

increases expression

benzo(b)fluoranthene results in increased expression of TRERF1 mRNA

NCBI chr 9:21,131,772...21,355,830
Ensembl chr 9:13,634,126...13,857,029

G

tribbles pseudokinase 2

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of TRIB2 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of TRIB2 mRNA

PMID:26377693 PMID:27858113

NCBI chr 6:44,274,762...44,299,139
Ensembl chr 6:38,545,975...38,569,370

G

tripartite motif-containing 11

increases expression

benzo(b)fluoranthene results in increased expression of TRIM11 mRNA

NCBI chr10:44,255,019...44,270,711
Ensembl chr10:43,758,354...43,771,138

G

tripartite motif-containing 16

increases expression

benzo(b)fluoranthene results in increased expression of TRIM16 mRNA

NCBI chr10:47,985,235...48,008,242
Ensembl chr10:47,486,297...47,551,907

G

tripartite motif-containing 34

increases expression

benzo(b)fluoranthene results in increased expression of TRIM34 mRNA

NCBI chr 1:158,707,172...158,720,214
Ensembl chr 1:158,707,172...158,718,674

G

tripartite motif-containing 35

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of TRIM35 mRNA

NCBI chr15:44,669,222...44,685,766
Ensembl chr15:40,493,755...40,510,240

G

tripartite motif-containing 59

increases expression

benzo(b)fluoranthene results in increased expression of TRIM59 mRNA

NCBI chr 2:153,269,210...153,281,185
Ensembl chr 2:153,268,584...153,281,031

G

thyroid hormone receptor interactor 12

increases expression

benzo(b)fluoranthene results in increased expression of TRIP12 mRNA

NCBI chr 9:93,364,791...93,491,015
Ensembl chr 9:85,916,691...86,051,403

G

thyroid hormone receptor interactor 13

increases expression

benzo(b)fluoranthene results in increased expression of TRIP13 mRNA

NCBI chr 1:31,185,700...31,230,638
Ensembl chr 1:29,357,130...29,402,074

G

transient receptor potential cation channel, subfamily C, member 6

increases expression

benzo(b)fluoranthene results in increased expression of TRPC6 mRNA

NCBI chr 8:14,044,216...14,148,808
Ensembl chr 8:5,758,935...5,828,092

G

transient receptor potential cation channel, subfamily V, member 4

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of TRPV4 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of TRPV4 mRNA

PMID:26377693 PMID:27858113

NCBI chr12:47,599,161...47,638,143
Ensembl chr12:41,938,560...41,977,517

G

TSC22 domain family, member 1

affects expression
multiple interactions

benzo(b)fluoranthene affects the expression of TSC22D1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of TSC22D1 mRNA

PMID:26377693 PMID:27858113

NCBI chr15:58,159,612...58,260,244
Ensembl chr15:51,749,510...51,850,958

G

TSC22 domain family, member 3

decreases expression

benzo(b)fluoranthene results in decreased expression of TSC22D3 mRNA

NCBI chr X:109,006,410...109,066,389
Ensembl chr X:104,217,925...104,276,861

G

thyroid stimulating hormone subunit beta

decreases expression

benzo(b)fluoranthene results in decreased expression of TSHB mRNA

NCBI chr 2:192,913,171...192,918,054
Ensembl chr 2:190,224,676...190,229,559

G

tetraspanin 17

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of TSPAN17 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of TSPAN17 mRNA

PMID:26377693 PMID:27858113

NCBI chr17:9,824,353...9,831,985
Ensembl chr17:9,819,202...9,826,834

G

tetraspanin 18

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of TSPAN18 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of TSPAN18 mRNA

PMID:26377693 PMID:27858113

NCBI chr 3:79,160,060...79,299,907
Ensembl chr 3:79,161,662...79,299,852

G

tetraspanin 4

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of TSPAN4 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of TSPAN4 mRNA

PMID:26377693 PMID:27858113

NCBI chr 1:206,001,731...206,021,414
Ensembl chr 1:196,572,228...196,617,448

G

testis specific protein, Y-linked 26

increases expression

benzo(b)fluoranthene results in increased expression of TSPYL3 mRNA

NCBI chr 3:141,690,653...141,692,729
Ensembl chr 3:141,689,899...141,692,670

G

thiosulfate sulfurtransferase like domain containing 3

increases expression

benzo(b)fluoranthene results in increased expression of TSTD3 mRNA

NCBI chr 5:40,091,438...40,101,509
Ensembl chr 5:35,294,645...35,304,101

G

tetratricopeptide repeat domain 13

increases expression

benzo(b)fluoranthene results in increased expression of TTC13 mRNA

NCBI chr19:69,534,989...69,589,590
Ensembl chr19:52,637,431...52,692,198

G

tetratricopeptide repeat domain 7A

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of TTC7 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of TTC7 mRNA

PMID:26377693 PMID:27858113

NCBI chr 6:7,159,285...7,261,826
Ensembl chr 6:7,159,061...7,261,892

G

transcription termination factor 2

increases expression

benzo(b)fluoranthene results in increased expression of TTF2 mRNA

NCBI chr 2:191,054,942...191,086,331
Ensembl chr 2:188,366,331...188,397,689

G

tubulin tyrosine ligase

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of TTL mRNA

NCBI chr 3:116,298,813...116,328,538
Ensembl chr 3:116,298,797...116,328,538

G

tubulin tyrosine ligase like 7

decreases expression

benzo(b)fluoranthene results in decreased expression of TTLL7 mRNA

NCBI chr 2:238,425,786...238,549,296
Ensembl chr 2:235,765,835...235,885,047

G

titin

decreases expression

benzo(b)fluoranthene results in decreased expression of TTN mRNA

NCBI chr 3:82,059,648...82,332,130
Ensembl chr 3:61,652,439...61,924,741

G

tubulin, alpha 1B

increases expression

benzo(b)fluoranthene results in increased expression of TUBA1B mRNA

NCBI chr 7:131,969,606...131,972,587
Ensembl chr 7:130,081,032...130,196,186

G

tubulin, beta 2A class IIa

decreases expression

benzo(b)fluoranthene results in decreased expression of TUBB2A mRNA

NCBI chr17:31,002,186...31,006,057
Ensembl chr17:30,747,503...30,800,714

G

tubulin, beta 2B class IIb

increases expression

benzo(b)fluoranthene results in increased expression of TUBB2B mRNA

NCBI chr17:30,953,086...30,956,133
Ensembl chr17:30,747,734...30,750,638

G

tubulin, beta 4B class IVb

increases expression

benzo(b)fluoranthene results in increased expression of TUBB4B mRNA

NCBI chr 3:28,435,999...28,438,455
Ensembl chr 3:8,037,799...8,040,296

G

tubulin, beta 5 class I

multiple interactions

[Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of TUBB5 mRNA

NCBI chr20:2,917,577...2,921,726
Ensembl chr20:2,912,778...2,916,940

G

tubulin, beta 6 class V

increases expression

benzo(b)fluoranthene results in increased expression of TUBB6 mRNA

NCBI chr18:63,213,287...63,222,926
Ensembl chr18:60,943,375...60,954,418

G

taurine up-regulated 1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of TUG1 mRNA

NCBI chr14:82,743,501...82,750,534
Ensembl chr14:78,522,506...78,526,927

G

TUB like protein 4

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of TULP4 mRNA

NCBI chr 1:46,682,416...46,813,167
Ensembl chr 1:46,682,863...46,809,688

G

tumor suppressor 2, mitochondrial calcium regulator

increases expression

benzo(b)fluoranthene results in increased expression of TUSC2 mRNA

NCBI chr 8:117,115,479...117,118,697
Ensembl chr 8:108,236,838...108,240,056

G

taxilin alpha

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of TXLNA mRNA

NCBI chr 5:141,969,337...141,985,054
Ensembl chr 5:141,969,346...141,984,583

G

TYRO3 protein tyrosine kinase

decreases expression

benzo(b)fluoranthene results in decreased expression of TYRO3 mRNA

NCBI chr 3:127,231,468...127,254,806
Ensembl chr 3:106,777,635...106,797,142

G

uveal autoantigen with coiled-coil domains and ankyrin repeats

increases expression

benzo(b)fluoranthene results in increased expression of UACA mRNA

NCBI chr 8:70,155,059...70,243,416
Ensembl chr 8:61,259,477...61,347,789

G

UBA-like domain containing 2

increases expression

benzo(b)fluoranthene results in increased expression of UBALD2 mRNA

NCBI chr10:101,662,507...101,667,089
Ensembl chr10:101,658,127...101,667,061

G

ubiquitin B

increases expression

benzo(b)fluoranthene results in increased expression of UBB mRNA

NCBI chr10:47,746,923...47,748,628
Ensembl chr10:47,245,637...47,249,333

G

ubiquitin-conjugating enzyme E2C

increases expression

benzo(b)fluoranthene results in increased expression of UBE2C mRNA

NCBI chr 3:173,925,975...173,928,375
Ensembl chr 3:153,506,636...153,513,339

G

UBX domain protein 10

decreases expression

benzo(b)fluoranthene results in decreased expression of UBXN10 mRNA

NCBI chr 5:156,237,041...156,242,877
Ensembl chr 5:150,950,731...150,959,744

G

ubiquitin C-terminal hydrolase L1

increases expression

benzo(b)fluoranthene results in increased expression of UCHL1 mRNA

NCBI chr14:41,838,859...41,849,743
Ensembl chr14:41,485,031...41,495,590

G

uncoupling protein 1

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of UCP1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of UCP1 mRNA

PMID:26377693 PMID:27858113

NCBI chr19:41,713,350...41,721,421
Ensembl chr19:24,808,783...24,816,852

G

UDP glucuronosyltransferase family 1 member A6

multiple interactions

[phenanthrene co-treated with pyrene co-treated with Benzo(a)pyrene co-treated with benzo(k)fluoranthene co-treated with dibenzo(a,l)pyrene co-treated with benzo(b)fluoranthene] results in increased expression of UGT1A6 mRNA

NCBI chr 9:96,195,018...96,256,264
Ensembl chr 9:88,713,184...88,808,465

G

ubiquitin-like with PHD and ring finger domains 1

increases expression

benzo(b)fluoranthene results in increased expression of UHRF1 mRNA

NCBI chr 9:1,220,162...1,241,792
Ensembl chr 9:1,134,909...1,154,631

G

unc-5 netrin receptor B

increases expression

benzo(b)fluoranthene results in increased expression of UNC5B mRNA

NCBI chr20:29,240,639...29,307,270
Ensembl chr20:28,697,726...28,764,537

G

beta-ureidopropionase 1

decreases expression

benzo(b)fluoranthene results in decreased expression of UPB1 mRNA

NCBI chr20:13,216,693...13,243,016
Ensembl chr20:13,217,258...13,243,590

G

uroplakin 1A

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of UPK1A mRNA

NCBI chr 1:94,987,110...94,998,083
Ensembl chr 1:85,859,671...85,870,354

G

uroplakin 3A

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of UPK3A mRNA

NCBI chr 7:116,128,981...116,139,950
Ensembl chr 7:116,134,874...116,139,948

G

USH1 protein network component harmonin binding protein 1

increases expression

benzo(b)fluoranthene results in increased expression of USHBP1 mRNA

NCBI chr16:18,091,311...18,101,927
Ensembl chr16:18,057,326...18,067,877

G

ubiquitin specific peptidase 2

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of USP2 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of USP2 mRNA

PMID:26377693 PMID:27858113

NCBI chr 8:53,308,264...53,336,800
Ensembl chr 8:44,411,607...44,438,331

G

UTP14A small subunit processome component

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of UTP14A mRNA

NCBI chr X:132,317,163...132,342,524
Ensembl chr X:127,439,268...127,464,633

G

utrophin

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of UTRN mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of UTRN mRNA

PMID:26377693 PMID:27858113

NCBI chr 1:8,541,061...9,044,487
Ensembl chr 1:6,722,594...7,224,313

G

vesicle-associated membrane protein 5

decreases expression

benzo(b)fluoranthene results in decreased expression of VAMP5 mRNA

NCBI chr 4:105,982,004...105,993,247
Ensembl chr 4:104,423,820...104,426,212

G

VAMP associated protein B and C

decreases expression

benzo(b)fluoranthene results in decreased expression of VAPB mRNA

NCBI chr 3:182,954,247...182,997,018
Ensembl chr 3:162,535,905...162,573,763

G

vasohibin 1

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of VASH1 mRNA

NCBI chr 6:112,060,086...112,076,689
Ensembl chr 6:106,329,123...106,345,726

G

vesicle amine transport 1

increases expression

benzo(b)fluoranthene results in increased expression of VAT1 mRNA

NCBI chr10:86,889,793...86,897,411
Ensembl chr10:86,389,545...86,397,224

G

vav guanine nucleotide exchange factor 3

increases expression

benzo(b)fluoranthene results in increased expression of VAV3 mRNA

NCBI chr 2:199,699,861...200,042,344
Ensembl chr 2:197,011,831...197,354,321

G

vascular endothelial growth factor C

increases expression

benzo(b)fluoranthene results in increased expression of VEGFC mRNA

NCBI chr16:44,445,293...44,560,887
Ensembl chr16:37,712,262...37,827,848

G

ventricular zone expressed PH domain-containing 1

increases expression

benzo(b)fluoranthene results in increased expression of VEPH1 mRNA

NCBI chr 2:152,592,648...152,847,566
Ensembl chr 2:150,296,573...150,537,266

G

villin 1

increases expression

benzo(b)fluoranthene results in increased expression of VIL1 mRNA

NCBI chr 9:83,440,248...83,467,963
Ensembl chr 9:75,991,141...76,018,858

G

vimentin

increases expression

benzo(b)fluoranthene results in increased expression of VIM mRNA

NCBI chr17:81,577,261...81,585,746
Ensembl chr17:76,668,647...76,677,187

G

vacuole membrane protein 1

multiple interactions
increases expression

[Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of VMP1 mRNA
benzo(b)fluoranthene results in increased expression of VMP1 mRNA

PMID:16269432 PMID:17690111

NCBI chr10:71,903,223...72,002,337
Ensembl chr10:71,405,452...71,505,007

G

VOPP1 WW domain binding protein

increases expression

benzo(b)fluoranthene results in increased expression of VOPP1 mRNA

NCBI chr 4:88,692,784...88,762,903
Ensembl chr 4:87,363,477...87,450,375

G

VPS16 core subunit of CORVET and HOPS complexes

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of VPS16 mRNA

NCBI chr 3:138,075,649...138,097,154
Ensembl chr 3:117,622,542...117,646,441

G

VPS39 subunit of HOPS complex

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of VPS39 mRNA

NCBI chr 3:107,266,846...107,304,884
Ensembl chr 3:107,267,310...107,304,975

G

VRK serine/threonine kinase 2

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of VRK2 mRNA

NCBI chr14:104,514,815...104,635,549
Ensembl chr14:100,313,601...100,434,527

G

V-set and immunoglobulin domain containing 10

decreases expression

benzo(b)fluoranthene results in decreased expression of VSIG10 mRNA

NCBI chr12:39,241,332...39,277,302
Ensembl chr12:39,241,334...39,275,360

G

V-set immunoregulatory receptor

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of VSIR mRNA

NCBI chr20:28,824,493...28,850,175
Ensembl chr20:28,281,596...28,303,878

G

von Willebrand factor A domain containing 8

increases expression

benzo(b)fluoranthene results in increased expression of VWA8 mRNA

NCBI chr15:60,661,764...60,985,971
Ensembl chr15:54,252,584...54,576,870

G

von Willebrand factor

increases expression

benzo(b)fluoranthene results in increased expression of VWF mRNA

NCBI chr 4:160,042,900...160,177,757
Ensembl chr 4:158,360,152...158,491,539

G

WASP like actin nucleation promoting factor

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of WASL mRNA

NCBI chr 4:54,049,081...54,097,653
Ensembl chr 4:53,083,536...53,132,022

G

WD repeat domain 45B

increases expression

benzo(b)fluoranthene results in increased expression of WDR45B mRNA

NCBI chr10:107,097,655...107,127,839
Ensembl chr10:106,599,364...106,629,441

G

WEE1 G2 checkpoint kinase

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of WEE1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of WEE1 mRNA

PMID:26377693 PMID:27858113

NCBI chr 1:173,605,609...173,632,450
Ensembl chr 1:164,174,779...164,197,688

G

WAP four-disulfide core domain 1

increases expression

benzo(b)fluoranthene results in increased expression of WFDC1 mRNA

NCBI chr19:47,720,191...47,739,121
Ensembl chr19:47,720,423...47,739,108

G

WAP four-disulfide core domain 12

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of WFDC12 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of WFDC12 mRNA

PMID:26377693 PMID:27858113

NCBI chr 3:173,280,844...173,282,167
Ensembl chr 3:152,862,341...152,862,690

G

WAS/WASL interacting protein family, member 3

increases expression

benzo(b)fluoranthene results in increased expression of WIPF3 mRNA

NCBI chr 4:83,550,075...83,629,929
Ensembl chr 4:83,550,468...83,629,386

G

Wnt family member 10B

decreases expression

benzo(b)fluoranthene results in decreased expression of WNT10B mRNA

NCBI chr 7:131,801,046...131,806,850
Ensembl chr 7:129,922,088...129,927,892

G

X-box binding protein 1

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of XBP1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of XBP1 mRNA

PMID:26377693 PMID:27858113

NCBI chr14:84,604,623...84,609,707
Ensembl chr14:80,390,643...80,395,693

G

X-prolyl aminopeptidase 1

increases expression

benzo(b)fluoranthene results in increased expression of XPNPEP1 mRNA

NCBI chr 1:262,006,761...262,057,479
Ensembl chr 1:252,001,367...252,051,479

G

X-prolyl aminopeptidase 2

decreases expression
multiple interactions

benzo(b)fluoranthene results in decreased expression of XPNPEP2 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of XPNPEP2 mRNA

PMID:26377693 PMID:27858113

NCBI chr X:132,165,696...132,194,937
Ensembl chr X:127,287,979...127,317,223

G

yippee-like 5

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of YPEL5 mRNA

NCBI chr 6:22,656,284...22,671,741
Ensembl chr 6:22,656,285...22,671,691

G

tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of YWHAZ mRNA

NCBI chr 7:69,826,404...69,848,702
Ensembl chr 7:67,940,017...67,963,668

G

zinc finger and BTB domain containing 20

decreases expression

benzo(b)fluoranthene results in decreased expression of ZBTB20 mRNA

NCBI chr11:70,558,010...71,297,039
Ensembl chr11:57,072,880...57,510,210

G

zinc finger and BTB domain containing 8 opposite strand

increases expression

benzo(b)fluoranthene results in increased expression of ZBTB8OS mRNA

NCBI chr 5:141,675,595...141,687,148
Ensembl chr 5:141,675,857...141,688,660

G

zinc finger CCCH type containing 7 A

increases expression

benzo(b)fluoranthene results in increased expression of ZC3H7A mRNA

NCBI chr10:4,473,177...4,512,668
Ensembl chr10:4,473,203...4,512,665

G

zinc finger DHHC-type palmitoyltransferase 23

increases expression

benzo(b)fluoranthene results in increased expression of ZDHHC23 mRNA

NCBI chr11:70,224,581...70,240,971
Ensembl chr11:56,718,826...56,734,194

G

zinc finger protein 280D

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ZFP280D mRNA

NCBI chr 8:72,992,655...73,080,482
Ensembl chr 8:72,992,650...73,080,480

G

zinc finger protein 346

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of ZFP346 mRNA

NCBI chr17:9,498,933...9,528,824
Ensembl chr17:9,493,803...9,523,635

G

zinc finger protein 365

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of ZFP365 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of ZFP365 mRNA

PMID:26377693 PMID:27858113

NCBI chr20:20,666,240...20,689,734
Ensembl chr20:20,666,240...20,691,238

G

zinc finger protein 367

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of ZFP367 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of ZFP367 mRNA

PMID:26377693 PMID:27858113

NCBI chr17:965,161...984,290
Ensembl chr17:965,161...984,287

G

zinc finger protein 423

increases expression

benzo(b)fluoranthene results in increased expression of ZFP423 mRNA

NCBI chr19:35,282,149...35,580,775
Ensembl chr19:19,110,238...19,407,373

G

zinc finger protein 512B

increases expression

benzo(b)fluoranthene results in increased expression of ZNF512B mRNA

NCBI chr 3:168,687,520...168,698,067
Ensembl chr 3:168,687,521...168,698,091

G

zinc finger protein 62

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ZFP62 mRNA

NCBI chr10:33,522,618...33,539,446
Ensembl chr10:33,500,323...33,542,013

G

zinc finger protein 628

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ZFP628 mRNA

NCBI chr 1:68,913,600...68,921,186
Ensembl chr 1:68,910,401...68,921,243

G

zinc finger protein 707

increases expression

benzo(b)fluoranthene results in increased expression of ZFP707 mRNA

NCBI chr 7:107,679,597...107,686,556
Ensembl chr 7:107,650,217...107,703,459

G

zinc finger FYVE-type containing 27

increases expression

benzo(b)fluoranthene results in increased expression of ZFYVE27 mRNA

NCBI chr 1:250,929,110...250,952,481
Ensembl chr 1:240,979,842...241,003,193

G

zinc finger, matrin type 3

increases expression
multiple interactions

benzo(b)fluoranthene results in increased expression of ZMAT3 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of ZMAT3 mRNA

PMID:26377693 PMID:27858113

NCBI chr 2:115,106,046...115,136,888
Ensembl chr 2:115,106,966...115,136,863

G

zinc finger, MYND-type containing 15

affects expression
multiple interactions

benzo(b)fluoranthene affects the expression of ZMYND15 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ZMYND15 mRNA

PMID:26377693 PMID:27858113

NCBI chr10:55,669,832...55,676,446
Ensembl chr10:55,171,198...55,177,812

G

zinc finger, MYND-type containing 8

multiple interactions

[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ZMYND8 mRNA

NCBI chr 3:174,948,162...175,061,382
Ensembl chr 3:154,529,043...154,628,463

G

zinc finger protein 750

increases expression

benzo(b)fluoranthene results in increased expression of ZFP750 mRNA

NCBI chr10:107,270,926...107,279,904
Ensembl chr10:106,772,669...106,781,200

G

zinc finger and SCAN domain containing 21

increases expression

benzo(b)fluoranthene results in increased expression of ZSCAN21 mRNA

NCBI chr12:22,112,204...22,142,506
Ensembl chr12:16,998,538...17,013,506

Term paths to the root

Path 1
Term	Annotations
CHEBI ontology	19887
role	19858
biological role	19856
aetiopathogenetic role	19224
genotoxin	17672
mutagen	17586
benzo[b]fluoranthene	1533
Path 2
Term	Annotations
CHEBI ontology	19887
subatomic particle	19885
composite particle	19885
hadron	19885
baryon	19885
nucleon	19885
atomic nucleus	19885
atom	19885
main group element atom	19824
main group molecular entity	19824
s-block molecular entity	19658
hydrogen molecular entity	19640
hydrides	19145
organic hydride	18698
organic fundamental parent	18698
hydrocarbon	18446
cyclic hydrocarbon	17240
arene	17221
polycyclic arene	17041
ortho- and peri-fused polycyclic arene	16291
benzo[b]fluoranthene	1533

paths to the root